Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 95
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early prevention

  • Martínez Santos, Paula
  • Baldán Martín, Montserrat
  • López, Juan A.
  • Martín Lorenzo, Marta
  • Santiago Hernández, Aránzazu
  • Agudiez, Marta
  • Cabrera Sierra, Martha
  • Calvo, Eva
  • Vázquez, Jesús
  • Ruiz Hurtado, Gema
  • Vivanco, Fernando
  • Ruilope Urioste, Luis Miguel
  • Barderas, María G.
  • Álvarez Llamas, Gloria
Background and aims The predictive value of traditional CV risk calculators is limited. Novel indicators of CVD progression are needed particularly in the young population. The main aim of this study was the identification of a molecular profile with added value to classical CV risk estimation. Methods: Eighty-one subjects (30–50 years) were classified in 3 groups according to their CV risk: healthy subjects; individuals with CV risk factors; and those who had suffered a previous CV event. The urine proteome was quantitatively analyzed and significantly altered proteins were identified between patients' groups, either related to CV risk or established organ damage. Target-MS and ELISA were used for confirmation in independent patients’ cohorts. Systems Biology Analysis (SBA) was carried out to identify functional categories behind CVD. Results: 4309 proteins were identified, 75 of them differentially expressed. ADX, ECP, FETUB, GDF15, GUAD and NOTCH1 compose a fingerprint positively correlating with lifetime risk estimate (LTR QRISK). Best performance ROC curve was obtained when ECP, GDF15 and GUAD were combined (AUC = 0.96). SBA revealed oxidative stress response, dilated cardiomyopathy, signaling by Wnt and proteasome, as main functional processes related to CV risk. Conclusions: A novel urinary protein signature is shown, which correlates with CV risk estimation in young individuals. Pending further confirmation, this six-protein-panel could help in CV risk assessment.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Urine Haptoglobin and Haptoglobin-Related Protein Predict Response to Spironolactone in Patients With Resistant Hypertension

  • Martín Lorenzo, Marta
  • Martínez, Paula J.
  • Baldán Martín, Montserrat
  • López, Juan A.
  • Mínguez, Pablo
  • Santiago Hernández, Aránzazu
  • Vázquez, Jesús
  • Segura, Julián
  • Ruiz Hurtado, Gema
  • Vivanco, Fernando
  • Barderas, María G.
  • Ruilope Urioste, Luis Miguel
  • Álvarez Llamas, Gloria
Resistant hypertension prevalence is progressively increasing, and prolonged exposure to suboptimal blood pressure control results in higher cardiovascular risk and end-organ damage. Among various antihypertensive agents, spironolactone seems the most effective choice to treat resistant hypertension once triple therapy including a diuretic fails. However success in blood pressure control is not guaranteed, adverse effects are not negligible, and no clinical tools are available to predict patient’s response. Complementary to our previous study of resistant hypertension metabolism, here we investigated urinary proteome changes with potential capacity to predict response to spironolactone. Twenty-nine resistant hypertensives were included. A prospective study was conducted and basal urine was collected before spironolactone administration. Patients were classified in responders or nonresponders in terms of blood pressure control. Protein quantitation was performed by liquid chromatography–mass spectrometry; ELISA and target mass spectrometry analysis were performed for confirmation. Among 3310 identified proteins, HP (haptoglobin) and HPR (haptoglobin-related protein) showed the most significant variations, with increased levels in nonresponders compared with responders before drug administration (variation rate, 5.98 and 7.83, respectively). Protein-coordinated responses were also evaluated by functional enrichment analysis, finding oxidative stress, chronic inflammatory response, blood coagulation, complement activation, and regulation of focal adhesions as physiopathological mechanisms in resistant hypertension. In conclusion, protein changes able to predict patients’ response to spironolactone in basal urine were here identified for the first time. These data, once further confirmed, will support clinical decisions on patients’ management while contributing to optimize the rate of control of resistant hypertensives with spironolactone.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel genotype-phenotype correlations, differential cerebellar allele-specific methylation, and a common origin of the (ATTTC)n insertion in spinocerebellar ataxia type 37

  • Sanchez-Flores, Marina
  • Corral-Juan, Marc|||0000-0001-9407-7516
  • Gasch-Navalón, Esther|||0000-0003-1605-3951
  • Cirillo, Davide
  • Sanchez, Ivelisse|||0000-0002-7605-5337
  • Matilla-Dueñas, Antoni|||0000-0002-3514-4181
Spinocerebellar ataxia subtype 37 (SCA37) is a rare disease originally identified in ataxia patients from the Iberian Peninsula with a pure cerebellar syndrome. SCA37 patients carry a pathogenic intronic (ATTTC)n repeat insertion flanked by two polymorphic (ATTTT)n repeats in the Disabled-1 (DAB1) gene leading to cerebellar dysregulation. Herein, we determine the precise configuration of the pathogenic 5ʹ(ATTTT)n-(ATTTC)n-3ʹ(ATTTT)n SCA37 alleles by CRISPR-Cas9 and long-read nanopore sequencing, reveal their epigenomic signatures in SCA37 lymphocytes, fibroblasts, and cerebellar samples, and establish new molecular and clinical correlations. The 5ʹ(ATTTT)n-(ATTTC)n-3ʹ(ATTTT)n pathogenic allele configurations revealed repeat instability and differential methylation signatures. Disease age of onset negatively correlated with the (ATTTC)n, and positively correlated with the 3ʹ(ATTTT)n. Geographic origin and gender significantly correlated with age of onset. Furthermore, significant predictive regression models were obtained by machine learning for age of onset and disease evolution by considering gender, the (ATTTC)n, the 3ʹ(ATTTT)n, and seven CpG positions differentially methylated in SCA37 cerebellum. A common 964-kb genomic region spanning the (ATTTC)n insertion was identified in all SCA37 patients analysed from Portugal and Spain, evidencing a common origin of the SCA37 mutation in the Iberian Peninsula originating 859 years ago (95% CI 647-1378). In conclusion, we demonstrate an accurate determination of the size and configuration of the regulatory 5ʹ(ATTTT)n-(ATTTC)n-3ʹ(ATTTT)n repeat tract, avoiding PCR bias amplification using CRISPR/Cas9-enrichment and nanopore long-read sequencing, resulting relevant for accurate genetic diagnosis of SCA37. Moreover, we determine novel significant genotype-phenotype correlations in SCA37 and identify differential cerebellar allele-specific methylation signatures that may underlie DAB1 pathogenic dysregulation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission, a randomised placebo-controlled clinical trial of GETECCU

  • P. Gisbert, Javier|||0000-0003-2090-3445
  • Donday, María G.
  • Riestra, Sabino|||0000-0002-9383-3698
  • Lucendo, Alfredo J.|||0000-0003-1183-1072
  • Benítez, José Manuel|||0000-0001-8898-3141
  • Navarro-Llavat, Mercè|||0000-0002-1132-0427
  • Barrio, Jesús|||0000-0001-7087-3921
  • Morales-Alvarado, Víctor J.
  • Rivero, Montserrat|||0000-0002-5834-1559
  • Busquets, David|||0000-0002-9385-1415
  • Leo Carnerero, Eduardo|||0000-0002-1267-5211
  • Merino, Olga|||0000-0002-1362-4475
  • Nantes Castillejo, Óscar|||0000-0002-3587-1039
  • Navarro, Pablo|||0000-0001-6228-3462
  • Van Domselaar, Manuel|||0000-0002-9950-2216
  • Gutiérrez Casbas, Ana|||0000-0002-5460-4139
  • Alonso-Abreu, Inmaculada|||0000-0003-0406-029X
  • Mejuto, Rafael
  • Fernández-Salazar, Luis|||0000-0002-9951-7979
  • Iborra, Marisa|||0000-0001-7360-7581
  • Martín-Arranz, María Dolores|||0000-0002-1872-0917
  • Pineda, Juan Ramón
  • Sampedro, Manuela Josefa
  • Serra Nilsson, Katja
  • Bouhmidi, Abdel
  • Batista, Lissette
  • Muñoz-Villafranca, Carmen|||0000-0002-8060-8889
  • Rodríguez-Lago, Iago|||0000-0003-1133-4578
  • Ceballos, Daniel
  • Guerra, Iván|||0000-0002-5175-2515
  • Mañosa i Ciria, Míriam|||0000-0002-9051-2581
  • Marín Jiménez, Ignacio|||0000-0001-5424-2484
  • Torrella, Emilio
  • Vera Mendoza, Maribel
  • Casanova, María José|||0000-0001-8233-9638
  • de Francisco, Ruth|||0000-0001-8476-1672
  • Arias-González, Laura|||0000-0003-2132-9350
  • Marín Pedrosa, Sandra
  • García-Bosch, Orlando
  • García Alonso, Francisco Javier
  • Delgado-Guillena, Pedro|||0000-0002-5798-5491
  • García García, María José|||0000-0002-6517-7005
  • Torrealba, Leyanira|||0000-0002-3144-3408
  • Núñez Ortiz, Andrea
  • Vicuña Arregui, Miren
  • Bosca-Watts, Marta Maia|||0000-0001-7495-8797
  • Blázquez, Isabel|||0000-0003-2429-8174
  • Acosta, Diana|||0000-0001-8347-6642
  • Garre, Ana
  • Baldán, Montse|||0000-0003-0848-8154
  • Martínez, Concepción
  • Barreiro de-Acosta, Manuel|||0000-0001-5915-1477
  • Domènech, Eugeni|||0000-0002-2315-7196
  • Esteve, Maria|||0000-0001-7716-0027
  • García-Sánchez, Valle
  • Nos, Pilar|||0000-0002-6619-1511
  • Panés, Julián|||0000-0002-4971-6902
  • Chaparro, María|||0000-0002-9275-4242
  • Ramírez, Esther
  • Alvarez-Manceñido, Felipe
  • Sánchez-Casanueva, Tomás
  • Cárdenas Aranzana, Manuel J.
  • Gracia García, Berta
  • Caro-Patón, Tomás
  • Seguí Solanes, Carlos
  • Giménez Poderós, Teresa|||0000-0002-7611-7358
  • Castelló Nòria, Àngela
  • Villalba Moreno, Angela|||0000-0002-8658-120X
  • Bustinza Txertudi, Alazne
  • Aranda Alcántara, María
  • Guillot Yacyszyn, Verónica
  • Morales Martínez, Lorena
  • Gracia, Ángel
  • Virgós Aller, Tirso
  • Espino Paisán, Esther
  • Hernando Verdugo, Mercedes
  • Tordera, María
  • Cárdenas, Cristina
  • Sánchez Ulayar, Azhara
  • Ferrer-Artola, Anna|||0000-0003-0424-7353
  • Ventura López, Purificación
  • Loizaga Diaz, Irunne
  • Santos, Amaya
  • Amat López, Mireya
  • Hernández Musiesa, Belén
  • Quiñones Ribas, Carles|||0000-0003-2974-2086
  • Mur Mur, Ana
  • García Motos, Consuelo
  • Sánchez Guerrero, Amelia
Background and objectives: Primary objectives: to compare the rates of sustained clinical remission at 12 months in patients treated with antitumour necrosis factor (anti-TNF) and immunomodulators who withdraw anti-TNF treatment versus those who maintain it. Secondary objectives: to evaluate the effect of anti-TNF withdrawal on relapse-free time, endoscopic and radiological activity, safety, quality of life and work productivity; and to identify predictive factors for relapse. Design: Prospective, quadruple-blind, multicentre, randomised, controlled trial. Patients with ulcerative colitis or Crohn's disease in clinical remission for.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5

  • Gamez-Garcia, Andrés|||0000-0003-4927-3678
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Bueno-Costa, Alberto|||0000-0001-8700-2540
  • Alari Pahissa, Elisenda|||0000-0001-7424-5383
  • Marazuela-Duque, Anna
  • Thackray, Joshua K.|||0000-0003-2828-452X
  • Ray, Chandni
  • Berenguer Balaguer, Clara
  • Kumari, Poonam
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • Braun, Thomas|||0000-0002-6165-4804
  • Ianni, Alessandro|||0000-0001-7398-589X
  • Tischfield, Jay A.|||0000-0003-3217-8287
  • Serrano, Lourdes
  • Esteller, M.|||0000-0003-4490-6093
  • Sardina, José Luis|||0000-0002-8493-3937
  • De La Torre, Carolina
  • Sigvardsson, Mikael|||0000-0001-8527-7276
  • Vazquez Prat, Berta Nieves|||0000-0002-8164-3926
  • Vaquero, Alejandro|||0000-0002-8735-4156
B lymphopoiesis is orchestrated by lineage-specific transcription factors. In B cell progenitors, lineage commitment is mediated by Pax5, which is commonly mutated in B cell acute lymphoblastic leukemia. Despite its essential role in immunity, the mechanisms regulating Pax5 function remain largely unknown. Here, we found that the NAD-dependent enzyme SIRT7 coordinates B cell development through deacetylation of Pax5 at K198, which promotes Pax5 protein stability and transcriptional activity. Neither Pax5 deacetylated nor acetylated mimics rescued B cell differentiation in Pax5 pro-B cells, suggesting that B cell development requires Pax5 dynamic deacetylation. The Pax5 deacetylation mimic restored lineage commitment in Pax5 pro-B cells and B cell differentiation in Sirt7 pro-B cells, suggesting the uncoupling of differentiation from lineage commitment. The SIRT7-Pax5 interplay was conserved in B cell acute lymphoblastic leukemia, where SIRT7 expression correlated with good prognosis. Our findings reveal a crucial mechanism for B lymphopoiesis and highlight the relevance of sirtuins in immune function.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications, a systematic review and meta-analysis

  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Vázquez, Juan Carlos
  • Ullmo, Johana|||0000-0002-9313-917X
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Evidence on the impact of low-molecular-weight heparin, alone or in combination with low-dose aspirin, for the prevention for preeclampsia in high-risk patients is conflicting. Objective: We conducted a meta-analysis of studies published to assess the effectiveness of low-molecular-weight heparin for the prevention of preeclampsia and other placenta-related complications in high-risk women. Data Sources: A systematic search was performed to identify relevant studies, using the databases PubMed and Cochrane Central Register of Controlled Trials, without publication time restrictions. Study Eligibility Criteria: Randomized controlled trials comparing treatment with low-molecular-weight heparin or unfractionated heparin (with or without low-dose aspirin), in high-risk women, defined as either history of preeclampsia, intrauterine growth restriction, fetal demise, or miscarriage or being at high risk after first-trimester screening of preeclampsia. Study Appraisal and Synthesis Methods: The systematic review was conducted according to the Cochrane Handbook guidelines. The primary outcome was the development of preeclampsia. We performed prespecified subgroup analyses according to combination with low-dose aspirin, low-molecular-weight heparin type, gestational age when treatment was started, and study population (patients with thrombophilia, at high risk of preeclampsia or miscarriage). Secondary outcomes included small for gestational age, perinatal death, miscarriage, and placental abruption. Pooled odds ratios with 95% confidence intervals were calculated using a random-effects model. Quality of evidence was assessed using the grading of recommendations assessment, development, and evaluation methodology. Results: A total of 15 studies (2795 participants) were included. In high-risk women, treatment with low-molecular-weight heparin was associated with a reduction in the development of preeclampsia (odds ratio, 0.62; 95% confidence interval, 0.43-0.90; P=.010); small for gestational age (odds ratio, 0.61; 95% confidence interval, 0.44-0.85; P=.003), and perinatal death (odds ratio, 0.49; 95% confidence interval, 0.25-0.94; P=.030). This reduction was stronger if low-molecular-weight heparin was started before 16 weeks' gestation (13 studies, 2474 participants) for preeclampsia (odds ratio, 0.55; 95% confidence interval, 0.39-0.76; P=.0004). When only studies including low-dose aspirin as an intervention were analyzed (6 randomized controlled trials, 920 participants), a significant reduction was observed in those with combined treatment (low-molecular-weight heparin plus low-dose aspirin) compared with low-dose aspirin alone (odds ratio, 0.62; 95% confidence interval, 0.41-0.95; P=.030). Overall, adverse events were neither serious nor significantly different. Quality of evidence ranged from very low to moderate, mostly because of the lack of blinding, imprecision, and inconsistency. Conclusion: Low-molecular-weight heparin use was associated with a significant reduction in the risk of preeclampsia and other placenta-mediated complications in high-risk women and when treatment was started before 16 weeks' gestation. Combined treatment with low-dose aspirin was associated with a significant reduction in the risk of preeclampsia compared with low-dose aspirin alone. However, there exists important clinical and statistical heterogeneity, and therefore, these results merit confirmation in large well-designed clinical trials.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cardiovascular risk assessment in women at high risk for pre-eclampsia in first half of pregnancy

  • Ullmo, Johana|||0000-0002-9313-917X
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Bos-Real, L.|||0000-0002-6159-0644
  • Padilla-Lopez, Mireia|||0000-0002-4374-3870
  • Coma-Barbarà, Marina
  • Martorell, Silvia
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Women diagnosed with pre-eclampsia (PE), especially those with early-onset and severe forms, are at heightened risk of future cardiovascular disease (CVD). It is uncertain if women at high-risk for PE present cardiovascular impairment at the beginning of pregnancy. The aim of this study was to assess cardiovascular biomarkers and cardiac function in the first half of pregnancy in women at high-risk for PE. Methods: This was a prospective cohort study including women attending first trimester screening for PE. Risk of PE in the first trimester was calculated using a previously validated model, which includes maternal factors and biophysical markers. A cut-off of 1 in 250 was used to classify high-risk for developing PE. Maternal echocardiographic function and morphometry were evaluated, and peripheral blood samples were obtained to assess hematological and biochemical variables, including lipid profile and cardiovascular and angiogenic factors. Results: A total of 349 pregnant individuals were included; 257 at high-risk and 92 at low-risk for PE. Maternal echocardiography was performed at a mean ± SD gestational age of 14.9 ± 1.3 weeks and blood sampling at 16.3 ± 1.9 weeks. The high-risk PE group exhibited a significantly worse lipid profile (lower levels of high-density lipoproteins 69.7 ± 14.2 vs 74.0 ± 14.6 mg/dL, p=0.020), lower placental growth factor (0.89 ± 0.63 vs 1.15 ± 0.58 MoM, p<0.001), and significantly lower levels of N-terminal pro-brain natriuretic peptide (51.0 ± 2.1 vs 52.1 ± 2.0 ng/L, p=0.008). Echocardiographic evaluation indicated concentric remodeling, along with an altered diastolic pattern in the high-risk group. Conclusions: Women at high risk of developing PE exhibit differences in lipid profile, angiogenic factors, and echocardiographic parameters, indicative of cardiac maladaptation or impairment during the first half of pregnancy. These findings suggest a link between subclinical cardiovascular dysfunction, PE development and later CVD risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

  • Jiménez, Natalia|||0000-0002-7057-0426
  • Garcia de Herreros, Marta
  • Reig, Oscar|||0000-0003-1166-6943
  • Marín Aguilera, Mercedes
  • Aversa, Caterina
  • Ferrer-Mileo, Laura
  • García-Esteve, Samuel|||0000-0002-7680-2048
  • Rodríguez-Carunchio, Leonardo|||0000-0002-7019-554X
  • Trias, Isabel|||0000-0001-9841-4380
  • Font, Albert|||0000-0003-3908-1111
  • Rodriguez-Vida, Alejo|||0000-0002-7304-6857
  • Climent, Miguel Ángel|||0000-0001-7523-0212
  • Cros Costa, Sara|||0000-0001-8279-784X
  • Chirivella, Isabel|||0000-0002-0733-3276
  • Domènech, Montserrat|||0000-0003-3973-0986
  • Figols, Mariona
  • Carles, Joan|||0000-0002-9983-5934
  • Suárez, Cristina|||0000-0002-0502-5528
  • Herrero Rivera, Daniel
  • Gonzalez-Billalabeitia, Enrique|||0000-0003-3143-3143
  • Cívico, Claudia
  • Sala-González, Núria
  • Ruiz de Porras, Vicenç|||0000-0002-4352-1784
  • Ribal, María J.|||0000-0001-8142-5382
  • Prat, Aleix|||0000-0003-2377-540X
  • Mellado, Begoña|||0000-0002-8088-5966
BACKGROUND: Androgen deprivation therapy (ADT) with docetaxel (D) and/or antiandrogen receptor therapies (ARTs) are the standard therapies in metastatic hormone-sensitive prostate cancer (mHSPC). Alterations in the tumor suppressor genes (TSGs) RB1, PTEN, and TP53 are associated with an aggressive evolution and treatment resistance in castration-resistant prostate cancer (CRPC). OBJECTIVE: To study the clinical implications of TSG mRNA expression in mHSPC patients. DESIGN, SETTING, AND PARTICIPANTS: This is a multicenter retrospective biomarker study in mHSPC patients. TSGlow status was defined when two or more out of the three TSGs presented low RNA expression by nCounter in formalin-fixed paraffin-embedded samples and TSGwt for the remaining cases. The microarray data from the CHAARTED trial were analyzed as an independent validation cohort. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Molecular data were correlated with CRPC-free survival (CRPC-FS) and overall survival (OS) by the Kaplan-Meier method and multivariate Cox analysis. RESULTS AND LIMITATIONS: A total of 226 patients were included, of whom 218 were eligible: 93 were treated with ADT and 125 with ADT + D; 75.7% presented de novo stage IV and 67.9% high-volume disease. TSGlow (19.2%) was independently correlated with shorter CRPC-FS (hazard ratio [HR] 1.8, p = 0.002) and OS (HR 2, p = 0.002). In the CHAARTED trial, TSGlow was independently correlated with lower CRPC-FS (HR 2.2, p = 0.02); no differences in clinical outcomes according to treatment were observed in TSGlow patients, while a significant benefit was observed for ADT + D in the TSGwt group for CRPC-FS (HR 0.4, p < 0.001) and OS (HR 0.4, p = 0.001). However, no interaction was observed between TSG signature and treatment in either series. Study limitations are the retrospective design, small sample size, and lack of inclusion of patients treated with ADT + ART. CONCLUSIONS: TSGlow expression correlates with adverse outcomes in patients with mHSPC. The investigation of new therapeutic strategies in these patients is warranted. PATIENT SUMMARY: The low RNA expression of tumor suppressor genes in the tumors is correlated with adverse outcomes in patients with metastatic hormone-sensitive prostate cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment

  • Cabrero-de las Heras, Sara|||0000-0002-9364-5371
  • Hernández-Yagüe, Xavier|||0000-0002-3742-1218
  • González Valencia, Andrea|||0009-0005-4236-0199
  • Losa, Ferran|||0000-0003-0111-8708
  • Soler, Gemma
  • Bugés, Cristina|||0000-0003-2013-1510
  • Baraibar, Iosune|||0000-0002-3500-9641
  • Esteve, Anna|||0000-0002-1962-971X
  • Pardo-Cea, Miguel Ángel|||0000-0003-4823-6613
  • Ree, Anne Hansen
  • Martínez Bosch, Neus|||0000-0003-3596-0039
  • Nieva, Maria
  • Musulén, Eva|||0000-0002-9667-6464
  • Meltzer, Sebastian
  • Lobato, Tania
  • Vendrell-Ayats, Carla|||0009-0000-2740-0918
  • Queralt, C|||0000-0001-9875-0173
  • Navarro, Pilar|||0000-0003-4314-4584
  • Montagut Viladot, Clara|||0000-0003-1438-2903
  • Grau-Leal, Ferran|||0000-0003-3072-2250
  • Camacho Martín, David
  • Legido, Raquel
  • Mulet-Margalef, Nuria|||0000-0002-2385-6448
  • Martínez Balibrea, Eva|||0000-0002-4501-7100
Metastatic colorectal cancer (mCRC) currently lacks reliable biomarkers for precision medicine, particularly for chemotherapy-based treatments. This study examines the behavior of 11 CXC chemokines in the blood of 104 mCRC patients undergoing first-line oxaliplatin-based treatment to pinpoint predictive and prognostic markers. Serum samples were collected before treatment, at response evaluation (EVAR), and at disease progression or last follow-up. Chemokines were assessed in all samples using a Luminex® custom panel. CXCL13 levels increased at EVAR in responders, while in non-responders it decreased. Increasing levels of CXCL13 at EVAR, independently correlated with improved progression-free survival (PFS) and overall survival (OS). Nanostring® analysis in primary tumor samples showed CXCL13 gene expression's positive correlation not only with gene profiles related to an immunogenic tumor microenvironment, increased B cells and T cells (mainly CD8+) but also with extended OS. In silico analysis using RNAseq data from liver metastases treated or not with neoadjuvant oxaliplatin-based combinations, and deconvolution analysis using the MCP-counter algorithm, confirmed CXCL13 gene expression's association with increased immune infiltration, improved OS, and Tertiary Lymphoid Structures (TLSs) gene signatures, especially in neoadjuvant-treated patients. CXCL13 analysis in serum from 36 oxaliplatin-treated patients from the METIMMOX study control arm, reported similar findings. In conclusion, the increase of CXCL13 levels in peripheral blood and its association with the formation of TLSs within the metastatic lesions, emerges as a potential biomarker indicative of the therapeutic efficacy in mCRC patients undergoing oxaliplatin-based treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biological processes modulating longevity across primates, A phylogenetic genome-phenome analysis

  • Muntané, Gerard|||0000-0003-1541-8365
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Rodriguez, Juan Antonio|||0000-0001-5195-315X
  • Pegueroles Queralt, Maria Cinta|||0000-0003-0701-9866
  • Hughes, David A.
  • de Magalhaes, Joao Pedro|||0000-0002-6363-2465
  • Gabaldón, Toni|||0000-0003-0019-1735
  • Navarro, Arcadi|||0000-0003-2162-8246
Aging is a complex process affecting different species and individuals in different ways. Comparing genetic variation across species with their aging phenotypes will help understanding the molecular basis of aging and longevity. Although most studies on aging have so far focused on short-lived model organisms, recent comparisons of genomic, transcriptomic, and metabolomic data across lineages with different lifespans are unveiling molecular signatures associated with longevity. Here, we examine the relationship between genomic variation and maximum lifespan across primate species. We used two different approaches. First, we searched for parallel amino-acid mutations that co-occur with increases in longevity across the primate linage. Twenty-five such amino-acid variants were identified, several of which have been previously reported by studies with different experimental setups and in different model organisms. The genes harboring these mutations are mainly enriched in functional categories such as wound healing, blood coagulation, and cardiovascular disorders. We demonstrate that these pathways are highly enriched for pleiotropic effects, as predicted by the antagonistic pleiotropy theory of aging. A second approach was focused on changes in rates of protein evolution across the primate phylogeny. Using the phylogenetic generalized least squares, we show that some genes exhibit strong correlations between their evolutionary rates and longevity-associated traits. These include genes in the Sphingosine 1-phosphate pathway, PI3K signaling, and the Thrombin/protease-activated receptor pathway, among other cardiovascular processes. Together, these results shed light into human senescence patterns and underscore the power of comparative genomics to identify pathways related to aging and longevity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ophthalmic artery Doppler and carotid intima-media thickness 3-6 years postpartum in women with and without a history of placental insufficiency

  • García Manau, Pablo|||0000-0002-2415-1626
  • Platero, Judit|||0000-0001-6007-9855
  • Costa, Noah
  • Garcia, Zoraida
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Pellicer, Claudia
  • Ullmo, Johana|||0000-0002-9313-917X
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Jordi, Mariona
  • Choliz, Marta
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Trilla, Cristina|||0000-0002-5650-1790
  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Llurba, Elisa|||0000-0003-4048-6407
Preeclampsia and fetal growth restriction, which are clinical presentations of placental dysfunction, are frequently associated with angiogenic imbalance during pregnancy and increased long-term cardiovascular risk. Whether this risk is driven by the pre-pregnancy risk factors, clinical disease, or by an elevated sFlt-1/PlGF ratio remains unclear. This study aimed to assess the association between vascular assessments (ophthalmic artery Doppler and carotid intima-media thickness) 3-6 years postpartum and a history of preeclampsia and fetal growth restriction, and to evaluate if associations were impacted by an angiogenic imbalance during pregnancy. This was a cross-sectional study, which included individuals prospectively recruited during their index pregnancy between 2018 and 2021 and re-evaluated 3-6 years postpartum. Preeclampsia, fetal growth restriction, and sFlt-1/PlGF values were defined from pregnancy data. Postpartum assessment included ophthalmic artery Doppler and carotid intima-media thickness performed by a single operator. Multivariable linear regression models assessed associations between placental dysfunction, angiogenic imbalance, and vascular parameters, adjusting for maternal covariates. 354 participants were included, 148 with and 206 without a history of preeclampsia or fetal growth restriction. Both placental dysfunction and angiogenic imbalance during pregnancy were independently associated with a significantly higher ophthalmic artery peak systolic velocity ratio 3-6 years postpartum. Participants with a history of placental dysfunction showed higher values compared to those without [0.75 (0.67-0.81) vs. 0.69 (0.63-0.78), p = 0.03], as did those with an elevated sFlt-1/PlGF ratio during pregnancy [0.76 (0.66-0.82) vs. 0.70 (0.64-0.78), p = 0.03]. The highest values were observed in women who had experienced both conditions. When preeclampsia and fetal growth restriction were analyzed separately, the association remained significant for preeclampsia, whereas in the fetal growth restriction group, a significant difference was observed only in the right eye. No statistically significant differences were observed in carotid intima-media thickness. Both a history of angiogenic imbalance and a clinical placental dysfunction presentation (particularly preeclampsia) during pregnancy were associated with increased ophthalmic artery peak systolic velocity ratio 3-6 years postpartum, whereas carotid intima-media thickness did not differ between the study groups. Both angiogenic imbalance and a history of placental dysfunction during pregnancy are associated with increased ophthalmic artery peak systolic velocity ratio 3-6 years postpartum, especially in cases where clinical disease (particularly preeclampsia) develops.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-Term Biochemical and Cardiovascular Profiles 3-6 Years After Preeclampsia, Impact of Angiogenic Imbalance During Pregnancy

  • Costa, Noah
  • Platero, Judit|||0000-0001-6007-9855
  • García Manau, Pablo|||0000-0002-2415-1626
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Jordi, Mariona
  • García Ruiz, Zoraida|||0009-0009-4631-763X
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Ullmo, Johana|||0000-0002-9313-917X
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Choliz, Marta
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
  • Pellicer, Claudia
  • Medina Mallen, Maria del Carmen|||0000-0002-1219-5947
Background/Objectives: Preeclampsia is associated with long-term cardiovascular and metabolic risks. This study aimed to evaluate metabolic and cardiovascular biochemical profiles in women with a history of preeclampsia and angiogenic imbalance during pregnancy. Methods: We conducted a cross-sectional study at Hospital de la Santa Creu i Sant Pau between August 2023 and July 2025. Participants had been prospectively enrolled during pregnancy (2018-2022) and were re-evaluated 3 to 6 years later. Blood and urine samples were collected after a 12-h fast to assess hematological, metabolic, and cardiovascular markers. Angiogenic profiles were determined using sFlt-1/PlGF ratios obtained during pregnancy. Multivariable linear regression models were used to assess associations with a history of PE and angiogenic imbalance, adjusting for relevant confounders. Results: 363 participants were included. 113 (31.1%) had a history of preeclampsia. Women with previous preeclampsia showed slightly higher high-sensitivity troponin T concentrations [4.0 (3.0-6.0) ng/L vs. 3.2 (3.0-5.0) ng/L, p = 0.03]. Women with sFlt-1/PlGF ≥38 exhibited significantly higher urinary protein [0.09 (0.07-0.18) g/L vs. 0.08 (0.07-0.13) g/L, p = 0.01], potassium [4.25 (4.07-4.40) mmol/L vs. 4.19 (4.02-4.37) mmol/L, p = 0.048], and LDH concentrations [168 (150-189) U/L vs. 163 (149-177) U/L, p = 0.046], and lower leukocyte counts [6150 (5348-7055) vs. 6250 (5430-7450) U/mL, p = 0.03]. Conclusions: Women with angiogenic imbalance during pregnancy display subtle alterations in renal and endothelial function markers years after delivery, whereas those with preeclampsia show slightly higher troponin concentrations. These findings, though clinically irrelevant, suggest that pregnancy-related vascular dysfunction may have different long-term manifestations depending on whether the maternal cardiovascular system was sufficiently compromised to develop overt preeclampsia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Role of Antigen Carbohydrate 125 in Modulating Soluble ST2, Prognostic-Related Effects in Acute Heart Failure

  • Martí-Martínez, Arancha
  • Núñez, Julio|||0000-0003-1672-7119
  • López Escribano, Herminio
  • Revuelta-López, Elena|||0000-0001-8962-5936
  • Mollar, Anna
  • Peiró, Marta
  • Sanchis, Juan|||0000-0003-0797-8709
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Carratala, Arturo|||0000-0003-4513-7214
  • Miró, Oscar|||0000-0002-7924-9751
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
Background: Acute heart failure (AHF) is a complex syndrome associated with high mortality and hospital readmissions, characterized by volume overload and inflammation. Soluble ST2 (sST2) and antigen carbohydrate 125 (CA125) are emerging biomarkers that reflect these processes and may interact to influence long-term outcomes in AHF patients. This study aims to examine the prognostic relationship between sST2 and CA125 in predicting mortality and heart failure (HF)-related hospitalizations in patients with decompensated heart failure. Methods: In a cohort of 635 patients with AHF, we investigated whether the prognostic value of sST2 varies according to CA125 levels (≤35 vs. >35 U/mL). The endpoints were: (a) time to all-cause death, and (b) the combination of time to death or new HF admission. Results: This study of EAHFE registry data shows that the association between sST2 and long-term adverse outcomes (mortality and HF hospitalizations) in patients with AHF was differentially influenced by CA125 concentrations (p-value for interactions = 0.031 and 0.029, respectively). Higher sST2 was associated with the risk of death and the combined risk of death/HF readmission when CA125 was >35 U/mL [HR = 1.02 (CI 95%: 1.01-1.04), p = 0.006 and 1.02 (CI 95%: 1.01-1.03); p = 0.013 per increase in 10 ng/mL, respectively], but not when CA125 was ≤35 U/mL. Conclusions: This study highlights the prognostic interaction between sST2 and CA125 in AHF. Elevated sST2 predicts poor outcomes mainly in patients with high CA125 levels (>35 U/mL), suggesting CA125's role in modulating inflammatory activity in HF. Further research is needed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications

  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Universitat Autònoma de Barcelona.
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Platero, Judit|||0000-0001-6007-9855
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • García Manau, Pablo|||0000-0002-2415-1626
  • Ullmo, Johana|||0000-0002-9313-917X
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Vila-Cortés, M.
  • Pelegay, M. J.
  • Ricart, M
  • Muñoz-Abellana, B.
  • Barrios, X. Gabaldó
Objective: A soluble fms-like tyrosine kinase-1 (sFlt-1)-to-placental growth factor (PlGF) ratio cut-off of 38 is currently considered optimal for ruling out pre-eclampsia (PE); however, implementation of this ratio in clinical practice is limited. N-terminal pro B-type natriuretic peptide (NT-proBNP) is elevated in PE owing to the cardiovascular effects of this disease. This study aimed to identify the predictive performance of NT-proBNP to detect PE and placental complications within 1 week after assessment, and compare it with the predictive performance of the sFlt-1/PlGF ratio. High-sensitivity troponin T (hs-TnT) and uric acid were also evaluated. Methods: This was a prospective nested case-control study conducted in five Spanish centers between March 2018 and December 2020, and comprised women with a singleton pregnancy and suspected PE between 24 + 0 and 41 + 0 weeks' gestation. We evaluated the ability of the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid to predict the development of any-onset (at any gestational age), early-onset (before 34 weeks) or term (at or after 37 weeks) PE within 1 week or 4 weeks after assessment. Predictive performance was assessed by estimating negative predictive values, positive predictive values, sensitivity, specificity and areas under the receiver-operating-characteristics curves (AUCs) for these biomarkers, with corresponding 95% CIs. We performed post-hoc exploratory analyses of associations between the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid in women who developed PE, as well as in women who developed complicated PE (PE plus fetal growth restriction, stillbirth or placental abruption) within 1 week and 4 weeks after assessment. Results: A total of 323 women with suspected PE at or before 41 + 0 weeks were enrolled in the study, of whom seven were lost to follow-up. The final analysis included 316 eligible participants, with 424 samples. The overall incidence of PE was 23.4% (n = 74) and early-onset PE developed in 8.5% (n = 27) of cases. The sFlt-1/PlGF ratio and NT-proBNP exhibited similar abilities to predict early-onset PE within 1 week after assessment (AUC, 0.970 (95% CI, 0.932-1.000) and 0.971 (95% CI, 0.942-1.000), respectively). hs-TnT and uric acid demonstrated inferior predictive capability compared with the sFlt-1/PlGF ratio for the prediction of any-onset PE, early-onset PE and term PE within 1 week and 4 weeks after assessment. The optimal cut-off for NT-proBNP was 116 pg/mL. At this cut-off, NT-proBNP showed a sensitivity of 90.9% (95% CI, 70.8-98.9%) and a specificity of 94.3% (95% CI, 91.2-96.5%), with a positive predictive value of 5.7% (95% CI, 3.7-8.7%) and a negative predictive value of 99.9% (95% CI, 99.9-100%) in predicting early-onset PE within 1 week of assessment, which was comparable with that of the sFlt-1/PlGF ratio. Participants with PE-related complications had higher levels of all biomarkers, but only NT-proBNP showed a similar predictive ability to the sFlt-1/PlGF ratio for complicated PE within 1 week after assessment (AUC, 0.818 (95% CI, 0.706-0.930) vs 0.822 (95% CI, 0.723-0.921), respectively). Conclusion: An NT-proBNP cut-off value of 116 pg/mL has a similar diagnostic performance to that of the sFlt-1/PlGF ratio in predicting the diagnosis of early-onset PE within 1 week after assessment. Thus, NT-proBNP could be used in clinical practice for the early identification and management of PE, particularly in cases for which the sFlt-1/PlGF ratio is not available. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
Repisalud
Publicación Artículo científico (JournalArticle)

IL7RA rs10491434 polymorphism is related to spontaneous HIV infection control in naïve HIV-infected patients: A retrospective study.

  • Sepulveda-Crespo, Daniel
  • Jimenez-Sousa, Maria Angeles
  • Fernandez-Rodriguez, Amanda
  • Muñoz-Fernández, María A
  • Jiménez, José L
  • Caraciolo, Begoña B
  • Reus Bañuls, Sergio
  • Vilchez, Helem
  • Mothe, Beatriz
  • Martinez, Isidoro
  • Benito, José M
  • Rallón, Norma
  • Resino, Salvador
Interleukin 7 receptor (IL7R) is vital in the adaptive immune response against human immunodeficiency viruses (HIV). We assessed IL7RA polymorphisms (SNPs) in antiretroviral therapy (ART)-naïve HIV patients for their association with spontaneous HIV infection control. We conducted a retrospective cohort study involving 667 ART-naïve patients categorized by HIV progression (ordinal variable): 150 rapid progressors, 334 moderate/typical progressors, 86 long-term nonprogressors elite controllers (LTNPs-EC), and 97 LTNPs-non-EC. We genotyped three IL7RA SNPs using Agena Bioscience's MassARRAY platform. The association between IL7RA SNPs and spontaneous HIV infection control was evaluated using ordinal logistic regression. Individuals carrying the rs10491434 G allele have a higher likelihood of spontaneous HIV infection control (adjusted odds ratio [aOR] = 1.33; p = 0.023). Moreover, the IL7RA GCT haplotype, consisting of three specific SNPs (rs6897932, rs987106, and rs10491434), demonstrated an association with the control of untreated HIV infection (aOR = 1.34; p = 0.050). Remarkably, the rs10491434 SNP and the IL7RA GCT haplotype exhibited similar aOR values, suggesting that rs10491434 may be primarily responsible for the observed effect of the haplotype. IL7RA rs10491434 G allele is associated with a higher likelihood of spontaneous HIV infection control, indicating its significant role in the pathogenesis of HIV, possibly influencing infection course and viral replication control.
Repisalud
Publicación Artículo científico (JournalArticle)

IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study.

  • Sepulveda-Crespo, Daniel
  • Jimenez-Sousa, Maria Angeles
  • Fernandez-Rodriguez, Amanda
  • Muñoz-Fernández, María A
  • Jiménez, José Luis
  • Moreno, Santiago
  • Garcia, Felipe
  • Martinez, Isidoro
  • Benito, José M
  • Rallón, Norma
  • Resino, Salvador
IRF5-TNPO3 polymorphisms have previously been related to immune response, and TNPO3 plays a role in human immunodeficiency virus (HIV)-1 infection after nuclear import. Therefore, we analyzed the genetic association between IRF5-TNPO3 polymorphisms and the HIV elite control in long-term nonprogressors (LTNPs). We performed a retrospective cohort study on 183 LTNPs, who were antiretroviral therapy-naïve with CD4  ≥ 500 cells/mm , viral load ≤10 000 copies/mL, and asymptomatic over 10 years after HIV seroconversion. The primary outcome variable was HIV elite control (undetectable viral load in at least 90% of the measurements for at least 1 year). Seven IRF5-TNPO3 polymorphisms were genotyped using Agena Bioscience's MassARRAY platform. We found a significant association between specific IRF5-TNPO3 genotypes and HIV elite control: rs2004640 TT (aOR = 2.05; p = 0.041), rs10954213 AA (aOR = 1.95; p = 0.035), rs2280714 TT (aOR = 2.02; p = 0.031), and rs10279821 CC (aOR = 2.12; p = 0.017). We also found a significant association between IRF5-TNPO3 haplotype TATC composed of the favorable significant polymorphisms (rs2004640, rs10954213, rs2280714, and rs10279821) and the HIV elite control (aOR = 1.59; p = 0.048). IRF5-TNPO3 rs2004640, rs10954213, rs2280714, and rs10279821 polymorphisms were related to HIV elite control in LTNPs. Our data provide new knowledge about the impact of IRF5-TNPO3 polymorphisms on HIV pathogenesis to understand the phenomenon of natural HIV control.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure

  • Mollar, Anna
  • Garcia-Conejo, Celia
  • Revuelta-Lopez, Elena
  • Cardells, Ingrid
  • Lopez, Raquel
  • Canto Serrano, Irene Del
  • de la Espriella, Rafael
  • Lopez-Lereu, Maria P.
  • Monmeneu, Jose Vicente
  • Maceira, Alicia
  • Lakhal-Littleton, Samira
  • Almenar, Luis
  • Cases, Aleix
  • Peiro, Marta
  • Bayes Genis, Antonio
[EN] Iron deficiency (ID) treated with ferric carboxymaltose (FCM) previously showed reduced platelet count; however, no studies have evaluated its biological significance in heart failure. In the current study, we aimed to: (a) assess the changes in platelet count at 7 and 30 days post-FCM, and (b) explore its association with non-invasive surrogates of myocardial iron uptake and left systolic function in patients with ID and heart failure with left ventricular ejection fraction < 50% (HFrEF and HFmrEF). This post-hoc analysis of a randomized, double-blind, FCM vs. placebo clinical trial (Myocardial-IRON Trail) involved 45 outpatients with HFrEF and HFmrEF and ID in which the platelet count value was available. Platelet count, cardiac magnetic resonance T1-mapping and 3D-global longitudinal strain (CMR-GLS) were assessed at baseline, 7, and 30 days. Linear regression models were used to evaluate the between-treatment differences and endpoints. The mean (SD) age was 71 +/- 8 years, and 32 (71%) were men. At 30 days, we found a significant reduction in platelet count in those treated with FCM (p-value = 0.027). In those treated with FCM, the greater 30-day decrease in platelets showed lower 30-day changes in T1-mapping (p = 0.024) and CMR-GLS (p = 0.028). After administration of FCM, we found a significant 30-day reduction in platelet count. The greater platelet count reduction was related to lower myocardial iron repletion and a smaller improvement in left ventricular systolic function., This work was supported in part by an unrestricted grant from Vifor Pharma, CIBER Cardiovascular [grant numbers 16/11/00420 and 16/11/00403], Unidad de Investigacion Clinica y Ensayos Clinicos INCLIVA Health Research Institute, Spanish Clinical Research Network (SCReN; PT13/0002/0031 and PT17/0017/0003), cofounded by Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III, and Proyectos de Investigacion de la Seccion de Insuficiencia Cardiaca 2017 from the Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Preparation of monolithic polymer-magnetite nanoparticle composites into poly(ethylene-co-tetrafluoroethylene) tubes for uses in micro-bore HPLC separation and extraction of phosphorylated compounds

  • Torres-Cartas, Sagrario|||0000-0002-5139-7891
  • Meseguer-Lloret, S.|||0000-0001-5726-032X
  • Gómez Benito, Carmen|||0000-0003-0964-6476
  • Catalá-Icardo, Mónica|||0000-0001-5897-8501
  • Simo-Alfonso, Ernesto F.
  • Herrero-Martínez, José Manuel
[EN] This paper describes the fabrication of a novel microbore monolithic column modified with magnetite nanoparticles (MNPs) prepared in a poly(ethylene-co-tetrafluoroethylene) (EFTE) tubing, and its application as stationary phase for the chromatographic separation of phosphorylated compounds. In order to obtain the composite column, a two-step procedure was performed. The formation of a glycidyl methacrylate-based monolith inside the activated ETFE tube was firstly carried out. Then, two incorporation approaches of MNPs in monoliths were investigated. The generic polymer was modified with 3-aminopropyltrimethoxysilane (APTMS) to be subsequently attached to MNP surfaces. Alternatively, APTMS-coated MNPs were firstly prepared and subsequently used for attachment onto the monolith surface through reaction of epoxy groups present in the generic monolith. This last strategy gave a reproducible layer of MNPs coated onto the polymer monolith as well as robust and permeable chromatographic columns. The retention behaviour of this MNP-based composite monolithic column was studied by using small phosphorylated compounds (adenosine phosphates). It was found that the retention of model analytes was ruled by partitioning and adsorption HILIC mechanisms. The columns also exhibited satisfactory performance in the separation of these target compounds, showing good chromatographic behaviour after two months of continued use. These composite monolithic columns were also successfully applied to the extraction of a tryptic digest of beta-casein., This work was supported by project RTI2018-095536-B-I00 (Ministry of Science, Innovation and Universities, Spain). The proteomic analysis was performed in the proteomics facility of SCSIE (University of Valencia) that belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001 (Instituto de Carlos III, Spain). The authors also thank Dr. Luz Valero-Rustarazo for her assistance in proteomic analysis and data treatment
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Clinical information modeling processes for semantic interoperability of electronic health records: systematic review and inductive analysis

  • Moreno-Conde, Alberto
  • Moner Cano, David
  • Da Cruz, Wellington Dimas
  • Santos, Marcelo R.
  • Maldonado Segura, José Alberto
  • Robles Viejo, Montserrat
  • Kalra, Dipak
[EN] [Objective] This systematic review aims to identify and compare the existing processes and methodologies that have been published in the literature for defining clinical information models (CIMs) that support the semantic interoperability of electronic health record (EHR) systems. [Material and Methods] Following the preferred reporting items for systematic reviews and meta-analyses systematic review methodology, the authors reviewed published papers between 2000 and 2013 that covered that semantic interoperability of EHRs, found by searching the PubMed, IEEE Xplore, and ScienceDirect databases. Additionally, after selection of a final group of articles, an inductive content analysis was done to summarize the steps and methodologies followed in order to build CIMs described in those articles. [Results] Three hundred and seventy-eight articles were screened and thirty six were selected for full review. The articles selected for full review were analyzed to extract relevant information for the analysis and characterized according to the steps the authors had followed for clinical information modeling. [Discussion] Most of the reviewed papers lack a detailed description of the modeling methodologies used to create CIMs. A representative example is the lack of description related to the definition of terminology bindings and the publication of the generated models. However, this systematic review confirms that most clinical information modeling activities follow very similar steps for the definition of CIMs. Having a robust and shared methodology could improve their correctness, reliability, and quality. [Conclusion] Independently of implementation technologies and standards, it is possible to find common patterns in methods for developing CIMs, suggesting the viability of defining a unified good practice methodology to be used by any clinical information modeler., This research has been partially funded by the Instituto de Salud Carlos III (Platform for Innovation in Medical Technologies and Health), grant PT13/0006/0036 and the Spanish Ministry of Economy and Competitiveness, grants TIN2010-21388-C02-01 and PTQ-12-05620.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Function of glutathione peroxidases in legume root nodules

  • Matamoros, Manuel A.
  • SAIZ ANDRES, ANA
  • Peñuelas, Maria
  • Bustos-Sanmamed, Pilar
  • Barja, Maria V.
  • Rouhier, Nicolas
  • Moore, Marten
  • James, Euan K.
  • Dietz, Karl-Josef
  • Becana, Manuel
  • Mulet, José Miguel|||0000-0002-9087-3838
[EN] Glutathione peroxidases (Gpxs) are antioxidant enzymes not studied so far in legume nodules, despite the fact that reactive oxygen species are produced at different steps of the symbiosis. The function of two Gpxs that are highly expressed in nodules of the model legume Lotus japonicus was examined. Gene expression analysis, enzymatic and nitrosylation assays, yeast cell complementation, in situ mRNA hybridization, immunoelectron microscopy, and LjGpx-green fluorescent protein (GFP) fusions were used to characterize the enzymes and to localize each transcript and isoform in nodules. The LjGpx1 and LjGpx3 genes encode thioredoxin-dependent phospholipid hydroperoxidases and are differentially regulated in response to nitric oxide (NO) and hormones. LjGpx1 and LjGpx3 are nitrosylated in vitro or in plants treated with S-nitrosoglutathione (GSNO). Consistent with the modification of the peroxidatic cysteine of LjGpx3, in vitro assays demonstrated that this modification results in enzyme inhibition. The enzymes are highly expressed in the infected zone, but the LjGpx3 mRNA is also detected in the cortex and vascular bundles. LjGpx1 is localized to the plastids and nuclei, and LjGpx3 to the cytosol and endoplasmic reticulum. Based on yeast complementation experiments, both enzymes protect against oxidative stress, salt stress, and membrane damage. It is concluded that both LjGpxs perform major antioxidative functions in nodules, preventing lipid peroxidation and other oxidative processes at different subcellular sites of vascular and infected cells. The enzymes are probably involved in hormone and NO signalling, and may be regulated through nitrosylation of the peroxidatic cysteine essential for catalytic function., AS and PBS were the recipients of predoctoral (Formacion de Personal Investigador) and postdoctoral (Marie Curie) contracts, respectively. We thank Martin Crespi for help with in situ RNA hybridization and Simon Avery for sharing the yeast mutant and for helpful advice. This work was supported by Ministerio de Economia y Competitividad-Fondo Europeo de Desarrollo Regional (AGL2011-24524 and AGL2014-53717-R). The UMR1136 is supported by a grant overseen by the French National Research Agency (ANR) as part of the 'Investissements d'Avenir' programme (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). MM and KJD acknowledge support within SPP1710. The proteomic analysis was performed in the CSIC/UAB Proteomics Facility of IIBB-CSIC that belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Photogeneration of Quinone Methides as Latent Electrophiles for Lysine Targeting

  • Pérez-Ruiz, Raúl|||0000-0003-1136-3598
  • Jiménez, M Consuelo|||0000-0002-8057-4316
  • Molins-Molina, Oscar
  • Lence, Emilio
  • González-Bello, Concepción
  • Miranda Alonso, Miguel Ángel
[EN] Latent electrophiles are nowadays very attractive chemical entities for drug discovery, as they are unreactive unless activated upon binding with the specific target. In this work, the utility of 4-trifluoromethyl phenols as precursors of latent electrophiles, quinone methides (QM), for lysine-targeting is demonstrated. These Michael acceptors were photogenerated for specific covalent modification of lysine residues using human serum albumin (HSA) as a model target. The reactive QM-type intermediates I or II, generated upon irradiation of 4-trifluoromethyl-1-naphthol (1)@HSA or 4-(4-trifluorometylphenyl)phenol (2)@HSA complexes, exhibited chemoselective reactivity toward lysine residues leading to amide adducts, which was confirmed by proteomic analysis. For ligand 1, the covalent modification of residues Lys106 and Lys414 (located in subdomains IA and IIIA, respectively) was observed, whereas for ligand 2, the modification of Lys195 (in subdomain IIA) took place. Docking and molecular dynamics simulation studies provided an insight into the molecular basis of the selectivity of 1 and 2 for these HSA subdomains and the covalent modification mechanism. These studies open the opportunity of performing protein silencing by generating reactive ligands under very mild conditions (irradiation) for specific covalent modification of hidden lysine residues., Financial support from the Spanish Ministry of Economy and Competiveness [CTQ2016-78875-P, SAF2016-75638-R and BES-2014-069404 (predoctoral fellowship to O.M.-M.)], the Generalitat Valenciana (PROMETEO/2017/075), the Community of Madrid (2016-T1/AMB-1275), the Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation 2016-2019, ED431G/09 and postdoctoral fellowship to E.L.), and the European Union (European Regional Development Fund, ERDF) is gratefully acknowledged. The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia that belongs to ProteoRed PRB2-ISCIII and is supported by grant PT13/0001, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER. We are grateful to the Centro de Supercomputacion de Galicia (CESGA) for use of the Finis Terrae computer.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Mapping a protein recognition centre with chiral photoactive ligands. An integrated approach combining photophysics, reactivity, proteomics and molecular dynamics simulation studies

  • Limones-Herrero, Daniel
  • Lence, Emilio
  • Gonzalez-Bello, Concepcion
  • Miranda Alonso, Miguel Ángel
  • Pérez-Ruiz, Raúl|||0000-0003-1136-3598
  • Jiménez, M Consuelo|||0000-0002-8057-4316
[EN] A multidisciplinary strategy to obtain structural information on the intraprotein region is described here. As probe ligands, (S)- and (R)-CPFMe (the methyl esters of the chiral drug carprofen) have been selected, while bovine &#61537;1-acid glycoprotein (BAAG) has been chosen as biological host. The procedure involves separate irradiation of the BAAG/(S)-CPFMe and BAAG/(R)-CPFMe complexes, coupled with fluorescence, laser flash photolysis, proteomic analysis, docking and molecular dynamic simulations. Thus, irradiation of the BAAG/CPFMe complexes at &#61548; = 320 nm, was followed by fluorescence spectroscopy. The intensity of the emission band obtained after irradiation indicated photodehalogenation, whereas its structureless shape suggested covalent binding of the resulting radical CBZMe&#9679; to the biopolymer. After gel filtration chromatography, the spectra still displayed emission, in agreement with covalent attachment of CBZMe&#9679; to BAAG. Stereodifferentiation was observed in this process. After trypsin digestion and ESI-MS/MS, incorporation of CBZMe was detected at Phe68. Docking and molecular dynamics simulation studies, which were carried out using a homology model of BAAG, reveal that the closer proximity of the aromatic moiety of the (S)- enantiomer to the phenyl group of Phe68 would be responsible for the experimentally observed more effective chemical modification of the protein. The proposed tridimensional structure of BAAG covalently modified by the two enantiomers is also provided. In principle, this approach can be extended to a variety of protein/ligand complexes., Financial support from the Spanish Ministry of Economy and Competitiveness (CTQ2013-47872-C2-1-P, SAF2013-42899-R, BES-2011-043706), Generalitat Valenciana (PROMETEOII/2013/005), Instituto de Salud Carlos III (RD12/0013/0009), Xunta de Galicia (GRC2013-041), the Conselleria de Cultura, Educacion e Ordenacion Universitaria (Centro singular de investigacion de Galicia accreditation 2016-2019, ED431G/09) and the European Regional Development Fund (ERDF) is gratefully acknowledged. E. L. thanks the Xunta de Galicia for a postdoctoral fellowship. We are grateful to the Centro de Supercomputacion de Galicia (CESGA) for use of the Finis Terrae II supercomputer. The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia that belongs to ProteoRed PRB2-ISCIII and is supported by grant PT13/0001, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Identification of a common recognition center for a photoactive non-steroidal antiinflammatory drug in serum albumins of different species

  • Molins-Molina, Oscar
  • Lence, Emilio
  • Limones-Herrero, Daniel
  • González-Bello, Concepción
  • Miranda Alonso, Miguel Ángel
  • Jiménez, M Consuelo|||0000-0002-8057-4316
[EN] The non-steroidal anti-inflammatory drug (S)-carprofen (CPF) has been used as a photoactive probe to investigate the possible existence of a common recognition center in serum albumins (SAs) of different species. The methodology involves irradiation of the CPF/SA complexes, coupled with gel filtration chromatography or proteomic analysis of the photolysates, docking and molecular dynamics simulations. Photolysis of CPF/SA complexes at = 320 nm, and gel filtration chromatography, revealed that the protein fraction still contained the drug fluorophore, in agreement with covalent attachment of the photogenerated radical intermediate CBZ to SAs. After trypsin digestion and ESI-MS/MS, the incorporation of CBZ was detected at several positions in the different albumins. Remarkably, modifications at the IB/IIIA interface were observed in all cases (Tyr452 in HSA, RbSA and RtSA and Tyr451 in BSA, PSA and SSA). The molecular basis of this common recognition, studied by docking and molecular dynamics simulation studies on the corresponding non-covalent complexes, corroborated the experimentally observed covalent modifications. Our computational studies also revealed that the previously reported displacement of CPF by (S)-ibuprofen, a site II specific drug, would be due to an allosteric effect in site II, rather than a direct molecular displacement, as expected., Financial support from the Spanish Ministry of Economy and Competiveness (CTQ2016-78875-P, SAF2016-75638-R and BES-2014-069404), Generalitat Valenciana (PROMETEO2017/075), Conselleria de Cultura, Educacion e Ordenacion Universitaria (Centro singular de investigacion de Galicia accreditation 2016-2019, ED431G/09) and the European Regional Development Fund (ERDF) is acknowledged. This work was also supported by Instituto de Salud Carlos III (ISCIII) co-funded by Fondo Europeo de Desarrollo Regional FEDER for the Thematic Networks and Co-operative Research Centres: ARADyAL (RD16/0006/0030). EL thanks the Xunta de Galicia for his postdoctoral fellowship. We are also grateful to the Centro de Supercomputacion de Galicia (CESGA) for use of the Finis Terrae II supercomputer. The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia that belongs to ProteoRed PRB2-ISCIII and is supported by grant PT13/0001, of the PE I+D+I 2013-2016, funded by ISCIII and FEDER.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes

  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Masia, Esther
  • Romera-Giner, Sergio
  • Malmierca-Merlo, Pablo
  • López-Guerrero, José A.
  • García-García, Francisco
  • Vicent, María J.
[EN] Identifying novel breast cancer biomarkers will improve patient stratification, enhance therapeutic outcomes, and help develop non-invasive diagnostics. We compared the proteomic profiles of whole-cell and exosomal samples of representative breast cancer cell subtypes to evaluate the potential of extracellular vesicles as non-invasive disease biomarkers in liquid biopsies. Overall, differentially-expressed proteins in whole-cell and exosome samples (which included markers for invasion, metastasis, angiogenesis, and drug resistance) effectively discriminated subtypes; furthermore, our results confirmed that the proteomic profile of exosomes reflects breast cancer cell-of-origin, which underscores their potential as disease biomarkers. Our study will contribute to identifying biomarkers that support breast cancer patient stratification and developing novel therapeutic strategies. We include an open, interactive web tool to explore the data as a molecular resource that can explain the role of these protein signatures in breast cancer classification., This study was supported by the European Research Council (grant ERC-CoG-2014-648831 MyNano ) and the H2020 EU-OpenScreen-Drive project (grant agreement No. 823893). Our screening platform is part of the European Infrastructure, ERIC EUOpenScreen, and the Excellence Network, TeNTaCLES (Translational NeTwork for the CLinical application of Extracellular Vesicle-Tentacles-RED2018-102411-T). This research was also supported by the Spanish Ministry of Science and Innovation (PID2019-108806RBI00; PID2020-117211GB-I00; PID2021-124430OA-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and by FEDER, UE; and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019), co-funded by ERDF and CIBERONC (project n. CB22/12/00048). The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia, which belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. Agreement 2019 between IVO and the Association Mou-te per elles.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial

  • del Canto Serrano, Irene
  • Santas, Enrique
  • Cardells, Ingrid
  • Miñana, Gema
  • Palau, Patricia
  • Llàcer, Pau
  • Fácila, Lorenzo
  • López-Vilella, Raquel
  • Almenar, Luis
  • Bodí, Vicent
  • López-Lereu, Maria P.
  • Monmeneu, Jose V.
  • Sanchis, Juan
  • Maceira, Alicia M.
  • Moratal, David|||0000-0002-2825-3646
[EN] BACKGROUND: The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial-IRON trial showed short-term cardiac magnetic resonance (CMR) changes suggesting myocardial iron repletion following administration of FCM but failed to find a significant increase in left ventricular ejection fraction in the whole sample. Conversely, the strain assessment could evaluate more specifically subtle changes in contractility. In this subanalysis, we aimed to evaluate the effect of FCM on the short-term left and right ventricular CMR feature tracking derived strain. METHODS AND RESULTS: This is a post hoc subanalysis of the double-blind, placebo-controlled, randomized clinical trial that enrolled 53 ambulatory patients with heart failure and left ventricular ejection fraction <50%, and iron deficiency [Myocardial-IRON trial (NCT03398681)]. Three-dimensional left and 2-dimensional right ventricular CMR tracking strain (longitudinal, circumferential, and radial) changes were evaluated before, 7 and 30 days after randomization using linear mixed-effect analysis. The median (interquartile range) age of the sample was 73 years (65-78), and 40 (75.5%) were men. At baseline, there were no significant differences in CMR feature tracking strain parameters across both treatment arms. At 7 days, the only global 3-dimensional left ventricular circumferential strain was significantly higher in the FCM treatment-arm (difference: -1.6%, P=0.001). At 30 days, and compared with placebo, global 3-dimensional left ventricular strain parameters significantly improved in those allocated to FCM treatment-arm [longitudinal (difference: -2.3%, P<0.001), circumferential (difference: -2.5%, P<0.001), and radial (difference: 4.2%, P=0.002)]. Likewise, significant improvements in global right ventricular strain parameters were found in the active arm at 30 days (longitudinal [difference: -3.3%, P=0.010], circumferential [difference: -4.5%, P<0.001], and radial [difference: 4.5%, P=0.027]). CONCLUSIONS: In patients with stable heart failure, left ventricular ejection fraction <50%, and iron deficiency, treatment with FCM was associated with short-term improvements in left and right ventricular function assessed by CMR feature tracking derived strain parameters., This work was supported in part by an unrestricted grant from Vifor Pharma, CIBER Cardiovascular [grant numbers 16/11/00420 and 16/11/00403], Unidad de Investigacion Clinica y Ensayos Clinicos INCLIVA Health Research Institute, Spanish Clinical Research Network (SCReN; PT13/0002/0031 and PT17/0017/0003), cofounded by Fondo Europeo de Desarrollo Regional-Instituto de Salud Carlos III, and Proyectos de Investigacion de la Seccion de Insuficiencia Cardiaca 2017 from Sociedad Espanola de Cardiologia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A New Pathway for Protein Haptenation by beta-Lactams

  • Pérez-Ruiz, Raúl|||0000-0003-1136-3598
  • Andreu, Inmaculada|||0000-0003-3409-9443
  • Jiménez, M Consuelo|||0000-0002-8057-4316
  • Lence, Emilio
  • Limones Herrero, Daniel
  • González-Bello, Concepción
  • Miranda Alonso, Miguel Ángel
[EN] The covalent binding of beta-lactams to proteins upon photochemical activation has been demonstrated by using an integrated approach that combines photochemical, proteomic and computational studies, selecting human serum albumin (HSA) as a target protein and ezetimibe (1) as a probe. The results have revealed a novel protein haptenation pathway for this family of drugs that is an alternative to the known nucleophilic ring opening of beta-lactams by the free amino group of lysine residues. Thus, photochemical ring splitting of the beta-lactam ring, following a formal retro-Staudinger reaction, gives a highly reactive ketene intermediate that is trapped by the neighbouring lysine residues, leading to an amide adduct. For the investigated 1/HSA system, covalent modification of residues Lys414 and Lys525, which are located in sub-domains IIIA and IIIB, respectively, occurs. The observed photobinding may constitute the key step in the sequence of events leading to photoallergy. Docking and molecular dynamics simulation studies provide an insight into the molecular basis of the selectivity of 1 for these HSA sub-domains and the covalent modification mechanism. Computational studies also reveal positive cooperative binding of sub-domain IIIB that explains the experimentally observed modification of Lys414, which is located in a barely accessible pocket (sub-domain IIIA)., Financial support from Ministerio de Economia, Industria y Competitividad (CTQ2013-47872-C2-1-P, CTQ2016-78875-P, SAF2013-42899-R, SAF2016-75638-R), Instituto de Salud Carlos III (RD12/0013/0009 and RD16/0006/0030), Generalitat Valenciana (PROMETEOII/2013/005), Xunta de Galicia (Centro singular de investigacion de Galicia accreditation 2016-2019, ED431G/09) and European Union (European Regional Development Fund -ERDF) is gratefully acknowledged. E.L. thanks the Xunta de Galicia for a postdoctoral fellowship. We are grateful to the Centro de Supercomputacion de Galicia (CESGA) for use of the Finis Terrae II supercomputer. The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia that belongs to ProteoRed PRB2-ISCIII and is supported by grant PT13/0001, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Effect of gelatin coating enriched with antioxidant tomato by-products on the quality of pork meat

  • Gallego, Marta
  • Toldrá, Fidel
  • Mora, Leticia
  • Arnal-Salinas, Milagros|||0000-0002-9301-2478
  • Talens Oliag, Pau|||0000-0001-7318-3336
[EN] The use of edible biopolymers and natural additives obtained from food processing by-products is a sustainable strategy for food packaging applications. Gelatin is a biopolymer with great potential as a coating due to its low cost, high availability, and technological and functional properties. Among them, gelatin can be used as a carrier of bioactive compounds such as antioxidants, which can retard oxidation processes and thus extend the shelf-life of highly-perishable products. This study evaluated the effect of gelatin coating enriched with antioxidant tomato by-products hydrolysate (TBPH) on the quality of pork meat during cold storage. Results showed that TBPH obtained from Alcalase hydrolysis presented antioxidant activity with good stability against cooking. Additionally, chromatographic and mass spectrometry techniques, as well as in silico analysis, were used for the peptidomic characterisation of TBPH. The application of enriched gelatin coating on meat led to some physicochemical changes including increased weight loss and colour differences; however, the pH and water activity, which control meat spoilage, were maintained during storage. Moreover, coating prevented lipid oxidation of meat, and enriched-coated meat presented high antioxidant activity after cooking. These results suggest the positive role of gelatin coating enriched with TBPH in extending the shelf-life of meat during storage., This research was funded by grant AGL2017-89381-R from the Spanish Ministry of Economy, Industry and Competitivity and FEDER funds. The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia that belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

A common epigenetic clock from childhood to old age

  • Freire Aradas, Ana María
  • Girón-Santamaría, Lorena
  • Mosquera Miguel, Ana
  • Ambroa Conde, Adrián
  • Phillips, Christopher Paul
  • Casares de Cal, María de los Ángeles
  • Gómez Tato, Antonio
  • Álvarez Dios, José Antonio
  • Aliferi, Anastasia
  • Syndercombe Court, Denise
  • Branicki, Wojciech
  • Lareu Huidobro, María Victoria
Forensic age estimation is a DNA intelligence tool that forms an important part of Forensic DNA Phenotyping. Criminal cases with no suspects or with unsuccessful matches in searches on DNA databases; human identification analyses in mass disasters; anthropological studies or legal disputes; all benefit from age estimation to gain investigative leads. Several age prediction models have been developed to date based on DNA methylation. Although different DNA methylation technologies as well as diverse statistical methods have been proposed, most of them are based on blood samples and mainly restricted to adult age ranges. In the current study, we present an extended age prediction model based on 895 evenly distributed Spanish DNA blood samples from 2 to 104 years old. DNA methylation levels were detected using Agena Bioscience EpiTYPER® technology for a total of seven CpG sites located at seven genomic regions: ELOVL2, ASPA, PDE4C, FHL2, CCDC102B, MIR29B2CHG and chr16:85395429 (GRCh38). The accuracy of the age prediction system was tested by comparing three statistical methods: quantile regression (QR), quantile regression neural network (QRNN) and quantile regression support vector machine (QRSVM). The most accurate predictions were obtained when using QRNN or QRSVM (mean absolute prediction error, MAE of ± 3.36 and ± 3.41, respectively). Validation of the models with an independent Spanish testing set (N = 152) provided similar accuracies for both methods (MAE: ± 3.32 and ± 3.45, respectively). The main advantage of using quantile regression statistical tools lies in obtaining age-dependent prediction intervals, fitting the error to the estimated age. An additional analysis of dimensionality reduction shows a direct correlation of increased error and a reduction of correct classifications as the training sample size is reduced. Results indicated that a minimum sample size of six samples per year-of-age covered by the training set is recommended to efficiently capture the most inter-individual variability
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

The RD-connect genome-phenome analysis platform: accelerating diagnosis, research, and gene discovery for rare diseases

  • Laurie, Steven
  • Piscia, Davide
  • Matalonga, Leslie
  • Corvó, Alberto
  • Fernández-Callejo, Marcos
  • Garcia-Linares, Carles
  • Hernandez-Ferrer, Carles
  • Luengo, Cristina
  • Martínez, Inés
  • Papakonstantinou, Anastasios
  • Picó-Amador, Daniel
  • Protasio, Joan
  • Thompson, Rachel
  • Tonda, Raúl
  • Bayés, Mónica
  • Bullich, Gemma
  • Camps-Puchadas, Jordi
  • Paramonov, Ida
  • Trotta, Jean Remí
  • Alonso Sánchez, Ángel Miguel
  • Attimonelli, Marcella
  • Béroud, Christophe
  • Bros-Facer, Virginie
  • Buske, Orion J.
  • Cañada-Pallarés, Andrés
  • Fernández, José M.
  • Hansson, Mats G.
  • Horvath, Rita
  • Jacobsen, Julius O. B.
  • Kaliyaperumal, Rajaram
  • Lair-Préterre, Séverine
  • Licata, Luana
  • Lopes, Pedro
  • López-Martín, Estrella
  • Mascalzoni, Deborah
  • Monaco, Lucia
  • Pérez-Jurado, Luis A.
  • Posada-de-la-Paz, Manuel
  • Rambla, Jordi
  • Rath, Ana
  • Riess, Olaf
  • Robinson, Peter N.
  • Salgado, David
  • Smedley, Damian
  • Spalding, Dylan
  • &apos;t Hoen, Peter A. C.
  • Töpf, Ana
  • Zaharieva, Irina
  • Graessner, Holm
  • Gut, Ivo Glynne
  • Lochmüller, Hanns
  • Beltrán, Sergi
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the wide adoption of next-generation sequencing. However, many cases remain undiagnosed even after exome or genome analysis, because the methods used missed the molecular cause in a known gene, or a novel causative gene could not be identified and/or confirmed. To address these challenges, the RD-Connect Genome-Phenome Analysis Platform (GPAP) facilitates the collation, discovery, sharing, and analysis of standardized genome-phenome data within a collaborative environment. Authorized clinicians and researchers submit pseudonymised phenotypic profiles encoded using the Human Phenotype Ontology, and raw genomic data which is processed through a standardized pipeline. After an optional embargo period, the data are shared with other platform users, with the objective that similar cases in the system and queries from peers may help diagnose the case. Additionally, the platform enables bidirectional discovery of similar cases in other databases from the Matchmaker Exchange network. To facilitate genome-phenome analysis and interpretation by clinical researchers, the RD-Connect GPAP provides a powerful user-friendly interface and leverages tens of information sources. As a result, the resource has already helped diagnose hundreds of rare disease patients and discover new disease causing genes., RD-Connect (RD-Connect, an integrated platform connecting registries, biobanks, and clinical bioinformatics) received funding from the Seventh Framework (FP7) Programme of the European Union under grant agreement No 305444. Data were analyzed using the RD-Connect GPAP, which received funding from EU projects Solve-RD, EJP-RD (grant numbers H2020 779257, H2020 825575), Instituto de Salud Carlos III (Grant numbers PT13/0001/0044, PT17/0009/0019; Instituto Nacional de Bioinformática, INB), ELIXIR-EXCELERATE (Grant number EU H2020 #676559) and ELIXIR Implementation Studies (Remote real-time visualization of human rare disease genomics data (RD-Connect) stored at the EGA ELIXIR. 2017-2018; ELIXIR IT-2017-INTEGRATION, Rare Disease Infrastructure ELIXIR, 2019-2020 and the Beacon ELIXIR, 2019-2021). The RD-Connect GPAP has leveraged developments funded through project VEIS (001-P-001647 co-financed by the European Regional Development Fund of the European Union in the framework of the Operational Program FEDER of Catalonia 2014-2020 with the support of the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya) and URD-Cat (PERIS SLT002/16/00174, Departament de Salut, Generalitat de Catalunya). The research leading to these results has received funding from Consequitur (Newton Fund UK/Turkey, MR/N027302/1), BBMRI-LPC (EU FP7 #313010), NeurOmics (EU FP7 #305121), the Economic Development Department of the Navarra Government (Grant number 001114112017), the European Reference Network for Rare Neurological Diseases (Project ID number 739510) and NIH, National Institute of Child Health and Human Development (1R01HD103805-01). We acknowledge the support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Generalitat de Catalunya through Departament de Salut and Departament d'Empresa i Coneixement and Co-financing by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. HL receives support from the Canadian Institutes of Health Research (Foundation Grant FDN-167281), the Canadian Institutes of Health Research and Muscular Dystrophy Canada (Network Catalyst Grant for NMD4C), the Canada Foundation for Innovation (CFI-JELF 38412), and the Canada Research Chairs program (Canada Research Chair in Neuromuscular Genomics and Health, 950-232279).
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Genome and transcriptome analysis of the Mesoamerican common bean and the role of gene duplications in establishing tissue and temporal specialization of genes

  • Vlasova, Anna
  • Capella-Gutiérrez, Salvador
  • Rendón-Anaya, Martha
  • Hernández-Oñate, Miguel
  • Minoche, André E.
  • Erb, Ionas
  • Câmara, Francisco
  • Prieto-Barja, Pablo
  • Corvelo, André
  • Sanseverino, Walter
  • Westergaard, Gastón
  • Dohm, Juliane C.
  • Pappas Jr, Georgios J.
  • Saburido-Alvarez, Soledad
  • Kedra, Darek
  • Gonzalez, Irene
  • Cozzuto, Luca
  • Gómez-Garrido, Jessica
  • Aguilar-Morón, María A.
  • Andreu, Nuria
  • Aguilar, O. Mario
  • Garcia-Mas, Jordi
  • Zehnsdorf, Maik
  • Vázquez, Martín P.
  • Delgado-Salinas, Alfonso
  • Delaye, Luis
  • Lowy, Ernesto
  • Mentaberry, Alejandro
  • Vianello-Brondani, Rosana P.
  • García, José Luís
  • Alioto, Tyler
  • Sánchez, Federico
  • Himmelbauer, Heinz
  • Santalla, Marta
  • Notredame, Cedric
  • Gabaldón, Toni
  • Herrera-Estrella, Alfredo
  • Guigó, Roderic
Background: Legumes are the third largest family of angiosperms and the second most important crop class. Legume genomes have been shaped by extensive large-scale gene duplications, including an approximately 58 million year old whole genome duplication shared by most crop legumes. Results: We report the genome and the transcription atlas of coding and non-coding genes of a Mesoamerican genotype of common bean (Phaseolus vulgaris L., BAT93). Using a comprehensive phylogenomics analysis, we assessed the past and recent evolution of common bean, and traced the diversification of patterns of gene expression following duplication. We find that successive rounds of gene duplications in legumes have shaped tissue and developmental expression, leading to increased levels of specialization in larger gene families. We also find that many long non-coding RNAs are preferentially expressed in germ-line-related tissues (pods and seeds), suggesting that they play a significant role in fruit development. Our results also suggest that most bean-specific gene family expansions, including resistance gene clusters, predate the split of the Mesoamerican and Andean gene pools. Conclusions: The genome and transcriptome data herein generated for a Mesoamerican genotype represent a counterpart to the genomic resources already available for the Andean gene pool. Altogether, this information will allow the genetic dissection of the characters involved in the domestication and adaptation of the crop, and their further implementation in breeding strategies for this important crop., info:eu-repo/semantics/publishedVersion
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

High-throughput mass spectrometry analysis of N -glycans and protein markers after FUT8 knockdown in the syngeneic SW480/SW620 colorectal cancer cell model

  • Lopez Cortes, Rubén
  • Muinelo Romay, Laura
  • Fernandez Briera, Maria Almudena
  • Gil Martín, Emilio
Disruption of the glycosylation machinery is a common feature in many types of cancer, and colorectal cancer (CRC) is no exception. Core fucosylation is mediated by the enzyme fucosyltransferase 8 (FucT-8), which catalyzes the addition of α1,6-l-fucose to the innermost GlcNAc residue of N-glycans. We and others have documented the involvement of FucT-8 and core-fucosylated proteins in CRC progression, in which we addressed core fucosylation in the syngeneic CRC model formed by SW480 and SW620 tumor cell lines from the perspective of alterations in their N-glycosylation profile and protein expression as an effect of the knockdown of the FUT8 gene that encodes FucT-8. Using label-free, semiquantitative mass spectrometry (MS) analysis, we found noticeable differences in N-glycosylation patterns in FUT8-knockdown cells, affecting core fucosylation and sialylation, the Hex/HexNAc ratio, and antennarity. Furthermore, stable isotopic labeling of amino acids in cell culture (SILAC)-based proteomic screening detected the alteration of species involved in protein folding, endoplasmic reticulum (ER) and Golgi post-translational stabilization, epithelial polarity, and cellular response to damage and therapy. This data is available via ProteomeXchange with identifier PXD050012. Overall, the results obtained merit further investigation to validate their feasibility as biomarkers of progression and malignization in CRC, as well as their potential usefulness in clinical practice, Xunta de Galicia | Ref. CN 2011/024, Xunta de Galicia | Ref. GRC 2014/019, Ministerio de Educación, Cultura y Deporte | Ref. FPU12/03662, Universidade de Vigo/CISUG, Instituto de Salud Carlos III | Ref. PT13/0001
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Combining targeted panel-based resequencing and copy-number variation analysis for the diagnosis of inherited syndromic retinopathies and associated ciliopathies

  • Sánchez Navarro, Iker
  • R. J. da Silva, Luciana
  • Blanco Kelly, Fiona
  • Zurita, Olga
  • Sánchez Bolivar, Noelia
  • Villaverde, Cristina
  • López Molina, María Isabel
  • García Sandoval, Blanca
  • Tahsin Swafiri, Saoud
  • Mínguez, Pablo
  • Riveiro Álvarez, Rosa
  • Lorda, Isabel
  • Sánchez Alcudia, Rocío
  • Pérez Carro, Raquel
  • Valverde Pérez, Diana
  • Liu, Yichuan
  • Tian, Lifeng
  • Hakonarson, Hakon
  • Ávila Fernández, Almudena
  • Corton, Marta
  • Ayuso, Carmen
Inherited syndromic retinopathies are a highly heterogeneous group of diseases that involve retinal anomalies and systemic manifestations. They include retinal ciliopathies, other well-defined clinical syndromes presenting with retinal alterations and cases of non-specific multisystemic diseases. The heterogeneity of these conditions makes molecular and clinical characterization of patients challenging in daily clinical practice. We explored the capacity of targeted resequencing and copy-number variation analysis to improve diagnosis of a heterogeneous cohort of 47 patients mainly comprising atypical cases that did not clearly fit a specific clinical diagnosis. Thirty-three likely pathogenic variants were identified in 18 genes (ABCC6, ALMS1, BBS1, BBS2, BBS12, CEP41, CEP290, IFT172, IFT27, MKKS, MYO7A, OTX2, PDZD7, PEX1, RPGRIP1, USH2A, VPS13B, and WDPCP). Molecular findings and additional clinical reassessments made it possible to accurately characterize 14 probands (30% of the total). Notably, clinical refinement of complex phenotypes was achieved in 4 cases, including 2 de novo OTX2-related syndromes, a novel phenotypic association for the ciliary CEP41 gene, and the co-existence of biallelic USH2A variants and a Koolen-de-Vries syndrome–related 17q21.31 microdeletion. We demonstrate that combining next-generation sequencing and CNV analysis is a comprehensive and useful approach to unravel the extensive phenotypic and genotypic complexity of inherited syndromic retinopathies, FEDER (Fondo Europeo de Desarrollo Regional) | Ref. PI016/00425, Instituto de Salud Carlos III | Ref. PT13/0010/0012
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Fibroblast Growth Factor 23 and Outcomes in Acute Heart Failure

  • Martí-Martínez, Arancha
  • Nuñez, Julio
  • López-Escribano, Herminio
  • de la Espriella, Rafael
  • Santas, Enrique
  • Rodríguez Borja, Enrique
  • Miró, Òscar
  • Llorens, Pere
  • Alquézar-Arbé, Aitor
  • Herrero-Puente, Pablo
  • Llorens, Pere|||/items/757956aa-c39c-4e15-850b-e5bf9ed72f94
Worsening heart failure (WHF) is a complex clinical syndrome associated with a high risk of mortality and further decompensations, characterized by fluid overload and upregulated inflammatory and fibrotic processes linked to organ dysfunction. Fibroblast growth factor 23 (FGF23) is an emerging proxy of fibrosis and may interact to influence long-term outcomes in WHF patients. This study evaluated the association between FGF23 levels and long-term outcomes in patients with WHF evaluated in the emergency department (ED). A total of 635 patients from the EAHFE registry, enrolled during 2007, 2009, and 2011, were prospectively included. FGF23 was measured in the first blood sample obtained at ED presentation. During a median follow-up of 380 days (interquartile range: 126 to 456), all-cause mortality occurred in 216 patients (34.0%), while 351 patients (55.3%) experienced the composite endpoint of death/WHF ED reconsultation and 295 (46.5%) experienced death/HF hospitalization. Event rates increased progressively across FGF23 levels. Patients with FGF23 above the median (48.4 pg/mL) displayed higher rates (per 100 patient-years) of all-cause mortality (49 vs. 31, p = 0.003), death/WHF ED reconsultation (93 vs. 65, p = 0.003), and death/HF hospitalization (77 vs. 56, p = 0.043). In continuous analyses, each doubling of FGF23 remained significantly associated with an increased risk of all three outcomes after multivariable adjustment. These associations were consistent across clinically relevant subgroups, including those defined by age, sex, and kidney function, supporting the potential prognostic value of FGF23 within this cohort, although external validation is warranted.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Inter-laboratory evaluation of instrument platforms and experimental workflows for quantitative accuracy and reproducibility assessment

  • Percy, Andrew J.
  • Tamura-Wells, Jessica
  • Albar, Juan Pablo
  • Aloria, Kerman
  • Amirkhani, Ardeshir
  • Araújo, Gabriel D.T.
  • Arizmendi, Jesús M.
  • Blanco García, Francisco J
  • Canals, Francesc
  • Cho, Jin-Young
  • Colomé-Calls, Núria
  • Corrales, Fernando J.
  • Domont, Gilberto
  • Espadas, Guadalupe
  • Fernández-Puente, Patricia
  • Gil, Concha
  • Haynes, Paul A.
  • Hernáez, María Luisa
  • Kim, Jin Young
  • Kopylov, Arthur T.
  • Marcilla, Miguel
  • McKay, Mathew J.
  • Mirzaei, Mehdi
  • Molloy, Mark P.
  • Ohlund, Leanne B.
  • Paik, Young-Ki
  • Paradela, Alberto
  • Raftery, Mark
  • Sabidó, Eduard
  • Sleno, Lekha
  • Wilffert, Daniel
  • Wolters, Justina C.
  • Yoo, Jong Shin
  • Zgoda, Victor G.
  • Parker, Carol E.
  • Borchers, Christoph H.
[Abstract] The reproducibility of plasma protein quantitation between laboratories and between instrument types was examined in a large-scale international study involving 16 laboratories and 19 LC-MS/MS platforms, using two kits designed to evaluate instrument performance and one kit designed to evaluate the entire bottom-up workflow. There was little effect of instrument type on the quality of the results, demonstrating the robustness of LC/MRM-MS with isotopically labeled standards. Technician skill was a factor, as errors in sample preparation and sub-optimal LC-MS performance were evident. This highlights the importance of proper training and routine quality control before quantitation is done on patient samples., The UVic-Genome BC Proteomics Centre would like to thank Genome Canada and Genome British Columbia for STIC funding and support, as well as Western Economic Diversification of Canada for instrumentation support. All laboratories from Spain are members of ProteoRed (Plataforma de Recursos Biomoleculares y Bioinformáticos) and are supported by grant PT13/0001 funded by Instituto de Salud Carlos III (ISCIII) and the European Regional Development Fund (FEDER). FC wishes to acknowledge support from Grant PRB2 (IPT13/0001 - ISCIII-SGEFI/FEDER). GD wishes to acknowledge support from grants FAPERJ E26-110.138/2013, FAPERJ E-26/111.697/2013, and FAPERJ E-26/0010.1582/2014. AK and VZ state that the Russian portion of the work was done in the framework of the State Academies Fundamental Research Program (2013-2020). Reynaldo Interior (Hospital for Sick Children; Toronto, ON, Canada), Jay Gambee (AAA Service Laboratory; Damascus, OR, USA), and David Chen (University of British Columbia; Vancouver, BC, Canada) are recognized for characterizing the 43 SIS peptides. PAH wishes to thank Ardeshir Amirkhani of the Australian Proteome Analysis Facility, Macquarie University, Sydney, Australia for assistance with sample preparation and data analysis.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Analysis of Autoantibody Profiles in Osteoarthritis Using Comprehensive Protein Array Concepts

  • Henjes, Frauke
  • Lourido, Lucía
  • Ruiz-Romero, Cristina
  • Fernández-Tajes, Juan
  • Schwenk, Jochen M.
  • González-González, María
  • Blanco García, Francisco J
  • Nilsson, Peter
  • Fuentes, Manuel
[Abstract] Osteoarthritis (OA) is the most common rheumatic disease and one of the most disabling pathologies worldwide. To date, the diagnostic methods of OA are very limited, and there are no available medications capable of halting its characteristic cartilage degeneration. Therefore, there is a significant interest in new biomarkers useful for the early diagnosis, prognosis, and therapeutic monitoring. In the recent years, protein microarrays have emerged as a powerful proteomic tool to search for new biomarkers. In this study, we have used two concepts for generating protein arrays, antigen microarrays, and NAPPA (nucleic acid programmable protein arrays), to characterize differential autoantibody profiles in a set of 62 samples from OA, rheumatoid arthritis (RA), and healthy controls. An untargeted screen was performed on 3840 protein fragments spotted on planar antigen arrays, and 373 antigens were selected for validation on bead-based arrays. In the NAPPA approach, a targeted screening was performed on 80 preselected proteins. The autoantibody targeting CHST14 was validated by ELISA in the same set of patients. Altogether, nine and seven disease related autoantibody target candidates were identified, and this work demonstrates a combination of these two array concepts for biomarker discovery and their usefulness for characterizing disease-specific autoantibody profiles., We gratefully acknowledge financial support from Euro-TEAM (EU FP7), Knut and Alice Wallenberg Foundation, SciLifeLab Stockholm, the Carlos III Health Institute of Spain (FIS PI11/02114, PI11/02397, PI12/00329; CIBER-CB06/01/0040; RETIC-RIER-RD12/0009/0018), FEDER (European Community), Xunta de Galicia (Red Gallega REDICENT), and Junta Castilla-León SA198A12-2. The Proteomics Unit at CIC belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly

  • Venegas-Moreno, Eva
  • Vázquez Borrego, María del Carmen
  • Dios, Elena
  • Gros-Herguido, Noelia
  • Flores Martínez, Álvaro
  • Rivero-Cortés, Esther
  • Madrazo Atutxa, Ainara M.
  • Japón, Miguel Ángel
  • Luque, Raúl M.
  • Castaño, Justo P.
  • Cano, David A.
  • Soto-Moreno, Alfonso
Acromegaly is a hormonal disorder resulting from excessive growth hormone (GH) secretion frequently produced by pituitary adenomas and consequent increase in insulin-like growth factor 1 (IGF-I). Elevated GH and IGF-I levels result in a wide range of somatic, cardiovascular, endocrine, metabolic and gastrointestinal morbidities. Somatostatin analogues (SSAs) form the basis of medical therapy for acromegaly and are currently used as first-line treatment or as second-line therapy in patients undergoing unsuccessful surgery. However, a considerable percentage of patients do not respond to SSAs treatment. Somatostatin receptors (SSTR1-5) and dopamine receptors (DRD1-5) subtypes play critical roles in the regulation of hormone secretion. These receptors are considered important pharmacological targets to inhibit hormone oversecretion. It has been proposed that decreased expression of SSTRs may be associated with poor response to SSAs. Here, we systematically examine SSTRs and DRDs expression in human somatotroph adenomas by quantitative PCR. We observed an association between the response to SSAs treatment and DRD4, DRD5, SSTR1 and SSTR2 expression. We also examined SSTR expression by immunohistochemistry and found that the immunohistochemical detection of SSTR2 in particular might be a good predictor of response to SSAs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival

  • Losada, Alejandro
  • Muñoz-Alonso, María J.
  • Martínez-Díez, Marta
  • Gago, Federico
  • Dominguez, Juan Manuel
  • Martínez-Leal, Juan Fernando
  • Galmarini, Carlos M.
Background: Through several not-fully-characterised moonlighting functions, translation elongation factor eEF1A2 is known to provide a fitness boost to cancer cells. Furthermore, eEF1A2 has been demonstrated to confer neoplastic characteristics on preneoplastic, nontumourigenic precursor cells. We have previously shown that eEF1A2 is the target of plitidepsin, a marine drug currently in development for cancer treatment. Herein, we characterised a new signalling pathway through which eEF1A2 promotes tumour cell survival. Methods: Previously unknown binding partners of eEF1A2 were identified through co-immunoprecipitation, high-performance liquid chromatography-mass spectrometry and proximity ligation assay. Using plitidepsin to release eEF1A2 from those protein complexes, their effects on cancer cell survival were analysed in vitro. Results: We uncovered that double-stranded RNA-activated protein kinase (PKR) is a novel eEF1A2-interacting partner whose pro-apoptotic effect is hindered by the translation factor, most likely through sequestration and inhibition of its kinase activity. Targeting eEF1A2 with plitidepsin releases PKR from the complex, facilitating its activation and triggering a mitogen-activated protein kinase signalling cascade together with a nuclear factor-κB-dependent activation of the extrinsic apoptotic pathway, which lead to tumour cell death. Conclusions: Through its binding to PKR, eEF1A2 provides a survival boost to cancer cells, constituting an Achilles heel that can be exploited in anticancer therapy., We thank Doctors César de Haro and Juan José Berlanga for fruitful discussions and for providing essential reagents. We also thank Rafael Sánchez for his technical assistance. The proteomic analysis was performed in the Proteomics Unit of Complutense University of Madrid that belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. F.G. is the recipient of a Spanish MEC/MICINN (SAF2015-64629- C2-2-R) grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial

  • Molina, José
  • Montero-Mateos, Enrique
  • Praena-Segovia, Julia
  • León Jiménez, Eva
  • Natera Kindelán, Clara
  • López-Cortés, Luis Eduardo
  • Valiente, Lucía
  • Rosso-Fernández, Clara
  • Herrero, Marta
  • Aller-García, Ana Isabel
  • Cano, Ángela
  • Gutiérrez-Gutiérrez, Belén
  • Márquez-Gómez, Ignacio
  • Álvarez-Marín, Rocío
  • Infante, Carmen
  • Roca, Cristina
  • Valiente-Méndez, Adoración
  • Pachón, Jerónimo
  • Reguera Iglesias, José María
  • Corzo, Juan E.
  • Torre-Cisneros, Julián
  • Rodríguez-Baño, Jesús
  • Cisneros, José Miguel
[Objective] To prove that 7-day courses of antibiotics for bloodstream infections caused by members of the Enterobacterales (eBSIs) allow a reduction in patients' exposure to antibiotics while achieving clinical outcomes similar to those of 14-day schemes., [Methods] A randomized trial was performed. Adult patients developing eBSI with appropriate source control were assigned to 7 or 14 days of treatment, and followed 28 days after treatment cessation; treatments could be resumed whenever necessary. The primary endpoint was days of treatment at the end of follow-up. Clinical outcomes included clinical cure, relapse of eBSI and relapse of fever. A superiority margin of 3 days was set for the primary endpoint, and a non-inferiority margin of 10% was set for clinical outcomes. Efficacy and safety were assessed together with a DOOR/RADAR (desirability of outcome ranking and response adjusted for duration of antibiotic risk) analysis., [Results] 248 patients were assigned to 7 (n = 119) or 14 (n = 129) days of treatment. In the intention-to-treat analysis, median days of treatment at the end of follow-up were 7 and 14 days (difference 7, 95%CI 7–7). The non-inferiority margin was also met for clinical outcomes, except for relapse of fever (–0.2%, 95%CI –10.4 to 10.1). The DOOR/RADAR showed that 7-day schemes had a 77.7% probability of achieving better results than 14-day treatments., [Conclusions] 7-day schemes allowed a reduction in antibiotic exposure of patients with eBSI while achieving outcomes similar to those of 14-day schemes. The possibility of relapsing fever in a limited number of patients, without relevance to final outcomes, may not be excluded, but was overcome by the benefits of shortening treatments., This work received technical support from the Spanish Network of Research in Infectious Diseases (REIPI) and the Spanish Clinical Research Network (SCReN) of the Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Spanish Government (PT13/0002/0010)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer

  • Lachiondo-Ortega, Sofía
  • Rejano-Gordillo, Claudia María
  • Simón, Jorge
  • Lopitz-Otsoa, Fernando
  • Delgado, Teresa C.
  • Mazan-Mamczarz, Krystyna
  • Goikoetxea-Usandizaga, Naroa
  • Zapata-Pavas, L. Estefanía
  • García-del Río, Ana
  • Guerra, Pietro
  • Peña-Sanfélix, Patricia
  • Hermán-Sánchez, Natalia
  • Al-Abdulla, Ruba
  • Fernández-Rodríguez, Carmen
  • Azkargorta, Mikel
  • Velázquez-Cruz, Alejandro
  • Guyon, Joris
  • Martín, César
  • Zalamea, Juan Diego
  • Egia-Mendikute, Leire
  • Sanz-Parra, Arantza
  • Serrano-Maciá, Marina
  • González-Recio, Irene
  • Gonzalez-López, Monika
  • Martínez-Cruz, Luis Alfonso
  • Pontisso, Patrizia
  • Aransay, Ana M.
  • Barrio, Rosa
  • Sutherland, James D.
  • Abrescia, Nicola G. A.
  • Elortza, Félix
  • Lujambio, Amaia
  • Banales, Jesús M.
  • Luque, Raúl M.
  • Gahete, Manuel D.
  • Palazón, Asís
  • Ávila, Matías A.
  • Marín, José J. G.
  • De, Supriyo
  • Daubon, Thomas
  • Diaz-Quintana, Antonio
  • Díaz-Moreno, Irene
  • Gorospe, Myriam
  • Rodríguez, Manuel S.
  • Martínez-Chantar, María Luz
© 2024 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)., The posttranslational modification of proteins critically influences many biological processes and is a key mechanism that regulates the function of the RNA-binding protein Hu antigen R (HuR), a hub in liver cancer. Here, we show that HuR is SUMOylated in the tumor sections of patients with hepatocellular carcinoma in contrast to the surrounding tissue, as well as in human cell line and mouse models of the disease. SUMOylation of HuR promotes major cancer hallmarks, namely proliferation and invasion, whereas the absence of HuR SUMOylation results in a senescent phenotype with dysfunctional mitochondria and endoplasmic reticulum. Mechanistically, SUMOylation induces a structural rearrangement of the RNA recognition motifs that modulates HuR binding affinity to its target RNAs, further modifying the transcriptomic profile toward hepatic tumor progression. Overall, SUMOylation constitutes a mechanism of HuR regulation that could be potentially exploited as a therapeutic strategy for liver cancer., This work was supported by grants to M.L.M.-C. from Departamento de Industria del Gobierno Vasco, Spain; Ministerio de Ciencia e Innovación, Spain (grant no. PID2020-117116RB-I00); European Regional Development Fund (ERDF), EU; and CIBERehd, which is funded by Instituto de Salud Carlos III (ISCIII), Spain. M.L.M.-C. and J.S. received funding from Ministerio de Ciencia e Innovación (grant no. RTC2019-007125-1) and ISCIII (grant no. DTS20/00138). M.L.M.-C. and R.M.L. acknowledge Ministerio de Ciencia e Innovación (grant no. RED2022-134397-T). M.L.M.-C. and J.M.B. were awarded with a grant from Fundación la Caixa, Spain (grant no. HR17-00601). M.L.M.-C., J.M.B., M.A.A., and J.J.G.M. acknowledge financial support from Fundación Científica de la Asociación Española Contra el Cáncer (AECC), Spain. M.S.R. recognizes funding from Fondo Sectorial de Investigación SRE - CONACYT, Mexico (grant no. 0280365); Horizon 2020 Research and Innovation Program funded under Marie Skłodowska-Curie Actions, EU (grant no. 765445); and REPÈRE and Programme de Prématuration from Région Occitanie, France. M.G., S.D., and K.M.-M. were supported by the National Institute on Aging (NIA), National Institutes of Health (NIH), US (grant no. Z01-AG000511-23). I.D.-M. is grateful for the grants received from Junta de Andalucía, Spain (grant no. BIO-198, US-1254317, P18-FR-3487, and P18-HO-4091); Ministerio de Ciencia, Innovación y Universidades, Spain (grant no. PGC2018-096049-BI00); and Fundación Ramón Areces, Spain. T.D. acknowledges Fondation ARC, France (grant no. 208084). J.J.G.M. was supported by Junta de Castilla y León, Spain (grant no. SA063P17); Fundación La Marató TV3, Spain (grant no. 201916-31); ISCIII (grant no. PI19/00819); CIBERehd; and ERDF (grant no. OLD-HEPAMARKER). M.A.A. recognizes Gobierno de Navarra, Spain (grant no. GºNa 42/21); Eurorregión Nueva Aquitania-Euskadi-Navarra, Spain; Ministerio de Ciencia e Innovación (grant no. PID2019-104878RB-I00); and CIBERehd. A.P. expresses gratitude to the European Research Council (ERC), EU (grant no. 804236) for their support. M.D.G. received financial support from Junta de Andalucía (grant no. PEMP-0036-2020 and BIO-0139); Ministerio de Universidades, Spain (grant no. FPU20/03957); ISCIII (grant no. PI20/01301), Fundación Sociedad Española de Endocrinología y Nutrición (FSEEN), Spain; CIBERehd; and CIBERobn, which is also funded by ISCIII. J.M.B. acknowledges Euskadi RIS3 (grant no. 2019222054, 2020333010, and 2021333003) and Elkartek programs from Gobierno Vasco (grant no. KK-2020/00008); ISCIII (grant no. PI18/01075, CPII19/00008, and PI21/00922); CIBERehd; PSC Support, UK; AMMF The Cholangiocarcinoma Charity, UK (grant no. EU/2019/AMMFt/001); Horizon 2020 Research and Innovation Program (grant no. 825510); ERDF; and PSC Partners Seeking a Cure, US. A.L. received financial support from the Damon Runyon-Rachleff Innovation Award, US (grant no. DR52-18) and the MERIT Award (R37) from the National Cancer Institute (NCI), NIH (grant no. R37CA230636). F.E. expresses his gratitude to ProteoRed from ISCIII (grant no. PT13/0001/0027) and CIBERehd. N.G.A.A. was funded by Ministerio de Ciencia, Innovación y Universidades (grant no. RTI2018-095700-B-I00). R.B. acknowledges financial support from Gobierno Vasco (grant no. IT1165-19); Ministerio de Economía, Industria y Competitividad, Spain (grant no. SAF2017-90900-REDT); Ministerio de Economía, Industria y Competitividad, ERDF (grant no. BFU2017-84653-P); Ministerio de Ciencia e Innovación (grant no. PID2020-114178GB-I00); and Horizon 2020 funded under Marie Skłodowska-Curie Actions (grant no. 765445-EU). A.M.A. acknowledges CIBERehd. L.A.M.-C. obtained grants from Ministerio de Economía y Competitividad (grant no. CSD2008-00005); Ministerio de Economía, Industria y Competitividad (grant no. BFU2016-77408-R); ISCIII; and EJP RD, EU (grant no. EJPRD19-040). I.G.-R. was supported by Ministerio de Economía, Industria y Competitividad (grant no. BES-2017-080435 ). M.S.-M. is grateful to the AECC, Sede de Bizkaia, Spain for the financial support. J.D.Z. was awarded with a grant from Ministerio de Economía, Industria y Competitividad (grant no. SEV-2016-0644-18-2). C.M. acknowledges Gobierno Vasco (grant no. IT-1264-19) and Ministerio de Ciencia e Innovación (grant no. PID2022-136788OB-I00). A.V.-C. was supported by Ministerio de Educación, Cultura y Deporte, Spain (grant no. FPU016/01513). C.F.-R. thanks Tekniker, Spain and CIC bioGUNE, Spain for financial support. A.G.-d.R. was funded by Bikaintek program from Gobierno Vasco (grant no. 48-AF-W1-2019-00012). N.G.-U. obtained a grant from Gobierno Vasco. T.C.D. expresses gratitude to AECC. J.S. received financial support from CIBERehd. C.M.R.-G. was supported by Ayudas a la Recualificación Margarita Salas from Universidad de Extremadura, Ministerio de Universidades financed by NextGenerationEU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: A post hoc emulation trial of the SIMPLIFY trial

  • Rando, Emanuele
  • Delgado-Valverde, Mercedes
  • Goikoetxea-Aguirre, Josune
  • Guio Carrión, Laura
  • Blanco-Vidal, María José
  • Barrios Andrés, José Luis
  • Pérez-Rodríguez, María Teresa
  • Martínez-Lamas, Lucía
  • Arnaiz de Las Revillas, Francisco
  • Armiñanzas, Carlos
  • Ruiz de Alegría, Carlos
  • Jiménez-Aguilar, Patricia
  • Martínez-Rubio, María del Carmen
  • Sáez-Béjar, Carmen
  • Cuevas, Carmen de las
  • Martín-Aspas, Andrés
  • Galán, Fátima
  • Yuste, José Ramón
  • Leiva-León, José
  • Bou, Germán
  • Capón González, Patricia
  • Boix-Palop, Lucía
  • Xercavins-Valls, Mariona
  • Goenaga Sánchez, Miguel Ángel
  • Anza, Diego Vicente
  • Castón, Juan José
  • Recio Rufián, Manuel
  • Merino, Esperanza
  • Rodríguez, Juan Carlos
  • Loeches, Belén
  • Rosso-Fernández, Clara
  • Bravo-Ferrer, José María
  • Retamar-Gentil, Pilar
  • Rodríguez-Baño, Jesús
  • López-Cortés, Luis Eduardo
[Objectives] We investigated the effectiveness of early oral switch for treating Enterobacterales bloodstream infection (BSI) by performing a post hoc emulation trial of the SIMPLIFY trial., [Methods] We conducted a post hoc analysis of a randomized controlled trial. We specified the target trial characteristics selecting patients who achieved clinical stability on day 5. We categorized patients into those who switched on day 5 and those who continued intravenously. The primary outcome was clinical cure at the test of cure. We set a propensity score for being switched on day 5 to reduce confounding. We ran simple, not-propensity-adjusted, and propensity-adjusted logistic regression models to ascertain the association of switch on day 5 with clinical cure., [Results] Among 303 patients who achieved clinical stability on day 5, 110 (36.3%) were switched orally on day 5, and 193 (63.7%) were kept intravenously. We detected no difference in clinical cure between those switched on day 5 and those continued intravenously (risk ratios 1.04, 95% confidence intervals [CI] 0.98-1.10). Propensity-adjusted analysis did not show an association between day 5 switch and clinical cure (OR 2.10, 95% CI 0.96-7.41)., [Conclusion] Oral step-down therapy on day 5 was not associated with worse clinical cure for Enterobacterales BSI., The study was funded by the Plan Nacional de I+D+i 2013‐2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001; 0002; 0003; 0005; 0007; 0008; 0009; 0011; 0012; 0015); Spanish Clinical Research and Clinical Trials Platform, (SCReN, PT13/0002/0010 and PT17/0017/0012, and PI15/00439), co‐financed by European Union; European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligence Growth 2014‐2020., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Fruit size and firmness QTL alleles of breeding interest identified in a sweet cherry ‘Ambrunés’ × ‘Sweetheart’ population

  • Calle, A.
  • Balas, F.
  • Cai, L.
  • Iezzoni, A.
  • López-Corrales, M.
  • Serradilla, M.J.
  • Wünsch, A.
The Spanish local cultivar ‘Ambrunés’ stands out due to its high organoleptic quality and fruit firmness. These characteristics make it an important parent for breeding cherries with excellent fresh and post-harvest quality. In this work, an F1 sweet cherry population (n = 140) from ‘Ambrunés’ × ‘Sweetheart’ was phenotyped for 2 years for fruit diameter, weight and firmness and genotyped with the RosBREED cherry Illumina Infinium® 6K SNP array v1. These data were used to construct a linkage map and to carry out quantitative trait locus (QTL) mapping of these fruit quality traits. Genotyping of the parental cultivars revealed that ‘Ambrunés’ is highly heterozygous, and its genetic map is the longest reported in the species using the same SNP array. Phenotypic data analyses confirmed a high heritability of fruit size and firmness and a distorted segregation towards softer and smaller fruits. However, individuals with larger and firmer fruits than the parental cultivars were observed, revealing the presence of alleles of breeding interest. In contrast to other genetic backgrounds in which a negative correlation was observed between firmness and size, in this work, no correlation or low positive correlation was detected between both traits. Firmness, diameter and weight QTLs detected validated QTLs previously found for the same traits in the species, and major QTLs for the three traits were located on a narrow region of LG1 of ‘Ambrunés’. Haplotype analyses of these QTLs revealed haplotypes of breeding interest in coupling phase in ‘Ambrunés’, which can be used for the selection of progeny with larger and firmer fruits.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

New Insights into Endogenous Retrovirus-K Transcripts in Amyotrophic Lateral Sclerosis

  • Moreno-Martinez, Laura
  • Macías-Redondo, Sofía
  • Strunk, Mark
  • Guillén-Antonini, María Isabel
  • Lunetta, Christian
  • Tarlarini, Claudia
  • Penco, Silvana
  • Calvo, Ana Cristina
  • Osta, Rosario
  • Schoorlemmer, Jon
Retroviral reverse transcriptase activity and the increased expression of human endogenous retroviruses (HERVs) are associated with amyotrophic lateral sclerosis (ALS). We were interested in confirming HERVK overexpression in the ALS brain, its use as an accessory diagnostic marker for ALS, and its potential interplay with neuroinflammation. Using qPCR to analyze HERVK expression in peripheral blood mononuclear cells (PBMCs) and in postmortem brain samples from ALS patients, no significant differences were observed between patients and control subjects. By contrast, we report alterations in the expression patterns of specific HERVK copies, especially in the brainstem. Out of 27 HERVK copies sampled, the relative expression of 17 loci was >1.2-fold changed in samples from ALS patients. In particular, the relative expression of two HERVK copies (Chr3-3 and Chr3-5) was significantly different in brainstem samples from ALS patients compared with controls. Further qPCR analysis of inflammation markers in brain samples revealed a significant increase in NLRP3 levels, while TNFA, IL6, and GZMB showed slight decreases. We cannot confirm global HERVK overexpression in ALS, but we can report the ALS-specific overexpression of selected HERVK copies in the ALS brain. Our data are compatible with the requirement for better patient stratification and support the potential importance of particular HERVK copies in ALS.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genome and transcriptome analysis of the Mesoamerican common bean and the role of gene duplications in establishing tissue and temporal specialization of genes

  • Vlasova, Anna
  • Capella-Gutiérrez, Salvador
  • Rendón-Anaya, Martha
  • Hernández-Oñate, Miguel
  • Minoche, André E.
  • Erb, Ionas
  • Câmara, Francisco
  • Prieto-Barja, Pablo
  • Corvelo, André
  • Sanseverino, Walter
  • Westergaard, Gastón
  • Dohm, Juliane C.
  • Pappas Jr, Georgios J.
  • Saburido-Alvarez, Soledad
  • Kedra, Darek
  • Gonzalez, Irene
  • Cozzuto, Luca
  • Gómez-Garrido, Jessica
  • Aguilar-Morón, María A.
  • Andreu, Nuria
  • Aguilar, O. Mario
  • Garcia-Mas, Jordi
  • Zehnsdorf, Maik
  • Vázquez, Martín P.
  • Delgado-Salinas, Alfonso
  • Delaye, Luis
  • Lowy, Ernesto
  • Mentaberry, Alejandro
  • Vianello-Brondani, Rosana P.
  • García, José Luís
  • Alioto, Tyler
  • Sánchez, Federico
  • Himmelbauer, Heinz
  • Santalla, Marta
  • Notredame, Cedric
  • Gabaldón, Toni
  • Herrera-Estrella, Alfredo
  • Guigó, Roderic
Background: Legumes are the third largest family of angiosperms and the second most important crop class. Legume genomes have been shaped by extensive large-scale gene duplications, including an approximately 58 million year old whole genome duplication shared by most crop legumes. Results: We report the genome and the transcription atlas of coding and non-coding genes of a Mesoamerican genotype of common bean (Phaseolus vulgaris L., BAT93). Using a comprehensive phylogenomics analysis, we assessed the past and recent evolution of common bean, and traced the diversification of patterns of gene expression following duplication. We find that successive rounds of gene duplications in legumes have shaped tissue and developmental expression, leading to increased levels of specialization in larger gene families. We also find that many long non-coding RNAs are preferentially expressed in germ-line-related tissues (pods and seeds), suggesting that they play a significant role in fruit development. Our results also suggest that most bean-specific gene family expansions, including resistance gene clusters, predate the split of the Mesoamerican and Andean gene pools. Conclusions: The genome and transcriptome data herein generated for a Mesoamerican genotype represent a counterpart to the genomic resources already available for the Andean gene pool. Altogether, this information will allow the genetic dissection of the characters involved in the domestication and adaptation of the crop, and their further implementation in breeding strategies for this important crop., info:eu-repo/semantics/publishedVersion
Docta Complutense
Publicación Artículo científico (JournalArticle)

Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial

  • Viana Tejedor, Ana Teresa
  • Martínez-Sellés D Oliveira Soares, Manuel
  • Fernández Ortiz, Antonio Ignacio
  • Pérez Villacastín Domínguez, Julián
El papel de la coronariografía urgente y angioplastia, si procede, en los pacientes con parada cardiaca extrahospitalaria (PCEH) recuperada que no presentan elevación del segmento ST es controvertido. Nuestro objetivo fue evaluar si la coronariografía urgente y la angioplastia mejoran la supervivencia con buen pronóstico neurológico en esta población. En este ensayo clínico multicéntrico, aleatorizado, abierto, incluimos 69 pacientes supervivientes a una PCEH sin elevación del ST y se aleatorizaron a recibir una coronariografía urgente (CU) o diferida (CD). El objetivo primario de eficacia fue el combinado de supervivencia hospitalaria libre de dependencia. El objetivo de seguridad fue un compuesto de eventos cardiacos mayores, incluyendo muerte, reinfarto, sangrado y arritmias ventriculares. Resultados: Se incluyó a 66 pacientes en el análisis primario (95,7%). La supervivencia hospitalaria fue 62,5% en el grupo CU y 58,8% en el grupo CD (HR = 0,96; IC95%, 0,45-2,09; p = 0,93). La supervivencia hospitalaria con buen pronóstico neurológico fue 59,4% en el grupo CU y 52,9% en el grupo CD (HR = 1,29; IC95%, 0,60-2,73; p = 0,4986). No se encontraron diferencias en los objetivos secundarios, salvo por la incidencia de fracaso renal agudo, que fue más frecuente en el grupo CU (15,6 frente a 0%, p = 0,002) y de infecciones, más prevalentes en el grupo CD (46,9 frente a 73,5%, p = 0,003). Conclusiones: En este estudio aleatorizado de pacientes con una PCEH sin elevación del ST, una coronariografía urgente no fue beneficiosa en términos de supervivencia con buen pronóstico neurológico comparada con una coronariografía diferida.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Candida albicans cell shaving uncovers new proteins involved in cell wall integrity, yeast to hypha transition, stress response and host-pathogen interaction.

  • Gil Bona, Ana
  • Parra Giraldo, Claudia Marcela
  • Hernáez, María Luisa
  • Reales Calderón, José Antonio
  • Solis, Norma V.
  • Filler, Scott G.
  • Monteoliva Díaz, Lucía
  • Gil , Concha
The ability to switch from yeast to hyphal growth is essential for virulence in Candida albicans. The cell surface is the initial point of contact between the fungus and the host. In this work, a free-gel proteomic strategy based on tryptic digestion of live yeast and hyphae cells and protein identification using LC-MS/MS methodology was used to identify cell surface proteins. Using this strategy, a total of 943 proteins were identified, of which 438 were in yeast and 928 were in hyphae. Of these proteins, 79 were closely related to the organization and biogenesis of the cell wall, including 28 GPI-anchored proteins, such as Hyr1 and Sod5 which were detected exclusively in hyphae, and Als2 and Sap10which were detected only in yeast. A group of 17 proteins of unknown function were subsequently studied by analysis of the corresponding deletion mutants. We found that four new proteins, Pst3, Tos1, Orf19.3060 and Orf19.5352 are involved in cell wall integrity and in C. albicans' engulfment by macrophages. Moreover, the putative NADH-ubiquinone-related proteins, Ali1, Mci4, Orf19.287 and Orf19.7590, are also involved in osmotic and oxidative resistance, yeast to hypha transition and the ability to damage and invade oral epithelial cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs

  • Nogales, Vanesa
  • Reinhold, William C.
  • Varma, Sudhir
  • Martínez Cardús, Anna|||0000-0002-3937-8794
  • Moutinho, Catia|||0000-0003-3885-0847
  • Moran, S.|||0000-0003-4192-8983
  • Heyn, Holger|||0000-0002-3276-1889
  • Sebio, Ana|||0000-0003-3333-2370
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
  • Pommier, Yves
  • Esteller, M.|||0000-0003-4490-6093
Platinum-derived drugs such as cisplatin and carboplatin are among the most commonly used cancer chemotherapy drugs, but very few specific molecular and cellular markers predicting differential sensitivity to these agents in a given tumor type have been clearly identified. Epigenetic gene silencing is increasingly being recognized as a factor conferring distinct tumoral drug sensitivity, so we have used a comprehensive DNA methylation microarray platform to interrogate the widely characterized NCI60 panel of human cancer cell lines with respect to CpG methylation status and cisplatin/carboplatin sensitivity. Using this approach, we have found promoter CpG island hypermethylation-associated silencing of the putative DNA/RNA helicase Schlafen-11 (SLFN11) to be associated with increased resistance to platinum compounds. We have also experimentally validated these findings in vitro. In this setting, we also identified the BRCA1 interacting DHX9 RNA helicase (also known as RHA) as a protein partner for SLFN11, suggesting a mechanistic pathway for the observed chemoresistance effect. Most importantly, we have been able to extend these findings clinically, following the observation that those patients with ovarian and non-small cell lung cancer carrying SLFN11 hypermethylation had a poor response to both cisplatin and carboplatin treatments. Overall, these results identify SLFN11 epigenetic inactivation as a predictor of resistance to platinum drugs in human cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Puiggros, Anna|||0000-0001-9627-4978
  • Baliakas, Panagiotis|||0000-0002-5634-7156
  • Athanasiadou, Anastasia
  • García-Malo, MaDolores
  • Collado, Rosa|||0000-0002-8205-6192
  • Xochelli, Aliki
  • Rodríguez-Rivera, María
  • Ortega, Margarita
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Luño, Elisa
  • Vargas, MªTeresa
  • Grau Cat, Javier
  • Martínez-Laperche, Carolina
  • Valiente, Alberto
  • Cervera, José|||0000-0001-8252-1106
  • Anagnostopoulos, Achilles|||0000-0003-4384-9031
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Stalika, Evangelia
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Robles, Diego
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Ivars, David
  • González, Marcos
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Stamatopoulos, Kostas|||0000-0001-8529-640X
  • Espinet Solà, Blanca|||0000-0002-4294-8145
Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53 abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53 abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, ≥3 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10-year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53 abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer

  • Sequeiros, Tamara|||0000-0002-0908-2263
  • Rigau, Marina|||0000-0002-1691-454X
  • Chiva, Cristina
  • Montes, Melania|||0000-0002-4268-6608
  • Garcia-Grau, Iolanda
  • García, Marta|||0000-0001-5155-4730
  • Diaz-Mercedes, Sherley|||0000-0002-8164-8639
  • Celma, Ana|||0000-0002-3128-3811
  • Bijnsdorp, Irene
  • Campos, Alexandre
  • Di Mauro, Primiano
  • Borrós, Salvador|||0000-0002-4003-0381
  • Reventós, Jaume
  • Doll, Andreas|||0000-0001-8965-8682
  • Paciucci, Rosanna|||0000-0001-5651-5933
  • Pegtel, Michiel
  • de Torres, Inés|||0000-0002-5495-9140
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Morote Robles, Juan|||0000-0002-2168-323X
  • Olivan, Mireia|||0000-0002-8464-0827
Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. Here, we describe a set of protein-combination panels in urinary extracellular vesicles (EVs), defined by targeted proteomics and immunoblotting techniques that improve early non-invasive detection and stratification of PCa patients.We report a two-protein combination in urinary EVs that classifies benign and PCa patients (ADSV-TGM4), and a combination of five proteins able to significantly distinguish between high- and low-grade PCa patients (CD63-GLPK5-SPHM-PSA-PAPP). Proteins composing the panels were validated by immunohistochemistry assays in tissue microarrays (TMAs) confirming a strong link between the urinary EVs proteome and alterations in PCa tissues. Moreover, ADSV and TGM4 abundance yielded a high diagnostic potential in tissue and promising TGM4 prognostic power. These results suggest that the proteins identified in urinary EVs distinguishing high- and low grade PCa are a reflection of histological changes that may be a consequence of their functional involvement in PCa development. In conclusion, our study resulted in the identification of protein-combination panels present in urinary EVs that exhibit high sensitivity and specificity for PCa detection and patient stratification. Moreover, our study highlights the potential of targeted proteomic approaches-such as selected reaction monitoring (SRM)-as diagnostic assay for liquid biopsies via urinary EVs to improve diagnosis and prognosis of suspected PCa patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

  • Zabala-Letona, Amaia
  • Arruabarrena-Aristorena, Amaia|||0000-0002-1636-3944
  • Martín Martín, Natalia
  • Fernández Ruiz, Sonia
  • Sutherland, James D.|||0000-0003-3229-793X
  • Clasquin, Michelle
  • Tomás Cortázar, Julen
  • Jiménez, José
  • Torres Ramírez, Inés Ma. de
  • Quang, Phong
  • Ximénez-Embún, Pilar|||0000-0002-2582-9443
  • Bago, Ruzica
  • Ugalde Olano, Aitziber
  • Loizaga Iriarte, Ana
  • Lacasa-Viscasillas, Isabel
  • Unda, Miguel
  • Torrano, Verónica
  • Cabrera, Diana
  • van Liempd, Sebastiaan M.
  • Cendon, Ylenia
  • Castro, Elena|||0000-0002-3691-6454
  • Murray, Stuart
  • Revandkar, Ajinkya
  • Alimonti, Andrea
  • Zhang, Yinan
  • Barnett, Amelia
  • Lein, Gina
  • Pirman, David
  • Cortazar, Ana Rosa|||0000-0002-7082-5695
  • Arreal, Leire
  • Prudkin, Ludmila
  • Astobiza, Ianire|||0000-0002-7142-7066
  • Valcarcel-Jimenez, Lorea
  • Zúñiga-García, Patricia
  • Fernández Domínguez, Itziar
  • Piva, Marco
  • Caro-Maldonado, Alfredo|||0000-0002-5431-7949
  • Sánchez Mosquera, Pilar
  • Castillo Martín, Mireia
  • Serra, Violeta|||0000-0001-6620-1065
  • Beraza, Naiara
  • Gentilella, Antonio|||0000-0002-6830-2086
  • Thomas, George|||0000-0002-1236-1714
  • Azkargorta, Mikel
  • Elortza, Felix|||0000-0001-8839-5438
  • Farràs, Rosa
  • Olmos, David
  • Efeyan, Alejo
  • Anguita, Juan
  • Muñoz, Javier|||0000-0003-3288-3496
  • Falcón-Pérez, Juan M.|||0000-0003-3133-0670
  • Barrio, Rosa|||0000-0002-9663-0669
  • Macarulla Mercadé, Teresa|||0000-0002-5856-4082
  • Mato, José M.
  • Martínez Chantar, Maria L.
  • Cordon Cardo, Carlos
  • Aransay, Ana M.|||0000-0002-8271-612X
  • Marks, Kevin
  • Baselga Torres, Josep
  • Tabernero, Josep|||0000-0002-2495-8139
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Manning, Brendan D.
  • Marjon, Katya
  • Carracedo, Arkaitz|||0000-0001-5957-1260
Activation of the PTEN-PI3K-mTORC1 pathway consolidates metabolic programs that sustain cancer cell growth and proliferation,. Here we show that mTORC1 regulates polyamine dynamics, a metabolic route that is essential for oncogenicity. Through the use of integrative metabolomics in a mouse model and human biopsies of prostate cancer, we identified alterations in tumours impacting on the production of decarboxylated S-adenosylmethionine (dcSAM) and polyamine synthesis. Mechanistically, this metabolic rewiring stems from mTORC1-dependent regulation of S-adenosylmethionine decarboxylase 1 (AMD1) stability. This novel molecular regulation was validated in murine and human cancer specimens. AMD1 was upregulated in prostate cancer specimens with activated mTORC1. Conversely, samples from a clinical trial with the mTORC1 inhibitor everolimus exhibited a predominant decrease in AMD1 immunoreactivity that was associated to a decrease in proliferation, in line with the requirement of dcSAM production for oncogenicity. These findings provide fundamental information about the complex regulatory landscape controlled by mTORC1 to integrate and translate growth signals into an oncogenic metabolic program.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

  • Puiggros, Anna|||0000-0001-9627-4978
  • Collado, Rosa|||0000-0002-8205-6192
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Ortega, Margarita
  • Ruiz-Xivillé, Neus
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Luño, Elisa
  • González, Teresa
  • Navarro, Blanca
  • García-Malo, MaDolores
  • Valiente, Alberto
  • Hernández, José Ángel
  • Ardanaz, María Teresa
  • Piñan, María Ángeles
  • Blanco, María Laura
  • Hernández-Sánchez, María|||0000-0001-9968-2782
  • Batlle Lopez, Ana|||0000-0003-4143-9020
  • Salgado Sánchez, Rocío Nieves|||0000-0003-1678-8982
  • Salido, Marta|||0000-0001-9988-5977
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Terol, María José
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Costa, Dolors|||0000-0002-8276-3292
  • Moreno, Carol|||0000-0003-3275-0271
  • Carbonell, Félix
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Delgado, Julio|||0000-0002-5157-4376
  • Espinet i Solà, Blanca
Genomic complexity identified by chromosome banding analysis (CBA) predicts a worse clinical outcome in CLL patients treated either with standard or new treatments. Herein, we analyzed the clinical impact of complex karyotypes (CK) with or without high-risk FISH deletions (ATM and/or TP53, HR-FISH) in a cohort of 1045 untreated MBL/CLL patients. In all, 99/1045 (9.5%) patients displayed a CK. Despite ATM and TP53 deletions were more common in CK (25% vs 7%; P < 0.001; 40% vs 5%; P < 0.001, respectively), only 44% (40/90) patients with TP53 deletions showed a CK. CK group showed a significant higher two-year cumulative incidence of treatment (48% vs 20%; P < 0.001), as well as a shorter overall survival (OS) (79 mo vs not reached; P < 0.001). When patients were categorized regarding CK and HR-FISH, those with both characteristics showed the worst median OS (52 mo) being clearly distinct from those non-CK and non-HR-FISH (median not reached), but no significant differences were detected between cases with only CK or HR-FISH. Both CK and TP53 deletion remained statistically significant in the multivariate analysis for OS. In conclusion, CK group is globally associated with advanced disease and poor prognostic markers. Further investigation in larger cohorts with CK lacking HR-FISH is needed to elucidate which mechanisms underlie the poor outcome of this subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Text mining and expert curation to develop a database on psychiatric diseases and their genes

  • Gutiérrez-Sacristán, Alba
  • Bravo, Àlex
  • Portero Tresserra, Marta|||0000-0003-4149-1339
  • Valverde, Olga|||0000-0003-2264-7852
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Blanco-Gandía, M. C.
  • Farré Martínez, Adriana|||0000-0001-5399-9389
  • Fernández Ibarrondo, Lierni|||0000-0003-2612-0484
  • Fonseca, Francina|||0000-0002-0779-6545
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Leis, Angela
  • Mané, Anna|||0000-0003-2127-349X
  • Mayer, M. A.
  • Montagud-Romero, Sandra
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Ortiz de Pablo, Jordi|||0000-0002-9748-2290
  • Pavon, Francisco Javier
  • Perez, Ezequiel Jesús
  • Rodríguez-Arias, Marta
  • Serrano, Antonia
  • Torrens, Marta
  • Warnault, Vincent
  • Sanz, Ferran|||0000-0002-7534-7661
  • Furlong, Laura I.
Psychiatric disorders constitute one of the main causes of disability worldwide. During the past years, considerable research has been conducted on the genetic architecture of such diseases, although little understanding of their etiology has been achieved. The difficulty to access up-to-date, relevant genotype-phenotype information has hampered the application of this wealth of knowledge to translational research and clinical practice in order to improve diagnosis and treatment of psychiatric patients. PsyGeNET () has been developed with the aim of supporting research on the genetic architecture of psychiatric diseases, by providing integrated and structured accessibility to their genotype-phenotype association data, together with analysis and visualization tools. In this article, we describe the protocol developed for the sustainable update of this knowledge resource. It includes the recruitment of a team of domain experts in order to perform the curation of the data extracted by text mining. Annotation guidelines and a web-based annotation tool were developed to support the curators' tasks. A curation workflow was designed including a pilot phase and two rounds of curation and analysis phases. Negative evidence from the literature on gene-disease associations (GDAs) was taken into account in the curation process. We report the results of the application of this workflow to the curation of GDAs for PsyGeNET, including the analysis of the inter-annotator agreement and suggest this model as a suitable approach for the sustainable development and update of knowledge resources. Database URL : PsyGeNET corpus:.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

PMut, a web-based tool for the annotation of pathological variants on proteins, 2017 update

  • López-Ferrando, Víctor
  • Gazzo, Andrea
  • de la Cruz, Xavier|||0000-0002-9738-8472
  • Orozco López, Modesto|||0000-0002-8608-3278
  • Gelpí, Josep Ll|||0000-0002-0566-7723
We present here a full update of the PMut predictor, active since 2005 and with a large acceptance in the field of predicting Mendelian pathological mutations. PMut internal engine has been renewed, and converted into a fully featured standalone training and prediction engine that not only powers PMut web portal, but that can generate custom predictors with alternative training sets or validation schemas. PMut Web portal allows the user to perform pathology predictions, to access a complete repository of pre-calculated predictions, and to generate and validate new predictors. The default predictor performs with good quality scores (MCC values of 0.61 on 10-fold cross validation, and 0.42 on a blind test with SwissVar 2016 mutations). The PMut portal is freely accessible at http://mmb.irbbarcelona.org/PMut. A complete help and tutorial is available at http://mmb.irbbarcelona.org/PMut/help.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer

  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Tonda, Raúl
  • Gausachs, Mireia
  • Trotta, Jean-Rémi
  • Castellanos, Elisabeth|||0000-0002-8133-5325
  • López-Doriga, Adriana
  • Teule, Alex|||0000-0003-0028-7200
  • Tornero, Eva
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Gel, Bernat|||0000-0001-8878-349X
  • Gut, Marta|||0000-0002-4063-7159
  • Pineda, Marta|||0000-0002-5403-5845
  • González, Sara
  • Menéndez, Mireia
  • Navarro, Matilde
  • Capella, Gabriel|||0000-0002-4669-7320
  • Gut, Ivo|||0000-0001-7219-632X
  • Serra, Eduard|||0000-0003-2895-9857
  • Brunet, Joan|||0000-0003-1945-3512
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Lázaro García, Conxi|||0000-0002-7198-5906
Next generation sequencing panels have been developed for hereditary cancer, although there is some debate about their cost-effectiveness compared to exome sequencing. The performance of two panels is compared to exome sequencing. Twenty-four patients were selected: ten with identified mutations (control set) and fourteen suspicious of hereditary cancer but with no mutation (discovery set). TruSight Cancer (94 genes) and a custom panel (122 genes) were assessed alongside exome sequencing. Eightythree genes were targeted by the two panels and exome sequencing. More than 99% of bases had a read depth of over 30x in the panels, whereas exome sequencing covered 94%. Variant calling with standard settings identified the 10 mutations in the control set, with the exception of MSH6 c.255dupC using TruSight Cancer. In the discovery set, 240 unique non-silent coding and canonic splice-site variants were identified in the panel genes, 7 of them putatively pathogenic (in ATM, BARD1, CHEK2, ERCC3, FANCL, FANCM, MSH2). The three approaches identified a similar number of variants in the shared genes. Exomes were more expensive than panels but provided additional data. In terms of cost and depth, panels are a suitable option for genetic diagnostics, although exomes also identify variants in non-targeted genes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples

  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Arpí Lluciá, Oriol|||0000-0002-5578-2092
  • Martinez-García, Maria
  • Pineda, Estela|||0000-0003-2128-747X
  • Mallo, Maria del Mar|||0000-0001-7741-498X
  • Gut, Marta|||0000-0002-4063-7159
  • Carrato, Cristina|||0000-0002-1953-8287
  • Rovira, Anna
  • Lopez, Raquel
  • Tortosa, Avelina|||0000-0002-9080-2976
  • Dabad, Marc|||0000-0002-6094-747X
  • Del Barco Berrón, Sonia|||0000-0002-4951-6871
  • Heath, Simon|||0000-0002-9550-0897
  • Bagué Rosell, Sílvia|||0000-0001-9980-7231
  • Ribalta Farres, Teresa|||0000-0003-2692-0051
  • Alameda, Francesc|||0000-0002-7302-6901
  • de la Iglesia, Nuria|||0000-0002-1083-7715
  • Balañá, Carmen|||0000-0003-0771-0390
The molecular classification of glioblastoma (GBM) based on gene expression might better explain outcome and response to treatment than clinical factors. Whole transcriptome sequencing using next-generation sequencing platforms is rapidly becoming accepted as a tool for measuring gene expression for both research and clinical use. Fresh frozen (FF) tissue specimens of GBM are difficult to obtain since tumor tissue obtained at surgery is often scarce and necrotic and diagnosis is prioritized over freezing. After diagnosis, leftover tissue is usually stored as formalin-fixed paraffin-embedded (FFPE) tissue. However, RNA from FFPE tissues is usually degraded, which could hamper gene expression analysis. We compared RNA-Seq data obtained from matched pairs of FF and FFPE GBM specimens. Only three FFPE out of eleven FFPE-FF matched samples yielded informative results. Several quality-control measurements showed that RNA from FFPE samples was highly degraded but maintained transcriptomic similarities to RNA from FF samples. Certain issues regarding mutation analysis and subtype prediction were detected. Nevertheless, our results suggest that RNA-Seq of FFPE GBM specimens provides reliable gene expression data that can be used in molecular studies of GBM if the RNA is sufficiently preserved.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exposure to disinfection by-products in swimming pools and biomarkers of genotoxicity and respiratory damage - The PISCINA2 Study

  • Font Ribera, Laia|||0000-0001-8447-4905
  • Marco, Esther
  • Grimalt, Joan|||0000-0002-7391-5768
  • Pastor Benito, Susana|||0000-0003-2454-5163
  • Marcos, Ricard|||0000-0001-7891-357X
  • Abramsson-Zetterberg, Lilianne
  • Pedersen, Marie
  • Grummt, Tamara
  • Junek, Ralf
  • Barreiro, Esther|||0000-0003-2708-3443
  • Heederik, Dick
  • Spithoven, Jack
  • Critelli, Rossana
  • Naccarati, Alessio
  • Schmalz, Christina
  • Zwiener, Christian
  • Liu, Jiaqi
  • Zhang, Xiangru
  • Mitch, William
  • Gracia-Lavedan, Esther
  • Arjona, Lourdes
  • De Bont, Jeroen|||0000-0001-9924-5961
  • Tarès, Lluïsa
  • Vineis, Paolo
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Villanueva, Cristina|||0000-0002-0783-1259
Background: Swimming in pools is a healthy activity that entails exposure to disinfection by-products (DBPs), some of which are irritant and genotoxic. Objectives: We evaluated exposure to DBPs during swimming in a chlorinated pool and the association with short-term changes in genotoxicity and lung epithelium permeability biomarkers. Methods: Non-smoker adults (N = 116) swimming 40 min in an indoor pool were included. We measured a range of biomarkers before and at different times after swimming: trihalomethanes (THMs) in exhaled breath (5 min), trichloroacetic acid (TCAA) in urine (30 min), micronuclei in lymphocytes (1 h), serum club cell protein (CC16) (1 h), urine mutagenicity (2 h) and micronuclei in reticulocytes (4 days in a subset, N = 19). Several DBPs in water and trichloramine in air were measured, and physical activity was extensively assessed. We estimated interactions with polymorphisms in genes related to DBP metabolism. Results: Median level of chloroform, brominated and total THMs in water was 37.3, 9.5 and 48.5, μg/L, respectively, and trichloramine in air was 472.6 μg/m. Median exhaled chloroform, brominated and total THMs increased after swimming by 10.9, 2.6 and 13.4, μg/m, respectively. Creatinine-adjusted urinary TCAA increased by 3.1 μmol/mol. Micronuclei in lymphocytes and reticulocytes, urine mutagenicity and serum CC16 levels remained unchanged after swimming. Spearman correlation coefficients showed no association between DBP exposure and micronuclei in lymphocytes, urine mutagenicity and CC16. Moderate associations were observed for micronuclei in reticulocytes and DBP exposure. Conclusions: The unchanged levels of the short-term effect biomarkers after swimming and null associations with personal estimates of exposure to DBPs suggest no measurable effect on genotoxicity in lymphocytes, urine mutagenicity and lung epithelium permeability at the observed exposure levels. The moderate associations with micronuclei in reticulocytes require cautious interpretation given the reduced sample size.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differential association between S100A4 levels and insulin resistance in prepubertal children and adult subjects with clinically severe obesity

  • Taxerås, Siri D.
  • Galán, María|||0000-0002-4758-8388
  • Campderrós, Laura
  • Piquer García, Irene|||0000-0002-6746-3558
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Martínez, Eva
  • Puig, Rocío
  • Lucena, Icíar
  • Tarascó, Jordi|||0000-0001-6820-7946
  • Moreno, Pau|||0000-0002-6652-120X
  • Balibrea Del Castillo, José María|||0000-0002-0764-7179
  • Bel, Joan|||0000-0002-3577-6322
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Martínez, María
  • Ramon-Krauel, Marta|||0000-0003-3027-9105
  • Puig Domingo, Manuel|||0000-0002-6744-7195
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Lerin, Carles|||0000-0003-0950-4363
  • Sánchez-Infantes, David|||0000-0001-6086-7501
Objectives: S100A4 has been recently identified as an adipokine associated with insulin resistance (IR) in adult subjects with obesity. However, no data about its levels in children with obesity and only a few approaches regarding its potential mechanism of action have been reported. To obtain a deeper understanding of the role of S100A4 in obesity, (a) S100A4 levels were measured in prepubertal children and adult subjects with and without obesity and studied the relationship with IR and (b) the effects of S100A4 in cultured human adipocytes and vascular smooth muscle cells (VSMCs) were determined. Methods: Sixty-five children (50 with obesity, age 9.0 ±1.1 years and 15 normal weight, age 8.4 ±0.8 years) and fifty-nine adults (43 with severe obesity, age 46 ±11 years and 16 normal weight, age 45 ±9 years) were included. Blood from children and adults and adipose tissue samples from adults were obtained and analysed. Human adipocytes and VSMC were incubated with S100A4 to evaluate their response to this adipokine. Results: Circulating S100A4 levels were increased in both children (P =.002) and adults (P <.001) with obesity compared with their normal-weight controls. In subjects with obesity, S100A4 levels were associated with homeostatic model assessment-insulin resistance (HOMA-IR) in adults (βstd =.42, P =.008) but not in children (βstd =.12, P =.356). Human adipocytes were not sensitive to S100A4, while incubation with this adipokine significantly reduced inflammatory markers in VSMC. Conclusions: Our human data demonstrate that higher S100A4 levels are a marker of IR in adults with obesity but not in prepubertal children. Furthermore, the in vitro results suggest that S100A4 might exert an anti-inflammatory effect. Further studies will be necessary to determine whether S100A4 can be a therapeutic target for obesity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnostic accuracy of non-melanocytic pink flat skin lesions on the legs, Dermoscopic and reflectance confocal microscopy evaluation

  • Gómez Martín, Ignacio
  • Moreno Fernández, Sara
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Segura, Sonia|||0000-0003-0653-1382
Pink flat skin lesions on the legs in elderly people represent a diagnostic challenge due to the paucity of clinical and dermoscopic evidence. A prospective study of 114 pink flat lesions on the legs of 85 elderly patients was performed to describe the utility of reflectance confocal microscopy in this clinical context. Evaluation of clinical, dermoscopic and confocal parameters and calculation of diagnostic accuracy/sensi-tivity/specificity for non-melanoma skin cancer diagnosis of each technique were carried out. Thirty-four benign and 80 malignant neoplasms were analysed. A correct clinical diagnosis was established in 49.1% of cases (sensitivity 68.7%, specificity 73.5%). Dermoscopy achieved 59.6% correct diagnosis (sensiti-vity 85%, specificity 67.6%) and confocal microscopy evaluation after clinical and dermoscopic evaluation rendered a correct diagnosis in 85.1% of cases (sensi-tivity 97.5%, specificity 88.2%). Confocal microscopy may improve diagnostic accuracy, sensitivity and specificity as a secondary evaluation after dermoscopy. A diagnostic confocal algorithm for pink flat lesions on the legs is proposed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BDNF genetic variants and methylation, effects on cognition in major depressive disorder

  • Ferrer, Alex|||0000-0002-3040-1177
  • Labad, Javier|||0000-0003-2214-1886
  • Salvat-Pujol, Neus|||0000-0001-5320-331X
  • Barrachina, Marta
  • Costas, Javier|||0000-0003-0306-3990
  • Urretavizcaya, Mikel|||0000-0002-9746-4068
  • De Arriba-Arnau, Aida|||0000-0002-7877-7341
  • Crespo, José M.
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soria, Virginia|||0000-0001-6412-6831
Brain-derived neurotrophic factor (BDNF) gene regulation has been linked to the pathophysiology of major depressive disorder (MDD). MDD patients show cognitive deficits, and altered BDNF regulation has a relevant role in neurocognitive functions. Our goal was to explore the association between BDNF genetic and epigenetic variations with neurocognitive performance in a group of MDD patients and healthy controls considering possible modulating factors. The sample included 134 subjects, 64 MDD patients, and 70 healthy controls. Clinical data, childhood maltreatment, and neurocognitive performance were assessed in all participants. Eleven single nucleotide polymorphisms (SNPs) and two promoter regions in the BDNF gene were selected for genotype and methylation analysis. The role of interactions between BDNF genetic and epigenetic variations with MDD diagnosis, sex, and Childhood Trauma Questionnaire (CTQ) scores was also explored. We observed significant associations between neurocognitive performance and two BDNF SNPs (rs908867 and rs925946), an effect that was significantly mediated by methylation values at specific promoter I sites. We identified significant associations between neurocognitive results and methylation status as well as its interactions with MDD diagnosis, sex, and CTQ scores. Our results support the hypothesis that BDNF gene SNPs and methylation status, as well as their interactions with modulating factors, can influence cognition. Further studies are required to confirm the effect of BDNF variations and cognitive function in larger samples.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

  • Janin, Maxime|||0000-0003-1013-4128
  • Ortiz-Barahona, V.
  • de Moura, M. C.
  • Martínez Cardús, Anna|||0000-0002-3937-8794
  • Llinàs-Arias, Pere|||0000-0002-3666-0532
  • Soler, Marta|||0000-0002-6656-957X
  • Nachmani, D.
  • Pelletier, Joffrey|||0000-0001-9174-044X
  • Schumann, U.
  • Calleja-Cervantes, María Eréndira|||0000-0003-0688-0793
  • Moran, S.|||0000-0003-4192-8983
  • Guil, Sonia|||0000-0002-2257-3331
  • Bueno-Costa, Alberto|||0000-0001-8700-2540
  • Piñeyro, David|||0000-0001-5633-3339
  • Perez-Salvia, Montserrat
  • Rosselló-Tortella, M.
  • Piqué, Laia
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • De La Torre Gómez, Gisela Carolina|||0000-0001-9363-291X
  • Vidal, August|||0000-0001-5727-2099
  • Martínez-Iniesta, M.
  • Martín-Tejera, J. F.
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Arias, Alexandra
  • Cuartas, Isabel
  • Aransay, Ana M.|||0000-0002-8271-612X
  • La Madrid, A. M.
  • Carcaboso, Angel M.|||0000-0002-8485-426X
  • Santa-Maria, V.
  • Mora, J.
  • Fernández, Agustín F.|||0000-0002-3792-4085
  • Fraga, M. F.
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Pedrosa, Leire|||0000-0002-1852-4975
  • Graus Ribas, Francesc|||0000-0002-8924-8322
  • Vidal, Noemí|||0000-0002-2852-6667
  • Martinez, Fina|||0000-0002-0940-1025
  • Tortosa, Avelina|||0000-0002-9080-2976
  • Carrato, Cristina|||0000-0002-1953-8287
  • Balañá, Carmen|||0000-0003-0771-0390
  • Boudreau, M. W.
  • Hergenrother, P. J.
  • Kötter, P.
  • Entian, K. D.
  • Hench, Jürgen
  • Frank, Stephan|||0000-0001-6165-0187
  • Mansouri, S.
  • Zadeh, G.
  • Dans, P. D.
  • Orozco López, Modesto|||0000-0002-8608-3278
  • Thomas, Gareth J.
  • Blanco, Sandra
  • Seoane Suárez, Joan|||0000-0002-6541-5974
  • Preiss, T.
  • Pandolfi, P. P.
  • Esteller, M.|||0000-0003-4490-6093
Tumors have aberrant proteomes that often do not match their corresponding transcriptome profiles. One possible cause of this discrepancy is the existence of aberrant RNA modification landscapes in the so-called epitranscriptome. Here, we report that human glioma cells undergo DNA methylation-associated epigenetic silencing of NSUN5, a candidate RNA methyltransferase for 5-methylcytosine. In this setting, NSUN5 exhibits tumor-suppressor characteristics in vivo glioma models. We also found that NSUN5 loss generates an unmethylated status at the C3782 position of 28S rRNA that drives an overall depletion of protein synthesis, and leads to the emergence of an adaptive translational program for survival under conditions of cellular stress. Interestingly, NSUN5 epigenetic inactivation also renders these gliomas sensitive to bioactivatable substrates of the stress-related enzyme NQO1. Most importantly, NSUN5 epigenetic inactivation is a hallmark of glioma patients with long-term survival for this otherwise devastating disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY), An open-label, randomised, non-inferiority clinical trial

  • Páez-Vega, Aurora
  • Cantisan, Sara
  • Vaquero, José Manuel|||0000-0002-3923-3245
  • Vidal, Elisa
  • Luque-Pineda, Antonio
  • Lobo-Acosta, María Ángeles|||0000-0002-8587-7201
  • Pérez, Ana Belén|||0000-0001-9655-817X
  • Alonso-Moralejo, Rodrigo|||0000-0002-7833-5084
  • Iturbe, David|||0000-0002-5241-266X
  • Monforte, Víctor|||0000-0002-2918-7679
  • Otero-González, Isabel|||0000-0003-4718-7477
  • Pastor, Amparo
  • Ussetti, Piedad|||0000-0002-3439-5536
  • Torre-Cisneros, J.|||0000-0003-1529-6302
Introduction Prolonged use of antivirals to prevent the development of cytomegalovirus (CMV) disease in lung transplant patients has been shown to have significant side effects, for which alternatives are being sought to reduce their use. The monitoring of cell immunity against CMV could be an alternative as it has shown to be useful in identifying transplant patients at low risk of infection, who could benefit from shorter prophylaxis. The aim of the CYTOCOR study is to demonstrate that the combination of a reduced prophylaxis strategy with subsequent CMV-specific immunological monitoring would allow CMV infection to be controlled in lung transplant patients as effectively as the usual strategy (prophylaxis followed by pre-emptive therapy), while reducing the side effects of antivirals due to the shorter duration of prophylaxis. Methods and analysis Phase III randomised, open, multicentre, parallel, non-inferiority clinical trial to study the efficacy and safety of the combination of a prophylaxis strategy up to month +3 post-transplant followed by immuno-guided prophylaxis using the QuantiFERON-CMV technique up to month +12 post-transplant to prevent CMV disease in CMV-seropositive lung transplant recipients. This strategy will be compared with a combination of a usual prophylaxis strategy up to month +6 post-transplant followed by pre-emptive therapy up to month +12. To study the incidence of CMV disease, patients will be followed up to 18 months post-transplantation. A total of 150 patients are expected to be recruited for the study. Ethics and public dissemination The clinical trial has been approved by the Research Ethics Committees and authorised by the Spanish Agency of Medicines and Medical Devices (AEMPS). If the hypothesis of this clinical trial is verified, the dissemination of the results could change clinical practice by increasing knowledge about the safety and efficacy of discontinuing valganciclovir prophylaxis in lung transplant recipients. Trial registration number NCT03699254.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

  • Jiménez De Ory, S.
  • Ramos Amador, José Tomás
  • Fortuny Guasch, Claudia
  • González-Tomé, María Isabel
  • Mellado Peña, María José|||0000-0003-2251-9666
  • Moreno Pérez, David|||0000-0002-7017-4095
  • Gavilán, C.
  • Menasalvas, A. I.
  • Piqueras, Ana Isabel
  • Frick, Marie Antoinette|||0000-0002-2553-5090
  • Muñoz-Fernández, M. A.
  • Navarro, Maria Luisa
Background There are not enough nationwide studies on perinatal HIV transmission in connection with a combination of antiretroviral treatments in Spain. Our objectives were to study sociodemographic changes and trends in the rates of HIV diagnoses and perinatal transmission in Spain from 1997 to 2015. Methods A retrospective study using data from Spanish Paediatric HIV Network (CoRISpe) and Spanish Minimum Basic Data Set (MDBS) was performed. HIV- diagnosed children between 1997 and 2015 were selected. Sociodemographic, clinical and immunovirological data of HIV-infected children and their mothers were studied in four calendar periods (P1: 1997-2000; P2: 2001-2005; P3: 2006-2010; P4: 2011-2015). Rates of perinatal HIV diagnoses and transmission from 1997 to 2015 were calculated. Results A total of 532 HIV-infected children were included in this study. Of these children, 406 were Spanish (76.3%) and 126 immigrants (23.7%). A decrease in the number of HIV diagnoses, 203 (38.2%) children in the first (P1), 149 (28%) in the second (P2), 130 (24.4%) in the third (P3) and 50 (9.4%) in the fourth (P4) calendar periods was studied. The same decrease in the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and P4, 19 (5.1%)) was monitored. However, an increase in the number of HIV diagnoses by sexual contact (P1: 0%; P2: 1.3%; P3: 4.6%; P4: 16%) was observed. The rates of new perinatal HIV diagnoses and perinatal transmission in Spanish children decreased from 0.167 to 0.005 per 100,000 inhabitants and 11.4% to 0.4% between 1997 and 2015, respectively. Conclusions A decline of perinatal HIV diagnoses and transmission was observed. However, an increase of teen-agers HIV diagnoses with sexual infection was studied. Public awareness campaigns directed to teen-agers are advisable to prevent HIV infection by sexual contact.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Extreme genomic erosion after recurrent demographic bottlenecks in the highly endangered Iberian lynx

  • Abascal, Federico
  • Corvelo, André
  • Cruz, Fernando
  • Villanueva-Cañas, José L.
  • Vlasova, Anna
  • Marcet-Houben, Marina|||0000-0003-4838-187X
  • Martínez-Cruz, Begoña
  • Cheng, Jade Yu
  • Prieto, Pablo
  • Quesada, Víctor|||0000-0002-8398-3457
  • Quilez, Javier|||0000-0002-0108-2672
  • Li, Gang|||0000-0001-8399-7771
  • García, Francisca|||0000-0002-2141-7628
  • Rubio-Camarillo, M.
  • Frias, Leonor
  • Ribeca, Paolo
  • Capella-Gutiérrez, Salvador
  • Rodríguez, J. M.
  • Câmara, F.
  • Lowy, Ernesto
  • Cozzuto, Luca|||0000-0003-3194-8892
  • Erb, Ionas|||0000-0002-2331-9714
  • Tress, M. L.
  • Rodriguez-Ales, J. L.
  • Ruiz-Orera, J.
  • Reverter, F.
  • Casas-Marce, M.
  • Soriano, L.
  • Arango, Javier R.
  • Derdak, Sophia
  • Galán, Beatriz
  • Blanc, Julie
  • Gut, Marta|||0000-0002-4063-7159
  • Lorente-Galdos, Belen|||0000-0001-5390-2452
  • Andrés Nieto, Marta|||0000-0001-5267-0039
  • López-Otín, C.
  • Valencia, A.
  • Gut, Ivo|||0000-0001-7219-632X
  • García, J. L.
  • Guigó, Roderic|||0000-0002-5738-4477
  • Murphy, W. J.
  • Ruiz-Herrera, Aurora|||0000-0003-3868-6151
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
  • Roma, Guglielmo
  • Notredame, C.
  • Mailund, Thomas
  • Albà, M. Mar
  • Gabaldón, Toni|||0000-0003-0019-1735
  • Alioto, Tyler Scott|||0000-0002-2960-5420
  • Godoy, José A.
Background: Genomic studies of endangered species provide insights into their evolution and demographic history, reveal patterns of genomic erosion that might limit their viability, and offer tools for their effective conservation. The Iberian lynx (Lynx pardinus) is the most endangered felid and a unique example of a species on the brink of extinction. - Results: ce generate the first annotated draft of the Iberian lynx genome and carry out genome-based analyses of lynx demography, evolution, and population genetics. We identify a series of severe population bottlenecks in the history of the Iberian lynx that predate its known demographic decline during the 20th century and have greatly impacted its genome evolution. We observe drastically reduced rates of weak-to-strong substitutions associated with GC-biased gene conversion and increased rates of fixation of transposable elements. We also find multiple signatures of genetic erosion in the two remnant Iberian lynx populations, including a high frequency of potentially deleterious variants and substitutions, as well as the lowest genome-wide genetic diversity reported so far in any species. -Conclusions: the genomic features observed in the Iberian lynx genome may hamper short- and long-term viability through reduced fitness and adaptive potential. The knowledge and resources developed in this study will boost the research on felid evolution and conservation genomics and will benefit the ongoing conservation and management of this emblematic species.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

IKKα Kinase Regulates the DNA Damage Response and Drives Chemo-resistance in Cancer

  • Colomer, Carlota
  • Margalef, Pol
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Vert, Anna
  • Pecharroman, Irene
  • Solé Font, Laura|||0000-0002-3195-0565
  • Gonzàlez-Farré, Mònica|||0000-0002-0653-0980
  • Alonso, Josune|||0000-0001-6783-5166
  • Montagut, Clara
  • Martinez-Iniesta, Maria
  • Bertran, Joan
  • Borràs, Eva|||0000-0002-3859-9907
  • Iglesias, Mar|||0000-0002-2274-4671
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Boulton, Simon J.
  • Espinosa, Lluis|||0000-0002-2897-4099
Phosphorylated IKKα(p45) is a nuclear active form of the IKKα kinase that is induced by the MAP kinases BRAF and TAK1 and promotes tumor growth independent of canonical NF-κB signaling. Insights into the sources of IKKα(p45) activation and its downstream substrates in the nucleus remain to be defined. Here, we discover that IKKα(p45) is rapidly activated by DNA damage independent of ATM-ATR, but dependent on BRAF-TAK1-p38-MAPK, and is required for robust ATM activation and efficient DNA repair. Abolishing BRAF or IKKα activity attenuates ATM, Chk1, MDC1, Kap1, and 53BP1 phosphorylation, compromises 53BP1 and RIF1 co-recruitment to sites of DNA lesions, and inhibits 53BP1-dependent fusion of dysfunctional telomeres. Furthermore, IKKα or BRAF inhibition synergistically enhances the therapeutic potential of 5-FU and irinotecan to eradicate chemotherapy-resistant metastatic human tumors in vivo. Our results implicate BRAF and IKKα kinases in the DDR and reveal a combination strategy for cancer treatment. Colomer et al. discover that IKKα kinase contributes to the chemo- and radio-resistance of cancer cells by facilitating ATM activation and DNA repair. BRAF inhibitors prevent damage-induced IKKα activation, leading to the attenuation of ATM signaling and DNA repair. IKKα depletion or BRAF inhibitors combined with 5-FU and irinotecan synergistically enhance the killing of patient-derived xenograft tumors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma

  • Gallardo, Fernando|||0000-0002-8996-3828
  • Bertran, Joan
  • López-Arribillaga, Erika|||0000-0002-9451-6635
  • González, Jéssica
  • Menéndez, Silvia
  • Sánchez, Ignacio
  • Colomo, Luis|||0000-0001-5236-5085
  • Iglesias, Mar|||0000-0002-2274-4671
  • Garrido, Marta
  • Santamaría-Babí, Luis Francisco
  • Torres, Ferran|||0000-0002-7355-7913
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Espinosa, Lluis|||0000-0002-2897-4099
Cutaneous T-cell lymphomas (CTCLs) represent different subtypes of lymphoproliferative disorders with no curative therapies for the advanced forms of the disease (namely mycosis fungoides and the leukemic variant, Sézary syndrome). Molecular events leading to CTCL progression are heterogeneous, however recent DNA and RNA sequencing studies highlighted the importance of NF-κB and β-catenin pathways. We here show that the kinase TAK1, known as essential in B-cell lymphoma, is constitutively activated in CTCL cells, but tempered by the MYPT1/PP1 phosphatase complex. Blocking PP1 activity, both pharmacologically and genetically, resulted in TAK1 hyperphosphorylation at residues T344, S389, T444, and T511, which have functional impact on canonical NF-κB signaling. Inhibition of TAK1 precluded NF-κB and β-catenin signaling and induced apoptosis of CTCL cell lines and primary Sézary syndrome cells both in vitro and in vivo. Detection of phosphorylated TAK1 at T444 and T344 is associated with the presence of lymphoma in a set of 60 primary human samples correlating with NF-κB and β-catenin activation. These results identified TAK1 as a potential biomarker and therapeutic target for CTCL therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

  • Genescà, Eulàlia|||0000-0002-5657-4842
  • Lazarenkov, Aleksey|||0000-0003-0652-8116
  • Morgades, Mireia|||0000-0003-0295-2534
  • Berbis, G.
  • Ruíz-Xivillé, Neus
  • Gómez-Marzo, Paula|||0000-0002-6829-9630
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Junca, Jordi|||0000-0003-0142-772X
  • Gonzalez-Perez, Abel|||0000-0002-8582-4660
  • Mercadal, Santiago|||0000-0003-4741-7885
  • Guàrdia, Ramón
  • Artola, Maria Teresa
  • Moreno, Maria José
  • Martínez-López, Joaquín F.
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Barba, Pere|||0000-0001-7076-7969
  • Gil, Cristina
  • Tormo, Mar|||0000-0001-9622-1649
  • Cladera, Antonia
  • Novo, Andrés
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • González Campos, José
  • Almeida Parra, María
  • Cervera, José|||0000-0001-8252-1106
  • Montesinos, Pau|||0000-0002-3275-5593
  • Batlle, Montserrat|||0000-0002-3034-2023
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Feliu Frasnedo, Evarist|||0000-0001-5780-3136
  • Sole, F.|||0000-0002-3251-2161
  • Orfao, Alberto|||0000-0002-0007-7230
  • Ribera, Jose-Maria|||0000-0003-1042-6024
Recurrent deletions of the CDKN2A/ARF/CDKN2B genes encoded at chromosome 9p21 have been described in both pediatric and adult acute lymphoblastic leukemia (ALL), but their prognostic value remains controversial, with limited data on adult T-ALL. Here, we investigated the presence of homozygous and heterozygous deletions of the CDKN2A/ARF and CDKN2B genes in 64 adult T-ALL patients enrolled in two consecutive trials from the Spanish PETHEMA group. Alterations in CDKN2A/ARF/CDKN2B were detected in 35/64 patients (55%). Most of them consisted of 9p21 losses involving homozygous deletions of the CDKNA/ARF gene (26/64), as confirmed by single nucleotide polymorphism (SNP) arrays and interphase fluorescence in situ hybridization (iFISH). Deletions involving the CDKN2A/ARF/CDKN2B locus correlated with a higher frequency of cortical T cell phenotype and a better clearance of minimal residual disease (MRD) after induction therapy. Moreover, the combination of an altered copy-number-value (CNV) involving the CDKN2A/ARF/CDKN2B gene locus and undetectable MRD (≤ 0.01%) values allowed the identification of a subset of T-ALL with better overall survival in the absence of hematopoietic stem cell transplantation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

B Cells and Tertiary Lymphoid Structures Influence Survival in Lung Cancer Patients with Resectable Tumors

  • Tang, Jun
  • Curull Serrano, Víctor|||0000-0003-2709-7431
  • Wang, Xuejie|||0000-0003-1398-3942
  • Mateu-Jiménez, Mercé
  • Pijuan, Lara|||0000-0002-9978-6933
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Qin, Liyun
  • Rodríguez-Fuster, Alberto|||0000-0002-4900-6126
  • Aguiló Espases, Rafael
  • Barreiro, Esther|||0000-0003-2708-3443
  • Ramis-Cabrer, Daniel|||0000-0001-7793-773X
Immune profile of B and T cells and tertiary lymphoid structures (TLSs) may differ in tumors of lung cancer (LC) patients with/without chronic obstructive pulmonary disease (COPD), and may also influence patient survival. We sought to analyze: (1) TLSs, germinal centers (GCs), B and T cells, and (2) associations of the immune biomarkers with the patients' 10-year overall survival (OS). TLSs (numbers and area), B [cluster of differentiation (CD) 20], and T (CD3), and GCs cells were identified in both tumor and non-tumor specimens (thoracotomy) from 90 LC-COPD patients and 43 LC-only patients. Ten-year OS was analyzed in the patients. Immune profile in tumors of LC-COPD versus LC: TLS numbers and areas significantly decreased in tumors of LC-COPD compared to LC patients. No significant differences were observed in tumors between LC-COPD and LC patients for B or T cells. Immune profile in tumors versus non-tumor specimens: TLS areas and B cells significantly increased, T cells significantly decreased in tumors of both LC and LC-COPD patients. Survival: in LC-COPD patients: greater area of TLSs and proportion of B cells were associated with longer survival rates. The immune tumor microenvironment differs in patients with underlying COPD and these different phenotypes may eventually impact the response to immunotherapy in patients with LC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia

  • Genescà, Eulàlia|||0000-0002-5657-4842
  • Morgades, Mireia|||0000-0003-0295-2534
  • Montesinos, Pau|||0000-0002-3275-5593
  • Barba, Pere|||0000-0001-7076-7969
  • Gil, Cristina
  • Guàrdia, Ramón
  • Moreno, Maria José
  • Martínez-Carballeira, Daniel|||0000-0003-4840-7822
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Ribera Salas, Jordi|||0000-0003-4796-6470
  • González Campos, José
  • González Gil, Celia|||0000-0002-7582-1482
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Ramirez, Jose Luis
  • Díaz-Beyá, Marina|||0000-0001-9624-2597
  • Mercadal, Santiago|||0000-0003-4741-7885
  • Artola, Maria Teresa
  • Cladera, Antonia
  • Tormo, Mar|||0000-0001-9622-1649
  • Bermúdez, Arancha
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Martínez Sánchez, Pilar|||0000-0002-7334-140X
  • Amigo, María-Luz|||0000-0002-3356-9290
  • Monsalvo, Silvia
  • Novo, Andrés
  • Cervera, Marta
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Junca, Jordi|||0000-0003-0142-772X
  • Ciudad Pizarro, Juana
  • Orfao, Alberto|||0000-0002-0007-7230
  • Ribera, Jose-Maria|||0000-0003-1042-6024
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cell therapy with hiPSC-derived RPE cells and RPCs prevents visual function loss in a rat model of retinal degeneration

  • Salas Torras, Anna|||0000-0002-8781-9611
  • Duarri, Anna|||0000-0003-4075-5478
  • Fontrodona Montals, Laura
  • Ramírez Mora, Diana|||0000-0002-8962-8974
  • Badia Pérez, Anna|||0000-0001-8254-1641
  • Isla-Magrané, Helena|||0000-0002-7203-3309
  • Ferreira-de-Souza, Barbara
  • Zapata, Miguel Angel|||0000-0002-0096-4569
  • Raya, Ángel|||0000-0003-2189-9775
  • García Arumí, José|||0000-0001-8827-1160
Photoreceptor loss is the principal cause of blindness in retinal degenerative diseases (RDDs). Whereas some therapies exist for early stages of RDDs, no effective treatment is currently available for later stages, and once photoreceptors are lost, the only option to rescue vision is cell transplantation. With the use of the Royal College of Surgeons (RCS) rat model of retinal degeneration, we sought to determine whether combined transplantation of human-induced pluripotent stem cell (hiPSC)-derived retinal precursor cells (RPCs) and retinal pigment epithelial (RPE) cells was superior to RPE or RPC transplantation alone in preserving retinal from degeneration. hiPSC-derived RPCs and RPE cells expressing (GFP) were transplanted into the subretinal space of rats. In vivo monitoring showed that grafted cells survived 12 weeks in the subretinal space, and rats treated with RPE + RPC therapy exhibited better conservation of the outer nuclear layer (ONL) and visual response than RPE-treated or RPC-treated rats. Transplanted RPE cells integrated in the host RPE layer, whereas RPC mostly remained in the subretinal space, although a limited number of cells integrated in the ONL. In conclusion, the combined transplantation of hiPSC-derived RPE and RPCs is a potentially superior therapeutic approach to protect retina from degeneration in RDDs. In this article, Anna Duarri and colleagues aim to develop a novel cell-based therapeutic approach to preserve retinal structure and function in retinal degenerative diseases caused by dysfunctional retinal pigment epithelium (RPE). Giving to the eye support of healthy RPE together with healthy retinal cells protects the retina from degeneration.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan

  • Jorba, Guillem|||0000-0001-5209-5353
  • Aguirre-Plans, Joaquim|||0000-0002-1971-1350
  • Junet, Valentin|||0000-0002-6138-0612
  • Segú-Vergés, Cristina|||0000-0002-8215-872X
  • Ruiz, José Luis
  • Pujol, Albert
  • Fernández-Fuentes, Narcís
  • Mas, José Manuel
  • Oliva Miguel, Baldomero|||0000-0003-0702-0250
Unveiling the mechanism of action of a drug is key to understand the benefits and adverse reactions of a medication in an organism. However, in complex diseases such as heart diseases there is not a unique mechanism of action but a wide range of different responses depending on the patient. Exploring this collection of mechanisms is one of the clues for a future personalized medicine. The Therapeutic Performance Mapping System (TPMS) is a Systems Biology approach that generates multiple models of the mechanism of action of a drug. Each molecular mechanism generated could be associated to particular individuals, here defined as prototype-patients, hence the generation of models using TPMS technology may be used for detecting adverse effects to specific patients. TPMS operates by (1) modelling the responses in humans with an accurate description of a protein network and (2) applying a Multilayer Perceptron-like and sampling strategy to find all plausible solutions. In the present study, TPMS is applied to explore the diversity of mechanisms of action of the drug combination sacubitril/valsartan. We use TPMS to generate a wide range of models explaining the relationship between sacubitril/valsartan and heart failure (the indication), as well as evaluating their association with macular degeneration (a potential adverse effect). Among the models generated, we identify a set of mechanisms of action associated to a better response in terms of heart failure treatment, which could also be associated to macular degeneration development. Finally, a set of 30 potential biomarkers are proposed to identify mechanisms (or prototype-patients) more prone of suffering macular degeneration when presenting good heart failure response. All prototype-patients models generated are completely theoretical and therefore they do not necessarily involve clinical effects in real patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells

  • Gil Varea, Elia|||0000-0001-5144-4144
  • Fedetz, Maria
  • Eixarch, Herena|||0000-0001-7525-9533
  • Spataro, Nino|||0000-0002-2127-2238
  • Villar, Luisa M.|||0000-0002-9067-3668
  • Urcelay, Elena|||0000-0001-8470-8396
  • Saiz, Albert|||0000-0002-5793-8791
  • Fernández Fernández, Óscar|||0000-0003-3696-789X
  • Leyva, Laura|||0000-0003-0620-9625
  • Ramió-Torrentà, Lluís|||0000-0002-6999-1004
  • Vandenbroeck, Koen|||0000-0002-6967-6485
  • Otaegui, David|||0000-0002-6625-5976
  • Castillo-Triviño, Tamara|||0000-0002-9249-3185
  • Izquierdo, Guillermo|||0000-0002-6340-5609
  • Malhotra, Sunny|||0000-0003-1112-7739
  • Bosch, Elena|||0000-0003-2848-103X
  • Navarro, Arcadi|||0000-0003-2162-8246
  • Alcina, Antonio|||0000-0001-7294-0948
  • Montalban, Xavier|||0000-0002-0098-9918
  • Matesanz, Fuencisla|||0000-0002-9429-1819
  • Comabella López, Manuel|||0000-0002-2373-6657
Genome-wide association studies and meta-analysis have contributed to the identification of more than 200 loci associated with multiple sclerosis (MS). However, a proportion of MS heritability remains unknown. We aimed to uncover new genetic variants associated with MS and determine their functional effects. For this, we resequenced the exons and regulatory sequences of 14 MS risk genes in a cohort of MS patients and healthy individuals (n = 1070) and attempted to validate a selection of signals through genotyping in an independent cohort (n = 5138). We identified three new MS-associated variants at C-X-C motif chemokine receptor 5 (CXCR5), Ts translation elongation factor, mitochondrial (TSFM) and cytochrome P450 family 24 subfamily A member 1 (CYP24A1). Rs10892307 resulted in a new signal at the CXCR5 region that explains one of the associations with MS within the locus. This polymorphism and three others in high linkage disequilibrium mapped within regulatory regions. Of them, rs11602393 showed allele-dependent enhancer activity in the forward orientation as determined by luciferase reporter assays. Immunophenotyping using peripheral blood mononuclear cells from MS patients associated the minor allele of rs10892307 with increased percentage of regulatory T cells expressing CXCR5. This work reports a new signal for the CXCR5 MS risk locus and points to rs11602393 as the causal variant. The expansion of CXCR5+ circulating regulatory T cells induced by this variant could cause its MS association.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Acute pancreatitis promotes the generation of two different exosome populations

  • Jiménez-Alesanco, A.
  • Marcuello, M.
  • Pastor-Jiménez, M.
  • López-Puerto, L.
  • Bonjoch, Laia|||0000-0002-3351-0037
  • Gironella, Meritxell|||0000-0003-4437-5181
  • Carrascal Pérez, Montserrat|||0000-0002-0205-2176
  • Abian, Joaquin|||0000-0003-2823-5429
  • de-Madaria, Enrique|||0000-0002-2412-9541
  • Closa Autet, Daniel|||0000-0003-3797-3095
Exosomes are small extracellular vesicles that act as intercellular messengers. Previous studies revealed that, during acute pancreatitis, circulating exosomes could reach the alveolar compartment and activate macrophages. However, proteomic analysis suggested that the most likely origin of these exosomes could be the liver instead of the pancreas. The present study aimed to characterize the exosomes released by pancreas to pancreatitis-associated ascitic fluid (PAAF) as well as those circulating in plasma in an experimental model of taurocholate-induced acute pancreatitis in rats. We provide evidence that during acute pancreatitis two different populations of exosomes are generated with relevant differences in cell distribution, protein and microRNA content as well as different implications in their physiological effects. During pancreatitis plasma exosomes, but not PAAF exosomes, are enriched in the inflammatory miR-155 and show low levels of miR-21 and miR-122. Mass spectrometry-based proteomic analysis showed that PAAF exosomes contains 10-30 fold higher loading of histones and ribosomal proteins compared to plasma exosomes. Finally, plasma exosomes have higher pro-inflammatory activity on macrophages than PAAF exosomes. These results confirm the generation of two different populations of exosomes during acute pancreatitis. Deep understanding of their specific functions will be necessary to use them as therapeutic targets at different stages of the disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy

  • Guillén Gómez, Elena|||0000-0002-8498-2579
  • Bardají de Quixano, Beatriz|||0000-0001-7456-355X
  • Ferrer, Sílvia
  • Brotons, Carlos|||0000-0001-9388-6581
  • Knepper, Mark A.
  • Carrascal Pérez, Montserrat|||0000-0002-0205-2176
  • Abian, Joaquin|||0000-0003-2823-5429
  • Mas, José M.
  • Calero, Francesca|||0000-0002-5758-0769
  • Ballarín Castan, José Aurelio|||0000-0002-4556-8164
  • Fernandez-Llama, Patricia|||0000-0002-7472-2124
Urinary proteome was analyzed and quantified by tandem mass tag (TMT) labeling followed by bioinformatics analysis to study diabetic nephropathy (DN) pathophysiology and to identify biomarkers of a clinical outcome. We included type 2 diabetic normotensive non-obese males with (n = 9) and without (n = 11) incipient DN (microalbuminuria). Sample collection included blood and urine at baseline (control and DN basal) and, in DN patients, after 3 months of losartan treatment (DN treated). Urinary proteome analysis identified 166 differentially abundant proteins between controls and DN patients, 27 comparing DN-treated and DN-basal patients, and 182 between DN-treated patients and controls. The mathematical modeling analysis predicted 80 key proteins involved in DN pathophysiology and 15 in losartan effect, a total of 95 proteins. Out of these 95, 7 are involved in both processes. VCAM-1 and neprilysin stand out of these 7 for being differentially expressed in the urinary proteome. We observed an increase of VCAM-1 urine levels in DN-basal patients compared to diabetic controls and an increase of urinary neprilysin in DN-treated patients with persistent albuminuria; the latter was confirmed by ELISA. Our results point to neprilysin and VCAM-1 as potential candidates in DN pathology and treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SETD7 Regulates the Differentiation of Human Embryonic Stem Cells

  • Castaño Cardoso, Julio|||0000-0002-0712-5856
  • Morera, Cristina
  • Sesé, Borja
  • Boue, Stephanie|||0000-0003-0680-4168
  • Bonet-Costa, Carles
  • Martí, Mercè|||0000-0002-1846-0043
  • Roque Córdova, Alicia|||0000-0002-6206-6481
  • Jordan, Albert|||0000-0002-3970-8693
  • Barrero, María José
The successful use of specialized cells in regenerative medicine requires an optimization in the differentiation protocols that are currently used. Understanding the molecular events that take place during the differentiation of human pluripotent cells is essential for the improvement of these protocols and the generation of high quality differentiated cells. In an effort to understand the molecular mechanisms that govern differentiation we identify the methyltransferase SETD7 as highly induced during the differentiation of human embryonic stem cells and differentially expressed between induced pluripotent cells and somatic cells. Knock-down of SETD7 causes differentiation defects in human embryonic stem cell including delay in both the silencing of pluripotency-related genes and the induction of differentiation genes. We show that SETD7 methylates linker histone H1 in vitro causing conformational changes in H1. These effects correlate with a decrease in the recruitment of H1 to the pluripotency genes OCT4 and NANOG during differentiation in the SETD7 knock down that might affect the proper silencing of these genes during differentiation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

  • Mota, Alba
  • Oltra, Sara S.
  • Selenica, Pier
  • Moiola, Cristian Pablo|||0000-0001-7218-0184
  • Casas-Arozamena, Carlos|||0000-0002-3279-2482
  • López-Gil, Carlos|||0000-0001-6540-1225
  • Diaz, Eva
  • Gatius, Sonia
  • Ruiz-Miro, María
  • Calvo, Ana|||0000-0002-7953-2629
  • Rojo-Sebastián, Alejandro
  • Hurtado Blanco, P.
  • Piñeiro, Roberto|||0000-0001-9479-139X
  • Colás Ortega, Eva|||0000-0003-0302-4828
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Reis-Filho, Jorge S.|||0000-0003-2969-3173
  • Muinelo-Romay, Laura|||0000-0002-7456-7531
  • Abal Posada, Miguel|||0000-0003-3533-7781
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Weigelt, Britta|||0000-0001-9927-1270
  • Moreno-Bueno, Gema
Analyzing different tumor regions by next generation sequencing allows the assessment of intratumor genetic heterogeneity (ITGH), a phenomenon that has been studied widely in some tumor types but has been less well explored in endometrial carcinoma (EC). In this study, we sought to characterize the spatial and temporal heterogeneity of 9 different ECs using whole-exome sequencing, and by performing targeted sequencing validation of the 42 primary tumor regions and 30 metastatic samples analyzed. In addition, copy number alterations of serous carcinomas were assessed by comparative genomic hybridization arrays. From the somatic mutations, identified by whole-exome sequencing, 532 were validated by targeted sequencing. Based on these data, the phylogenetic tree reconstructed for each case allowed us to establish the tumors' evolution and correlate this to tumor progression, prognosis, and the presence of recurrent disease. Moreover, we studied the genetic landscape of an ambiguous EC and the molecular profile obtained was used to guide the selection of a potential personalized therapy for this patient, which was subsequently validated by preclinical testing in patient-derived xenograft models. Overall, our study reveals the impact of analyzing different tumor regions to decipher the ITGH in ECs, which could help make the best treatment decision.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transplantation of human induced pluripotent stem cell-derived retinal pigment epithelium in a swine model of geographic atrophy

  • Duarri, Anna|||0000-0003-4075-5478
  • Rodríguez-Bocanegra, Eduardo|||0000-0003-3019-8911
  • Martínez-Navarrete, Gema|||0000-0002-9795-2846
  • Biarnés, Marc|||0000-0003-2584-4894
  • García, Miriam
  • Ferraro, Lucia Lee|||0000-0002-3741-1220
  • Kuebler, Bernd|||0000-0002-4472-871X
  • Aran, Begoña|||0000-0002-5011-7755
  • Izquierdo, Elisabeth
  • Aguilera-Xiol, Eli
  • Casaroli-Marano, Ricardo Pedro|||0000-0003-1812-9323
  • Trias, Esteve|||0000-0001-7635-4428
  • Fernandez, Eduardo|||0000-0002-7052-6011
  • Raya, Ángel|||0000-0003-2189-9775
  • Veiga, Anna|||0000-0002-0943-9904
  • Monés Carilla, Jordi|||0000-0003-3685-2160
Background: The aim of this study was to test the feasibility and safety of subretinal transplantation of human induced pluripotent stem cell (hiPSC)-derived retinal pigment epithelium (RPE) cells into the healthy margins and within areas of degenerative retina in a swine model of geographic atrophy (GA). Methods: Well-delimited selective outer retinal damage was induced by subretinal injection of NaIO3 into one eye in minipigs (n = 10). Thirty days later, a suspension of hiPSC-derived RPE cells expressing green fluorescent protein was injected into the subretinal space, into the healthy margins, and within areas of degenerative retina. In vivo follow-up was performed by multimodal imaging. Post-mortem retinas were analyzed by immunohistochemistry and histology. Results: In vitro differentiated hiPSC-RPE cells showed a typical epithelial morphology, expressed RPE-related genes, and had phagocytic ability. Engrafted hiPSC-RPE cells were detected in 60% of the eyes, forming mature epithelium in healthy retina extending towards the border of the atrophy. Histological analysis revealed RPE interaction with host photoreceptors in the healthy retina. Engrafted cells in the atrophic zone were found in a patchy distribution but failed to form an epithelial-like layer. Conclusions: These results might support the use of hiPSC-RPE cells to treat atrophic GA by providing a housekeeping function to aid the overwhelmed remnant RPE, which might improve its survival and therefore slow down the progression of GA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers

  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Álvarez Menéndez, Francisco V.|||0000-0002-2553-5402
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Carretero, Francisco
  • Fernández-Oliva, Antonio|||0000-0002-8610-2600
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Sánchez García, Olga|||0000-0002-5279-440X
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Alijotas-Reig, Jaume|||0000-0002-9212-3619
  • Llurba, Elisa|||0000-0003-4048-6407
N-terminal pro-brain natriuretic peptide (NT-proBNP) and uric acid are elevated in pregnancies with preeclampsia (PE). Short-term prediction of PE using angiogenic factors has many false-positive results. Our objective was to validate a machine-learning model (MLM) to predict PE in patients with clinical suspicion, and evaluate if the model performed better than the sFlt-1/PlGF ratio alone. A multicentric cohort study of pregnancies with suspected PE between 24 +0 and 36 +6 weeks was used. The MLM included six predictors: gestational age, chronic hypertension, sFlt-1, PlGF, NT-proBNP, and uric acid. A total of 936 serum samples from 597 women were included. The PPV of the MLM for PE following 6 weeks was 83.1% (95% CI 78.5-88.2) compared to 72.8% (95% CI 67.4-78.4) for the sFlt-1/PlGF ratio. The specificity of the model was better; 94.9% vs. 91%, respectively. The AUC was significantly improved compared to the ratio alone [0.941 (95% CI 0.926-0.956) vs. 0.901 (95% CI 0.880-0.921), p < 0.05]. For prediction of preterm PE within 1 week, the AUC of the MLM was 0.954 (95% CI 0.937-0.968); significantly greater than the ratio alone [0.914 (95% CI 0.890-0.934), p < 0.01]. To conclude, an MLM combining the sFlt-1/PlGF ratio, NT-proBNP, and uric acid performs better to predict preterm PE compared to the sFlt-1/PlGF ratio alone, potentially increasing clinical precision.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases

  • Bullich Vilanova, Gemma|||0000-0002-0737-4422
  • Matalonga, Leslie
  • Pujadas, Montserrat
  • Papakonstantinou, Anastasios
  • Piscia, Davide
  • Tonda, Raúl
  • Artuch, R.|||0000-0002-3422-9685
  • Gallano, Pia|||0000-0001-8104-2197
  • Garrabou, Glòria|||0000-0001-8973-9933
  • González, Juan R.|||0000-0003-3267-2146
  • Grinberg, Daniel|||0000-0001-9859-2590
  • Guitart, Maria|||0000-0003-2957-7404
  • Laurie, Steven|||0000-0003-3913-5829
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Luengo, Cristina
  • Martí, Ramon A.|||0000-0002-8273-9540
  • Milà, Montserrat
  • Ovelleiro, David|||0000-0002-9415-2229
  • Parra, Genís
  • Pujol, Aurora|||0000-0002-9606-0600
  • Tizzano, Eduardo F.|||0000-0002-7116-6310
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Palau, Francesc|||0000-0002-8635-5421
  • Ribes, Antònia
  • Pérez-Jurado, Luis Alberto|||0000-0002-1988-3005
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Schlüter, Agatha|||0000-0001-6732-1528
  • Rodríguez-Palmero, Agustí|||0000-0002-4141-5515
  • Cáceres, Alejandro|||0000-0001-8551-6695
  • Nascimento, Andrés
  • García-Cazorla, Àngels
  • Cueto-González, Anna Mª|||0000-0001-7694-6124
  • Marcé-Grau, Anna|||0000-0001-5762-4023
  • Ruiz Nel Lo, Anna
  • Martínez-Monseny, Antonio
  • Sánchez, Aurora|||0000-0003-1167-1451
  • García, Belén
  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
  • Gel, Bernat|||0000-0001-8878-349X
  • Fusté, Berta
  • Hernández Ferrer, Carles
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • Ortez González, Carlos Ignacio|||0000-0001-8187-8103
  • Arjona, César
  • Hernando Davalillo, Cristina
  • Natera de Benito, Daniel
  • Picó Amador, Daniel
  • Gómez-Andrés, David|||0000-0001-5654-7791
  • Yubero, Délia
  • Pelegrí-Sisó, Dolors|||0000-0002-5993-3003
  • Verdura, Edgard|||0000-0003-3856-2060
  • García Arumí, Elena|||0000-0003-1848-005X
  • Castellanos, Elisabeth|||0000-0002-8133-5325
  • Gabau, Elisabeth|||0000-0001-8120-7393
  • Tobías, Ester|||0000-0002-9968-3651
  • López-Grondona, Fermina
  • Cardellach, Francesc|||0000-0003-3286-3436
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Munell Casadesus, Francina|||0000-0001-8580-2819
  • Tort, Frederic|||0000-0003-2733-1603
  • Aznar, Gemma
  • Olive Cirera, Gemma
  • Tell-Martí, Gemma|||0000-0003-2728-6961
  • Muñoz-Pujol, Gerard|||0000-0002-6863-3993
  • Paramonov, Ida
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Madrigal, Irene|||0000-0002-7229-1199
  • Valenzuela, Irene|||0000-0003-2350-6058
  • Gut, Ivo|||0000-0001-7219-632X
  • Cusco, Ivon|||0000-0003-2104-9332
  • Trotta, Jean-Rémi
  • Cruz, Jordi
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Milisenda, José César|||0000-0003-0151-7872
  • Ma Grau, Josep
  • Garcia-Villoria, Judit
  • Armstrong, Judith|||0000-0003-0588-9307
  • Cantó, Judith
  • Sala-Coromina, Júlia|||0000-0001-5116-6316
  • Rodríguez-Revenga, Laia
  • Alías, Laura|||0000-0003-2193-6185
  • Gort, Laura|||0000-0003-4746-1034
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Costa, Mar
  • Fernández-Callejo, Marcos
  • López Sánchez, Marcos|||0000-0002-1517-5968
  • Álvarez Mora, María Isabel|||0000-0003-3788-8915
  • Gut, Marta|||0000-0002-4063-7159
  • Serrano, Mercedes|||0000-0002-2056-2428
  • Raspall-Chaure, Miquel|||0000-0002-3132-3342
  • Del Toro, Mireia|||0000-0002-8163-1853
  • Bayés, Mònica
  • Baena Díez, Neus|||0000-0003-0677-240X
  • Spataro, Nino|||0000-0002-2127-2238
  • Capdevila, Núria|||0000-0003-2080-7381
  • Ugarteburu, Olatz|||0000-0003-4214-3301
  • Muñoz-Cabello, Patricia|||0000-0002-5242-9605
  • Romero Duque, Penélope|||0000-0003-3509-1320
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • Calvo-Escalona, Rosa|||0000-0001-9572-4228
  • Urreizti, Roser|||0000-0003-3617-7134
  • Bernal, Sara|||0000-0003-4427-0574
  • Boronat Guerrero, Susana|||0000-0001-7096-5578
  • Balcells, Susana|||0000-0003-1211-1907
  • Vendrell, Teresa
Many patients experiencing a rare disease remain undiagnosed even after genomic testing. Reanalysis of existing genomic data has shown to increase diagnostic yield, although there are few systematic and comprehensive reanalysis efforts that enable collaborative interpretation and future reinterpretation. The Undiagnosed Rare Disease Program of Catalonia project collated previously inconclusive good quality genomic data (panels, exomes, and genomes) and standardized phenotypic profiles from 323 families (543 individuals) with a neurologic rare disease. The data were reanalyzed systematically to identify relatedness, runs of homozygosity, consanguinity, single-nucleotide variants, insertions and deletions, and copy number variants. Data were shared and collaboratively interpreted within the consortium through a customized Genome-Phenome Analysis Platform, which also enables future data reinterpretation. Reanalysis of existing genomic data provided a diagnosis for 20.7% of the patients, including 1.8% diagnosed after the generation of additional genomic data to identify a second pathogenic heterozygous variant. Diagnostic rate was significantly higher for family-based exome/genome reanalysis compared with singleton panels. Most new diagnoses were attributable to recent gene-disease associations (50.8%), additional or improved bioinformatic analysis (19.7%), and standardized phenotyping data integrated within the Undiagnosed Rare Disease Program of Catalonia Genome-Phenome Analysis Platform functionalities (18%).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Longitudinal Behavior of Left-Ventricular Strain in Fetal Growth Restriction

  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Ginjaume García, Nuria|||0000-0003-0785-0115
  • Ullmo, Johana|||0000-0002-9313-917X
  • Fernández-Oliva, Antonio|||0000-0002-8610-2600
  • Parra Roca, Juan|||0000-0001-6011-7815
  • Vázquez Fariñas, Ana|||0000-0001-6732-1667
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
Fetal growth restriction (FGR) is associated with an increased risk of adverse outcomes resulting from adaptive cardiovascular changes in conditions of placental insufficiency, leading to cardiac deformation and dysfunction, which can be evaluated with 2D speckle tracking echocardiography (2D-STE). The aim of the present study was to evaluate whether reduced fetal growth is associated with cardiac left-ventricle (LV) dysfunction, using 2D-STE software widely used in postnatal echocardiography. A prospective longitudinal cohort study was performed, and global (GLO) and segmental LV longitudinal strain was measured offline and compared between FGR and appropriate-for-gestational-age (AGA) fetuses throughout gestation. All cases of FGR fetuses were paired 1:2 to AGA fetuses, and linear mixed model analysis was performed to compare behavior differences between groups throughout pregnancy. Our study shows LV fetal longitudinal strain in FGR and AGA fetuses differed upon diagnosis and behaved differently throughout gestation. FGR fetuses had lower LV strain values, both global and segmental, in comparison to AGA, suggesting subclinical cardiac dysfunction. Our study provides more data regarding fetal cardiac function in cases of placental dysfunction, as well as highlights the potential use of 2D-STE in the follow-up of cardiac function in these fetuses.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis, A Randomized Clinical Trial

  • Pujol, Miquel|||0000-0002-6475-6208
  • Miró, José M.|||0000-0001-8057-7755
  • Shaw, Evelyn|||0000-0002-1882-1259
  • Aguado, José María|||0000-0002-9520-8255
  • Puig-Asensio, Mireia|||0000-0002-0722-2218
  • Pigrau, Carlos|||0000-0003-4232-4049
  • Calbo Sebastián, Esther|||0000-0001-7750-5347
  • Montejo, Miguel
  • Rodriguez-Álvarez, Regino José
  • Garcia-Pais, Mª José
  • Pintado, Vicente
  • Escudero Sánchez, Rosa|||0000-0001-5736-8111
  • López-Contreras, Joaquín|||0000-0002-3166-4016
  • Morata, Laura|||0000-0001-5795-0814
  • Montero, Milagros
  • Andrés Granyó, Marta|||0000-0003-3214-1636
  • Pasquau, Juan
  • Arenas, Maria Del Mar
  • Padilla Ortega, Belén
  • Murillas, Javier|||0000-0003-2169-7110
  • Jover-Saenz, Alfredo|||0000-0001-5207-7200
  • López Cortés, Luis Eduardo|||0000-0002-9347-527X
  • García-Pardo, Graciano|||0000-0003-0274-6001
  • Gasch, Oriol|||0000-0001-8518-458X
  • Videla, Sebastián|||0000-0001-5049-1379
  • Hereu, Pilar|||0000-0002-9191-8962
  • Tebé, Cristian|||0000-0003-2320-1385
  • Pallares Fontanet, Natalia|||0000-0002-1462-379X
  • Sanllorente, Mireia
  • Domínguez, María-Ángeles
  • Càmara, Jordi|||0000-0002-0817-0931
  • Ferrer, Anna
  • Padullés, Ariadna|||0000-0003-1541-6001
  • Cuervo, Guillermo|||0000-0002-7075-943X
  • Carratalà, Jordi|||0000-0003-3209-2563
We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis. A randomized (1:1) phase 3 superiority, open-label, and parallel group clinical trial of adult inpatients with MRSA bacteremia was conducted at 18 Spanish hospitals. Patients were randomly assigned to receive either 10 mg/kg of daptomycin intravenously daily plus 2 g of fosfomycin intravenously every 6 hours, or 10 mg/kg of daptomycin intravenously daily. Primary endpoint was treatment success 6 weeks after the end of therapy. Of 167 patients randomized, 155 completed the trial and were assessed for the primary endpoint. Treatment success at 6 weeks after the end of therapy was achieved in 40 of 74 patients who received daptomycin plus fosfomycin and in 34 of 81 patients who were given daptomycin alone (54.1% vs 42.0%; relative risk, 1.29 [95% confidence interval,. 93-1.8]; P = .135). At 6 weeks, daptomycin plus fosfomycin was associated with lower microbiologic failure (0 vs 9 patients; P = .003) and lower complicated bacteremia (16.2% vs 32.1%; P = .022). Adverse events leading to treatment discontinuation occurred in 13 of 74 patients (17.6%) receiving daptomycin plus fosfomycin, and in 4 of 81 patients (4.9%) receiving daptomycin alone (P = .018). Daptomycin plus fosfomycin provided 12% higher rate of treatment success than daptomycin alone, but this difference did not reach statistical significance. This antibiotic combination prevented microbiological failure and complicated bacteremia, but it was more often associated with adverse events.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure, A Substudy of the Myocardial-IRON Trial

  • del Canto, Irene
  • Santas, Enrique
  • Cardells, Ingrid
  • Miñana, Gema|||0000-0001-8777-2588
  • Palau, Patricia|||0000-0001-5040-0924
  • Llàcer, Pau
  • Facila Rubio, Lorenzo|||0000-0003-1402-4364
  • López-Vilella, Raquel
  • Almenar Bonet, Luis|||0000-0002-7710-361X
  • Bodi, Vicente|||0000-0001-6425-5828
  • López-Lereu, Maria P.
  • Monmeneu, Jose V.
  • Sanchis, Juan|||0000-0003-0797-8709
  • Moratal, David|||0000-0002-2825-3646
  • Maceira, Alicia M.|||0000-0001-5486-4232
  • De la Espriella, Rafael|||0000-0002-8720-3999
  • Chorro, Francisco J.
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Núñez, Julio|||0000-0003-1672-7119
The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial-IRON trial showed short-term cardiac magnetic resonance (CMR) changes suggesting myocardial iron repletion following administration of FCM but failed to find a significant increase in left ventricular ejection fraction in the whole sample. Conversely, the strain assessment could evaluate more specifically subtle changes in contractility. In this subanalysis, we aimed to evaluate the effect of FCM on the short-term left and right ventricular CMR feature tracking derived strain. This is a post hoc subanalysis of the double-blind, placebo-controlled, randomized clinical trial that enrolled 53 ambulatory patients with heart failure and left ventricular ejection fraction <50%, and iron deficiency [Myocardial-IRON trial (NCT03398681)]. Three-dimensional left and 2-dimensional right ventricular CMR tracking strain (longitudinal, circumferential, and radial) changes were evaluated before, 7 and 30 days after randomization using linear mixed-effect analysis. The median (interquartile range) age of the sample was 73 years (65-78), and 40 (75.5%) were men. At baseline, there were no significant differences in CMR feature tracking strain parameters across both treatment arms. At 7 days, the only global 3-dimensional left ventricular circumferential strain was significantly higher in the FCM treatment-arm (difference: -1.6%, P =0.001). At 30 days, and compared with placebo, global 3-dimensional left ventricular strain parameters significantly improved in those allocated to FCM treatment-arm [longitudinal (difference: -2.3%, P <0.001), circumferential (difference: -2.5%, P <0.001), and radial (difference: 4.2%, P =0.002)]. Likewise, significant improvements in global right ventricular strain parameters were found in the active arm at 30 days (longitudinal [difference: -3.3%, P =0.010], circumferential [difference: -4.5%, P <0.001], and radial [difference: 4.5%, P =0.027]). In patients with stable heart failure, left ventricular ejection fraction <50%, and iron deficiency, treatment with FCM was associated with short-term improvements in left and right ventricular function assessed by CMR feature tracking derived strain parameters. URL: ; Unique identifier: NCT03398681.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5, Prognostic signature of immune recovery status in treated HIV-positive patients

  • Yeregui, Elena|||0000-0003-2994-4219
  • Viladés, Consuelo|||0000-0002-2991-9593
  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Ceausu, Andra
  • Pacheco, Yolanda M.|||0000-0002-9451-8083
  • Veloso Esteban, Sergio|||0000-0001-7943-1169
  • Inciarte, Alexy|||0000-0003-1896-3457
  • Vidal-González, Judit
  • Peraire, Maria
  • Perpiñán, Carles|||0000-0003-2398-3276
  • Falcó, Vicenç|||0000-0001-9626-0023
  • Masip, Jenifer|||0000-0002-9233-5195
  • Alba, Verónica|||0000-0002-5925-9573
  • Vargas Laguna, Montserrat|||0000-0001-7650-0587
  • Martí, Anna
  • Reverté Calvet, Laia|||0000-0003-4690-2387
  • Mallolas Masferrer, Josep|||0000-0002-8365-141X
  • Vidal, Francesc|||0000-0002-6692-6186
  • Peraire, Joaquim|||0000-0001-7808-5479
  • Rull, Anna|||0000-0002-8907-7754
The underlying mechanisms of incomplete immune reconstitution in treated HIV-positive patients are very complex and may be multifactorial, but perturbation of chemokine secretion could play a key role in CD4 T-cell turnover. We evaluated the circulating baseline and 48-week follow-up concentrations of SDF-1/CXCL12, fractalkine/CX3CL1, MCP-1/CCL2, MIP-α/CCL3, MIP-β/CCL4 and RANTES/CCL5, and we estimated their association with CXCL12, CX3CR1, CCR2, CCL5 and CCR5 single nucleotide polymorphisms (SNPs) to investigate multiple chemokine-chemokine receptor signatures associated with immune dysregulation preceding poor immune recovery. The circulating concentrations and gene expression patterns of SDF-1/CXCL12 (CXCL12 rs1801157) and MCP-1/CCL2 (CCR2 rs1799864_814) were associated with immune recovery status. CCR2 rs1799864_814 and CCR5 rs333_814 (Δ32) determine the baseline plasma RANTES and MIP-α concentrations, respectively, in participants with poor immune response. SDF-1/CXCL12 and MCP-1/CCL2 could be considered prognostic markers of immune failure despite suppressive antiretroviral therapy. The strong linkage disequilibrium (LD) between CCR2 rs1799864_814 and CCR5 rs1800024 indicated that the alleles of each gene are inherited together more often than would be expected by chance. This work was supported by Fondo de Investigacion Sanitaria and SPANISH AIDS Research Network (ISCIII-FEDER); AGAUR and Gilead Fellowship. FV and YMP are supported by grants from the Programa de Intensificación (ISCIII) and Servicio Andaluz de Salud, respectively. JVG,EY and LR are supported by the Instituto de Salud Carlos III (ISCIII). AR is supported by Departament de Salut, Generalitat de Catalunya and by the Instituto de Salud Carlos III (ISCIII).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses

  • Chacón-Solano, Esteban|||0000-0002-5697-7625
  • León Canseco, Carlos
  • Díaz, F.
  • García-García, Francisco
  • García, Montserrat|||0000-0002-3437-3185
  • Escámez, M.J.|||0000-0002-5434-1885
  • Guerrero-Aspizua, Sara
  • Conti, C.J.
  • Mencía, None
  • Martínez Santamaría, Lucía|||0000-0002-9637-2364
  • Llames, Sara|||0000-0001-5456-1389
  • Pévida, M.
  • Carbonell-Caballero, J.
  • Puig-Butille, Joan Anton
  • Maseda Pedrero, Rocío
  • Puig, Susana|||0000-0003-1337-9745
  • Lucas, Raúl de
  • Baselga Torres, Eulàlia|||0000-0003-1086-8439
  • Larcher, Fernando
  • Dopazo, Joaquín|||0000-0003-3318-120X
  • del Río, Marcela
Background: Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three cancer-prone genodermatoses whose causal genetic mutations cannot fully explain, on their own, the array of associated phenotypic manifestations. Recent evidence highlights the role of the stromal microenvironment in the pathology of these disorders. Objectives: To investigate, by means of comparative gene expression analysis, the role played by dermal fibroblasts in the pathogenesis of RDEB, KS and XPC. Methods: We conducted RNA-Seq analysis, which included a thorough examination of the differentially expressed genes, a functional enrichment analysis and a description of affected signalling circuits. Transcriptomic data were validated at the protein level in cell cultures, serum samples and skin biopsies. Results: Interdisease comparisons against control fibroblasts revealed a unifying signature of 186 differentially expressed genes and four signalling pathways in the three genodermatoses. Remarkably, some of the uncovered expression changes suggest a synthetic fibroblast phenotype characterized by the aberrant expression of extracellular matrix (ECM) proteins. Western blot and immunofluorescence in situ analyses validated the RNA-Seq data. In addition, enzyme-linked immunosorbent assay revealed increased circulating levels of periostin in patients with RDEB. Conclusions: Our results suggest that the different causal genetic defects converge into common changes in gene expression, possibly due to injury-sensitive events. These, in turn, trigger a cascade of reactions involving abnormal ECM deposition and underexpression of antioxidant enzymes. The elucidated expression signature provides new potential biomarkers and common therapeutic targets in RDEB, XPC and KS. What's already known about this topic?. Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three genodermatoses with high predisposition to cancer development. Although their causal genetic mutations mainly affect epithelia, the dermal microenvironment likely contributes to the physiopathology of these disorders. What does this study add?. We disclose a large overlapping transcription profile between XPC, KS and RDEB fibroblasts that points towards an activated phenotype with high matrix-synthetic capacity. This common signature seems to be independent of the primary causal deficiency, but reflects an underlying derangement of the extracellular matrix via transforming growth factor-β signalling activation and oxidative state imbalance. What is the translational message?. This study broadens the current knowledge about the pathology of these diseases and highlights new targets and biomarkers for effective therapeutic intervention. It is suggested that high levels of circulating periostin could represent a potential biomarker in RDEB.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS)

  • Kuebler, Bernd|||0000-0002-4472-871X
  • Aran, Begoña|||0000-0002-5011-7755
  • Miquel-Serra, Laia|||0000-0001-8382-3341
  • Muñoz, Yolanda
  • Ars, Elisabet|||0000-0002-4118-4358
  • Bullich Vilanova, Gemma|||0000-0002-0737-4422
  • Furlano, Monica|||0000-0003-1025-3901
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Martí, Mercè|||0000-0002-1846-0043
  • Veiga, Anna|||0000-0002-0943-9904
  • Raya, Ángel|||0000-0003-2189-9775
Skin biopsies were obtained from two male patients with X-linked Alport syndrome (XLAS) with hemizygous COL4A5 mutations in exon 41 or exon 46. Dermal fibroblasts were extracted and reprogrammed by nucleofection with episomal plasmids carrying OCT3/4, SOX2, KLF4 LIN28, L-MYC and p53 shRNA. The generated induced Pluripotent Stem Cell (iPSC) lines AS-FiPS2-Ep6F-28 and AS-FiPS3-Ep6F-9 were free of genomically integrated reprogramming genes, had the specific mutations, a stable karyotype, expressed pluripotency markers and generated embryoid bodies which were differentiated towards the three germ layers in vitro. These iPSC lines offer a useful resource to study Alport syndrome pathomechanisms and drug testing.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS)

  • Kuebler, Bernd|||0000-0002-4472-871X
  • Aran, Begoña|||0000-0002-5011-7755
  • Miquel-Serra, Laia|||0000-0001-8382-3341
  • Muñoz, Yolanda
  • Ars, Elisabet|||0000-0002-4118-4358
  • Bullich Vilanova, Gemma|||0000-0002-0737-4422
  • Furlano, Monica|||0000-0003-1025-3901
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Martí, Mercè|||0000-0002-1846-0043
  • Veiga, Anna|||0000-0002-0943-9904
  • Raya, Ángel|||0000-0003-2189-9775
A skin biopsy was obtained from a 25-year-old female patient with autosomal recessive Alport syndrome (ARAS) with the homozygous COL4A3 mutation c.345delG, p.(P166Lfs*37). Dermal fibroblasts were derived and reprogrammed by nucleofection with episomal plasmids carrying OCT3/4, SOX2, KLF4 LIN28, L-MYC and p53shRNA. The generated induced Pluripotent Stem Cell (iPSC) clone AS FiPS1 Ep6F-2 was free of genomically integrated reprogramming genes, had the specific homozygous mutation, a stable karyotype, expressed pluripotency markers and generated embryoid bodies which were differentiated towards the three germ layers in vitro. This iPSC line offers a useful resource to study Alport syndrome pathomechanisms and drug testing.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GEIS-21, A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)

  • Mora, J.
  • Castañeda, A.
  • Perez-Jaume, S.
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Maradiegue, E.
  • Valverde, C.
  • Martín Broto, Javier|||0000-0001-7350-6916
  • Garcia del Muro, Xavier|||0000-0001-5571-2847
  • Cruz, O.
  • Cruz, J.
  • Martinez-Trufero, J.
  • Maurel, Joan|||0000-0002-9413-5592
  • Vaz, M.A.
  • De Álava, Enrique|||0000-0001-8400-046X
  • De Torres, C.
First Spanish trial of Ewing sarcoma (ES) including adults and children with the aim to test the efficacy of Gemcitabine and Docetaxel (G/D) in newly diagnosed high-risk (HR) patients. This was a prospective, multicentric, non-randomised, open study for patients 1/240 years with newly diagnosed ES. HR patients (metastatic, axial-pelvic primaries or bone marrow micrometastasis) received 2 window cycles of G/D. Patients with an objective response (OR) to G/D received 12 monthly cycles of G/D after completion of mP6. The primary end point was the OR rate to the G/D window phase and the event-free survival (EFS) and overall survival (OS) for all patients. The study is registered at ClinicalTrials.gov (identifier: NCT00006734).Results: Forty-three patients were enroled, median age 17 years (range, 3-40). After a median follow-up of 43.4 months, the 5-year OS rate is 55.0% (95% CI, 41-74%) with an EFS of 50.0% (95% CI, 36-68%). The 5-year OS and EFS rates for standard risk (SR) patients was 76.0% (95% CI, 57-100%) and 71.0% (CI, 54-94%); for HR 36.0% (CI, 20-65%) and 29.0% (CI, 15-56%). Twelve of 17 (70.6%) high-risk (HR) patients showed an OR (7 PR and 5 SD) to G/D window therapy. The 5-year OS rate for patients 218 years of age was 74.0% (CI, 56-97%) and 31.0% for.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Novel Role for Nanog As An Early Cancer Risk Marker in Patients with Laryngeal Precancerous Lesions

  • Rodrigo, Juan P.
  • Villaronga, M. Ángeles
  • Menéndez, Sofía T.
  • Hermida-Prado, Francisco
  • Quer, Miquel|||0000-0003-2563-6729
  • Vilaseca, Isabel|||0000-0003-4399-5522
  • Allonca, Eva|||0000-0002-2532-5421
  • Pedregal Mallo, Daniel
  • Astudillo, Aurora
  • García-Pedrero, Juana María|||0000-0002-5891-9488
NANOG is a master regulator of embryonic stem cell pluripotency, found to be frequently aberrantly expressed in a variety of cancers, including laryngeal carcinomas. This study investigates for the first time the role of NANOG expression in early stages of laryngeal tumourigenesis and its potential utility as cancer risk marker. NANOG protein expression was evaluated by immunohistochemistry using two large independent cohorts of patients with laryngeal precancerous lesions, and correlated with clinicopathological parameters and laryngeal cancer risk. NANOG expression was detected by immunohistochemistry in 49 (60%) of 82 laryngeal dysplasias, whereas expression was negligible in patient-matched normal epithelia. Strong NANOG expression was found in 22 (27%) lesions and was established as cut-off point, showing the most robust association with laryngeal cancer risk (P = 0.003) superior to the histological classification (P = 0.320) the current gold standard in the clinical practice. Similar trends were obtained using a multicenter validation cohort of 86 patients with laryngeal dysplasia. Our findings uncover a novel role for NANOG expression in laryngeal tumourigenesis, and its unprecedented application as biomarker for cancer risk assessment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome

  • Prasad, Aparna|||0000-0002-6786-2313
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Zapata Fenor, Luis|||0000-0003-4829-8363
  • Puiggros, Anna|||0000-0001-9627-4978
  • Melero, Carme
  • Puig, Anna
  • Sarria-Trujillo, Yaris|||0000-0003-2667-4372
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Garcia Muret, Maria Pilar|||0000-0003-1714-5815
  • Estrach, Teresa|||0000-0002-4601-2811
  • Servitje, Octavio|||0000-0002-9910-9617
  • Lopez-Lerma, Ingrid|||0000-0002-7690-8926
  • Gallardo, Fernando|||0000-0002-8996-3828
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Estivill, Xavier|||0000-0002-0723-2256
Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. The goal of our study was to understand the genetic basis of the disease by looking for driver gene mutations and fusion genes in 15 erythrodermic patients with circulating Sézary cells, 14 of them fulfilling the diagnostic criteria of Sézary syndrome. We have discovered genes that could be involved in the pathogenesis of Sézary syndrome. Some of the genes that are affected by somatic point mutations include ITPR1, ITPR2, DSC1, RIPK2, IL6, and RAG2, with some of them mutated in more than one patient. We observed several somatic copy number variations shared between patients, including deletions and duplications of large segments of chromosome 17. Genes with potential function in the T-cell receptor signaling pathway and tumorigenesis were disrupted in Sézary syndrome patients, for example, CBLB, RASA2, BCL7C, RAMP3, TBRG4, and DAD1. Furthermore, we discovered several fusion events of interest involving RASA2, NFKB2, BCR, FASN, ZEB1, TYK2, and SGMS1. Our work has implications for the development of potential therapeutic approaches for this aggressive disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas

  • Matas-Nadal, Clara|||0000-0001-9911-6924
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • Gatius, Sònia
  • Gomez, Xavier
  • Ribes-Santolaria, Marina
  • Guasch-Vallés, Marta
  • Pedraza, Neus
  • Casanova, Josep M.
  • De La Torre Gómez, Gisela Carolina|||0000-0001-9363-291X
  • Gari, Eloi|||0000-0002-3505-4901
  • Aguayo-Ortiz, Rafael S.
Basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (SCCs) are the most frequent types of cancer, and both originate from the keratinocyte transformation, giving rise to the group of tumors called keratinocyte carcinomas (KCs). The invasive behavior is different in each group of KC and may be influenced by their tumor microenvironment. The principal aim of the study is to characterize the protein profile of the tumor interstitial fluid (TIF) of KC to evaluate changes in the microenvironment that could be associated with their different invasive and metastatic capabilities. We obtained TIF from 27 skin biopsies and conducted a label-free quantitative proteomic analysis comparing seven BCCs, 16 SCCs, and four normal skins. A total of 2945 proteins were identified, 511 of them quantified in more than half of the samples of each tumoral type. The proteomic analysis revealed differentially expressed TIF proteins that could explain the different metastatic behavior in both KCs. In detail, the SCC samples disclosed an enrichment of proteins related to cytoskeleton, such as Stratafin and Ladinin-1. Previous studies found their upregulation positively correlated with tumor progression. Furthermore, the TIF of SCC samples was enriched with the cytokines S100A8/S100A9. These cytokines influence the metastatic output in other tumors through the activation of NF-kB signaling. According to this, we observed a significant increase in nuclear NF-kB subunit p65 in SCCs but not in BCCs. In addition, the TIF of both tumors was enriched with proteins involved in the immune response, highlighting the relevance of this process in the composition of the tumor environment. Thus, the comparison of the TIF composition of both KCs provides the discovery of a new set of differential biomarkers. Among them, secreted cytokines such as S100A9 may help explain the higher aggressiveness of SCCs, while Cornulin is a specific biomarker for BCCs. Finally, the proteomic landscape of TIF provides key information on tumor growth and metastasis, which can contribute to the identification of clinically applicable biomarkers that may be used in the diagnosis of KC, as well as therapeutic targets.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Serum DNA methylome of the colorectal cancer serrated pathway enables non-invasive detection

  • Gallardo-Gómez, María
  • Costas-Ríos, Lara
  • García-Prieto, Carlos A.|||0000-0001-5021-6916
  • Álvarez-Rodríguez, Lara
  • Bujanda, Luis|||0000-0002-4353-9968
  • Barrero, Maialen
  • Castells, Antoni|||0000-0001-8431-2033
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Jover, Rodrigo
  • Esteller, M.|||0000-0003-4490-6093
  • Tardío Baiges, Antoni
  • González-Carreró Fojón, Joaquín
  • Cubiella, Joaquín|||0000-0002-9994-4831
  • De Chiara, Loretta
The clinical relevance of the colorectal cancer serrated pathway is evident, but the screening of serrated lesions remains challenging. We aimed to characterize the serum methylome of the serrated pathway and to evaluate circulating cell-free DNA (cfDNA) methylomes as a potential source of biomarkers for the non-invasive detection of serrated lesions. We collected serum samples from individuals with serrated adenocarcinoma (SAC), traditional serrated adenomas, sessile serrated lesions, hyperplastic polyps and individuals with no colorectal findings. First, we quantified cfDNA methylation with the MethylationEPIC array. Then, we compared the methylation profiles with tissue and serum datasets. Finally, we evaluated the utility of serum cfDNA methylation biomarkers. We identified a differential methylation profile able to distinguish high-risk serrated lesions from no serrated neoplasia, showing concordance with tissue methylation from SAC and sessile serrated lesions. Serum methylation profiles are pathway-specific, clearly separating serrated lesions from conventional adenomas. The combination of ninjurin 2 (NINJ2) and glutamate-rich 1 (ERICH1) methylation discriminated high-risk serrated lesions and SAC with 91.4% sensitivity (64.4% specificity), while zinc finger protein 718 (ZNF718) methylation reported 100% sensitivity for the detection of SAC (96% specificity). This is the first study exploring the serum methylome of serrated lesions. Differential methylation of cfDNA can be used for the non-invasive detection of colorectal serrated lesions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fetal Left Ventricle Function Evaluated by Two-Dimensional Speckle-Tracking Echocardiography across Clinical Stages of Severity in Growth-Restricted Fetuses

  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Ginjaume García, Nuria|||0000-0003-0785-0115
  • Ullmo, Johana|||0000-0002-9313-917X
  • Parra Roca, Juan|||0000-0001-6011-7815
  • Vázquez Fariñas, Ana|||0000-0001-6732-1667
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
Fetal growth restriction (FGR) can result in adverse perinatal outcomes due to cardiac dysfunction. This study used 2D speckle-tracking echocardiography to assess left ventricle (LV) longitudinal strain across FGR severity stages. A prospective longitudinal cohort study measured global (GLS) and segmental LV longitudinal strain in FGR fetuses, with evaluations conducted at various time points. FGR was classified into subtypes based on published criteria using fetal weight centile and Doppler parameters. A linear mixed model was employed to analyze repeated measures and compare Z-score measurements between groups throughout gestational age. The study included 40 FGR fetuses and a total of 107 evaluations were performed: 21 from small for gestational age (SGA), 74 from the FGR stage I, and 12 from the FGR stage ≥ II. The results indicate that SGA and stage I FGR fetuses exhibit higher LV GLS than stages ≥ II. Throughout gestation, SGA and FGR stage I fetuses showed similar behavior with consistently better LV GLS values when compared to FGR stages ≥ II. No significant differences were observed in LV GLS strain behavior between SGA and FGR stage I. In conclusion, all FGRs show signs of early cardiac dysfunction, with severe cases demonstrating significantly a lower LV GLS when compared to mild cases, suggesting deterioration of cardiac dysfunction with progression of fetal compromise.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections, A Randomized Clinical Trial

  • Sojo-Dorado, Jesús
  • López-Hernández, I.
  • Rosso-Fernandez, C.
  • Palacios-Baena, Z.R.
  • Hernández-Torres, A.
  • Merino de Lucas, Esperanza|||0000-0003-3854-4874
  • Escolà-Vergé, Laura|||0000-0002-5608-3090
  • Bereciartua, Elena|||0000-0002-8603-779X
  • García-Vázquez, E.
  • Pintado, Vicente
  • Boix-Palop, Lucía|||0000-0002-4080-0008
  • Natera-Kindelán, C.
  • Sorlí, Luisa|||0000-0001-9562-514X
  • Borrell, Nuria
  • Giner-Oncina, L.
  • Amador-Prous, C.
  • Shaw, Evelyn|||0000-0002-1882-1259
  • Jover-Saenz, Alfredo|||0000-0001-5207-7200
  • Molina, J.
  • Martínez-Alvarez, R.M.
  • Dueñas, C.J.
  • Calvo-Montes, J.
  • Silva, J.T.
  • Cárdenes, M.A.
  • Lecuona, M.
  • Pomar, Virginia|||0000-0002-8473-5834
  • Valiente De Santis, L.
  • Yagüe-Guirao, G.
  • Lobo-Acosta, M.A.
  • Merino-Bohórquez, V.
  • Pascual, A.
  • Rodríguez-Baño, Jesús|||0000-0001-6732-9001
  • Almirante Gragera, Benito|||0000-0002-1189-2361
  • Mirelis, Beatriz
  • Pigrau, Carlos|||0000-0003-4232-4049
  • Viñado, Belén|||0000-0001-6212-5886
  • Puig-Asensio, Mireia|||0000-0002-0722-2218
  • Ardanuy, Carmen|||0000-0003-0225-607X
  • Pujol, Miquel|||0000-0002-6475-6208
The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected drugs may be an option. To determine whether fosfomycin is noninferior to ceftriaxone or meropenem in the targeted treatment of bacteremic urinary tract infections (bUTIs) due to MDR E coli. Design, Setting, and Participants: This multicenter, randomized, pragmatic, open clinical trial was conducted at 22 Spanish hospitals from June 2014 to December 2018. Eligible participants were adult patients with bacteremic urinary tract infections due to MDR E coli; 161 of 1578 screened patients were randomized and followed up for 60 days. Data were analyzed in May 2021. Patients were randomized 1 to 1 to receive intravenous fosfomycin disodium at 4 g every 6 hours (70 participants) or a comparator (ceftriaxone or meropenem if resistant; 73 participants) with the option to switch to oral fosfomycin trometamol for the fosfomycin group or an active oral drug or parenteral ertapenem for the comparator group after 4 days. Main Outcomes and Measures: The primary outcome was clinical and microbiological cure (CMC) 5 to 7 days after finalization of treatment; a noninferiority margin of 7% was considered. Among 143 patients in the modified intention-to-treat population (median [IQR] age, 72 [62-81] years; 73 [51.0%] women), 48 of 70 patients (68.6%) treated with fosfomycin and 57 of 73 patients (78.1%) treated with comparators reached CMC (risk difference, -9.4 percentage points; 1-sided 95% CI, -21.5 to ∞ percentage points; P =.10). While clinical or microbiological failure occurred among 10 patients (14.3%) treated with fosfomycin and 14 patients (19.7%) treated with comparators (risk difference, -5.4 percentage points; 1-sided 95% CI, -∞ to 4.9; percentage points; P =.19), an increased rate of adverse event-related discontinuations occurred with fosfomycin vs comparators (6 discontinuations [8.5%] vs 0 discontinuations; P =.006). In an exploratory analysis among a subset of 38 patients who underwent rectal colonization studies, patients treated with fosfomycin acquired a new ceftriaxone-resistant or meropenem-resistant gram-negative bacteria at a decreased rate compared with patients treated with comparators (0 of 21 patients vs 4 of 17 patients [23.5%]; 1-sided P =.01). This study found that fosfomycin did not demonstrate noninferiority to comparators as targeted treatment of bUTI from MDR E coli; this was due to an increased rate of adverse event-related discontinuations. This finding suggests that fosfomycin may be considered for selected patients with these infections. ClinicalTrials.gov Identifier: NCT02142751.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multiocular organoids from human induced pluripotent stem cells displayed retinal, corneal, and retinal pigment epithelium lineages

  • Isla-Magrané, Helena|||0000-0002-7203-3309
  • Veiga, Anna|||0000-0002-0943-9904
  • García Arumí, José|||0000-0001-8827-1160
  • Duarri, Anna|||0000-0003-4075-5478
Recently, great efforts have been made to design protocols for obtaining ocular cells from human stem cells to model diseases or for regenerative purposes. Current protocols generally focus on isolating retinal cells, retinal pigment epithelium (RPE), or corneal cells and fail to recapitulate the complexity of the tissue during eye development. Here, the generation of more advanced in vitro multiocular organoids from human induced pluripotent stem cells (hiPSCs) is demonstrated. A 2-step method was established to first obtain self-organized multizone ocular progenitor cells (mzOPCs) from 2D hiPSC cultures within three weeks. Then, after the cells were manually isolated and grown in suspension, 3D multiocular organoids were generated to model important cellular features of developing eyes. In the 2D culture, self-formed mzOPCs spanned the neuroectoderm, surface ectoderm, neural crest, and RPE, mimicking early stages of eye development. After lifting, mzOPCs developed into different 3D multiocular organoids composed of multiple cell lineages including RPE, retina, and cornea, and interactions between the different cell types and regions of the eye system were observed. Within these organoids, the retinal regions exhibited correct layering and contained all major retinal cell subtypes as well as retinal morphological cues, whereas the corneal regions closely resembled the transparent ocular-surface epithelium and contained of corneal, limbal, and conjunctival epithelial cells. The arrangement of RPE cells also formed organoids composed of polarized pigmented epithelial cells at the surface that were completely filled with collagen matrix. This approach clearly demonstrated the advantages of the combined 2D-3D construction tissue model as it provided a more ocular native-like cellular environment than that of previous models. In this complex preparations, multiocular organoids may be used to model the crosstalk between different cell types in eye development and disease. The online version contains supplementary material available at 10.1186/s13287-021-02651-9.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Fluorescein labelled cationic carbosilane dendritic systems for biological studies

  • Fuentes Paniagua, María Elena
  • Serramía Lobera, María Jesús
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
  • Álvarez, Susana
  • Muñoz Fernández, María Ángeles
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
Cationic carbosilane dendrimers and dendrons labelled with one fluorescein unit have been synthesized. For dendrimers (generations 1–3), a random procedure was followed by successive addition of two types of thiol compounds to vinyl terminated derivatives, first one with –NH3Cl and second one with –NMe2HCl functions, subsequent reaction with FITC and finally quaternization with MeI. For dendrons, the use of compounds with a –NH2 group at the focal point and –NMe2 functions at the periphery allowed us to obtain the corresponding fluoresceinated cationic derivatives. The toxicity of these dendritic molecules was studied by MTT and their interaction with siRNA Nef by electrophoresis. Finally, second generation dendrimer and their dendriplexes with siRNA Nef were chosen as a model to analyse their in vivo biodistribution in a BALB/c mouse model. The highest levels for dendriplexes were found in spleen and liver, followed in lymph nodes, while lower levels were found in kidneys. This distribution is in accordance with long circulation times., Ministerio de Economía y Empresa, Comunidad de Madrid, Ministerio de Educación y Ciencia
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Dendronized Anionic Gold Nanoparticles: Synthesis, Characterization and Antiviral Activity

  • Peña González, Cornelia Emeritina|||0000-0002-9049-8804
  • García Broncado, Pilar
  • Ottaviani, Maria Francesca
  • Cangiotti, Michela
  • Fattori, Alberto
  • Hierro Oliva, Margarita
  • González Martín, M. Luisa
  • Pérez Serrano, Jorge|||0000-0002-4870-8978
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Muñoz Fernández, María Ángeles
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
Anionic carbosilane dendrons decorated with sulfonate functions and with a thiol moiety at the focal point have been used to synthesize water soluble gold nanoparticles (AuNPs) by direct reaction of dendrons, gold precursor and reducing agent in water and also by place-exchange reaction. These nanoparticles have been characterized by nuclear magnetic resonance (NMR), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), X-ray photoelectron spectroscopy (XPS), UV, elemental analysis, and Z potential. Also, the interacting ability of the anionic sulfonate functions was investigated by electron paramagnetic resonance (EPR) using copper(II) as a probe. It was found that the different structures and conformations of the AuNPs modulate the availability of sulfonate and thiol groups to be complexed by copper(II). Toxicity assays of AuNPs showed that those produced by direct reaction were less toxic than those obtained by ligand exchange. Inhibition of HIV-1 infection was higher for dendronized AuNPs than for dendrons., Ministerio de Economía y Empresa, Comunidad de Madrid, Universidad de Alcalá